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Periods of strong electrical activity can initiate neuronal plasticity leading to 
long-lasting changes of network properties. A key event in the modification of the 
synaptic connectivity after neuronal activity is the activation of new gene 
transcription. Moreover, calcium (Ca2+) influx is crucial for transducing synaptic 
activity into gene expression through the activation of many signalling pathways. 
In our work we are interested in studying changes in electrical activity and in 
gene expression profile at the network level. In particular, we want to understand the 
interplay between neuronal and gene networks to clarify how electrical activity can 
alter the gene expression profile and how gene expression profile can modify the 
electrical and functional properties of neuronal networks. Thus, we investigated the 
neuronal network at three different levels: gene transcription profile, electrical 
activity and Ca2+ dynamics. 
Blockage of GABAA receptor by pharmacological inhibitors such as gabazine 
or bicuculline triggers synchronous bursts of spikes initiating neuronal plasticity. We 
have used this model of chemically-induced neuronal plasticity to investigate the 
modifications that occur at different network levels in rat hippocampal cultures. By 
combining multielectrode extracellular recordings and calcium imaging with DNA 
microarrays, we were able to study the concomitant changes of the gene expression 
profile, network electrical activity and Ca2+ concentration. 
First, we have investigated the time course of the electrical activity and the 
molecular events triggered by gabazine treatment. The analysis of the electrical 
activity revealed three main phases during gabazine-induced neuronal plasticity: an 
early component of synchronization (E-Sync) that appeared immediately after the 
termination of the treatment persisted for 3 hours and was blocked by inhibitors of 
the MAPK/ERK pathway; a late component (L-Sync) -from 6 to 24 hours- that was 
blocked by inhibitors of the transcription. And, an intermediate phase, from 3 to 6 
hours after the treatment, in which the evoke response was maximally potentiated. 
Moreover, gabazine exposure initiated significant changes of gene expression; the 
genomic analysis identified three clusters of genes that displayed a characteristic 
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temporal profile. An early rise of transcription factors (Cluster 1), which were 
maximally up-regulated at 1.5 hours. More than 200 genes, many of which known to 
be involved in LTP were maximally up-regulated in the following 2-3 hours (Cluster 
2) and then were down-regulated at 24 hours. Among these genes, we have found 
several genes coding for K+ channels and the HNC1 channels. Finally, genes 
involved in cellular homeostasis were up-regulated at longer time (Cluster 3). 
Therefore, this approach allows relating changes of electrical properties occurring 
during neuronal plasticity to specific molecular events.    
 Second, we have investigated which sources of Ca2+ entry were involved in 
mediating the new gene transcription activated in response to bursting activity. Using 
Ca2+ imaging, a detailed characterization of Ca2+ contributions was performed to 
allow investigating which sources of Ca2+ entry could be relevant to induce gene 
transcription. At the same time, changes of gene expression were specifically 
investigated blocking NMDA receptors and L-, N- and P/Q-type VGCCs. Therefore, 
the analysis of the Ca2+ contribution and gene expression changes revealed that the 
NMDA receptors and the VGCCs specifically induced different groups of genes.  
Thus, the combination of genome-wide analysis, MEA technology and calcium 
imaging offers an attractive strategy to study the molecular events underlying long-
term synaptic modification.  
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2.1 EXPERIENCE CAN ALTER NEURAL CIRCUITRY 
 
Sensory experience and the subsequent synaptic activity within the brain 
modify the neural circuits. Sensory organs transduce physical or chemical stimuli that 
change the membrane potential which, in this case, can be integrated to produce an 
action potential. The precise pattern of neuronal activity, in terms of spatial and 
temporal characteristics, that a sensory stimulus elicits is thought to regulate specific 
changes in the structure and function of the nervous system (Fig. 1). 
 
 
 
 
Fig.1: A dynamic model of the molecular, cellular, and systems interactions involved in the establishment and 
maintenance of memory. Neuronal activation driven by external inputs (e.g, sensory experience) and intrinsic brain network 
activity (information of the internal state of the organism) activate second messenger systems in brain neurons which modify the 
gene expression profiling (transcriptome) and the subsequent protein network. These changes occur via rapid post-translational 
modification (PTM) of pre-existing proteins and through alterations in gene expression (via regulated transcription and 
translation). Modifications of the protein interactome alter functional properties of neurons within an ensemble to entrain them 
into a representation encoding a discrete experience. (Modified from Miyashita, 2007). 
 
 
Synaptic activity leads to membrane depolarization and to Ca2+ influx in 
neurons. This action then triggers a wide variety of cellular changes within these 
neurons, which are capable of altering the synaptic connectivity of the circuit. To 
determine which are the cellular mechanisms that underlie these events, has been the 
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subject of several investigations in recent years. One hypothesis is that neuronal 
activity may lead to long-lasting changes in neuronal structure and function by 
regulating the expression of specific genes and proteins. With this theory in mind, 
over two decades ago, it was shown that the activation of an ion channel could lead 
rapidly to the expression of a gene (Greenberg et al., 1986). 
In the rapid coupling of ion channel activation and gene transcription, Ca2+ has 
a pivotal role. Calcium can activate several Ca2+-sensitive signalling pathways, which 
lead to post-translation modification of proteins or translation of pre-existing mRNA 
(Malinow and Malenka, 2002; Sutton and Schuman, 2006). In addition to these local 
effects, Ca2+ entry into the postsynaptic neuron can alter cellular function by 
activating new gene transcription (Bito et al., 1997). Calcium influx activates a 
number of signalling pathways that converge on transcription factors within the 
nucleus; these transcription factors, in turn, control the expression of a large number 
of neuronal activity-regulated genes that alter the structure and function of the cell. 
Several works have revealed a number of signalling pathways that mediate activity-
dependent transcription (for reviews see Ghosh and Greenberg, 1995; Rosen et al., 
1995; Bradley and Finkbeiner, 2002).  
 
Considered all together these features give special relevance to the functional 
connections among neuronal activity, Ca2+ influx and gene expression; and these 
three main topics will be discussed in the present introduction. 
 
The nervous system has the unique ability to shape and reshape itself in long 
lasting manners after brief sensory stimulation. Specifically, a large number of 
studies have provided evidence that neuronal activity plays a critical role in different 
cellular functions: i) dendrites outgrowth, ii) synaptic maturation or elimination, and 
iii) synaptic plasticity. 
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2.1.1 Dendrites Outgrowth 
 
Environmental stimuli can alter dendrites outgrowth. Dendrites commonly 
sprout new branches and extend or retract existing branches. Blockade of N-methyl-
D-aspartate (NMDA) subtype of glutamate receptors slows both new dendritic 
branch addition and branch extension (Rajan and Cline, 1998). Additional in vitro 
data (Redmond et al., 2002) suggested that synaptic activity promotes dendrites 
outgrowth. These cellular modifications are mediated by Ca2+ via new gene 
transcription. In fact, in this study the authors have demonstrated that in cortical slice 
cultures, dendritic growth is attenuated by inhibitors of voltage gated calcium 
channels (VGCCs) and by dominant negative of cyclic adenosine monophosphate 
(cAMP) response element binding protein (CREB). 
 
2.1.2 Synapse Maturation/Elimination 
 
Synapses form on the dendrites and undergo extensive maturation. For 
example, this maturation involves arborisation of the axon at the presynaptic site of 
neuromuscular junction (Sanes and Lichtman, 1999), whereas on the postsynaptic 
site, maturation can be detected as an increase in synaptic current (Chen and Regehr, 
2000). In addition to synapse maturation, also synapse elimination can occur. In fact, 
after synaptic activity an excess of synapses are formed but only a subset of these 
synapses is strengthened while the others are eliminated. Synaptic activity has an 
important role in mediating both synapse maturation and elimination (Colman et al., 
1997; Chen and Regehr, 2000).  
 
2.1.3 Synaptic Plasticity 
 
Experience can alter synaptic connectivity and synaptic efficacy in adults, in 
fact this is how the information is thought to be stored in the brain. Studies of 
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associative learning give significant evidence in the experience-dependent memory 
formation. An example is the Pavlovian fear conditioning paradigm, in which an 
electrical shock to the foot is administered to an animal shortly after an auditory tone 
is presented. After several repetitions, the animal learns that the tone and the shock 
are paired. So, they display a fear response when the tone is presented even in the 
absence of the electrical shock. Recordings from the dorsolateral nucleus of 
amygdala, which receives direct inputs from the auditory system, demonstrated that 
these neurons had an increased firing rate in response to the tone after the paradigm 
had occurred (Maren and Quirk, 2004). This is a clear example of how, in adult 
animals, experience can trigger a memory and influence the behaviour, by modifying 
the synaptic efficiency of neurons.  
A very useful experimental model called long-term potentiation (LTP) has 
given the opportunity to investigate which are the molecular and cellular mechanisms 
that underlie these changes. This model demonstrated that the activity-dependent 
plasticity is a fundamental property of the nervous system and it is at the basis of the 
formation and consolidation of memory and learning (Bliss and Collingridge, 1993). 
 
 
2.2 MODELS OF ACTIVITY-DEPENDENT SYNAPTIC PLASTICITY 
 
2.2.1 Long-Term Potentiation 
 
In the late 1940s Hebb and Konorsky proposed a rule to produce synapse 
potentiation: the synapse linking two cells is strengthened if the cells are active at the 
same time. The first example of such synapse that was identified in the mammalian 
brain was the excitatory connection made by perforant path fibres onto granule cells 
of the hippocampus. In 1973 Bliss et al. described a model in which brief trains of 
high-frequency stimulation to monosynaptic excitatory pathways in the hippocampus 
caused an increase in the efficacy of synaptic transmission.  
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This model has been called long-term potentiation (LTP). In the last decades, 
LTP of synaptic transmission has become the primary experimental model of 
activity-dependent synaptic plasticity in the mammalian brain. Using this model, the 
mechanisms underlying its induction and expression were then investigated in order 
to elucidate the synaptic basis of memory and learning (Bliss and Collingridge, 
1993). In fact, hippocampal LTP and processes like memory and learning were 
compared and several similarities were discovered. These new findings included: 
rapid induction, synaptic potentiation by repetition of the stimulus, long-lasting 
persistence, dependence on NMDA receptors in most protocols of induction and 
correlation of LTP decay with the time course of normal forgetting (Otto et al., 1991; 
Whitlock et al., 2006; Pastalkova et al., 2006).  
LTP is characterized by a persistent increase in the size of the synaptic 
component of the evoked response, for many hours in the in vitro hippocampal slice 
preparation, and for days or months in freely moving animals (in vivo models). 
Although LTP depends on the cell type, developmental stage and induction protocol, 
it has also been established that LTP has distinct temporal phases (Abraham, 2003). 
The first nomenclature created by Racine et al. in 1983 divided LTP in an early phase 
(E-LTP) and in a late phase (L-LTP). The early phase, beginning immediately after 
stimulation and lasting for 1 to 3 hours, was induced by a single high-frequency train 
and did not require protein synthesis. The late phase was long-lasting (more than 3 
hours), was induced by three or more high-frequency trains and was dependent on 
protein synthesis (Racine et al., 1983). During the past two decades, significant 
evidence supporting a more precise categorization method has been produced. 
Abraham and Otani analysed the LTP decay in the dentate gyrus (DG) in vivo. They 
observed three discrete groups of LTP-decay time constants that had been defined in 
order of persistence, as LTP1, LTP2 and LTP3. LTP1 was induced by a weak 
stimulus protocol and was rapidly decaying, LTP2 was at an intermediate phase of 
LTP, and LTP3 was defined as the most persistent form of LTP (Otani and Abraham, 
1989). 
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Considerable efforts have been made to understand the biochemical pathways 
that underlie these forms of LTP and, although differences can still be found in 
literature, three broad mechanisms are clearly involved in the different forms of LTP: 
post-translational modification of pre-existing proteins, translation of pre-existing 
messenger RNA (mRNA) and new gene transcription. Calcium entry through 
different channels, such as the NMDA receptors and the VGCCs plays a major role in 
these mechanisms.  
It has been established that post-translational modifications, primarily 
phosphorylation, are important mechanisms in LTP induction. The two most 
common protein kinases implicated in the early phase of LTP are the serine/threonine 
kinases, Ca2+/calmodulin-dependent kinase II (CaMKII) and protein kinase C (PKC) 
(Bliss and Collingridge, 1993). The time window of activity of both these kinases and 
the relative contribution to different phases of LTP is currently a matter of debate 
(Lisman et al., 2002; Reymann and Frey, 2007). Although CaMKII is involved in 
multiple forms of the NMDA receptor dependent LTP (Lisman et al., 2002), the 
current hypothesis is that this component is the primary effector of LTP1. There are 
also other kinases that seem to be important for supporting long-lasting LTP. The 
extracellular signal-regulated kinase (ERK)–mitogen-activated protein kinase 
(MAPK) pathway has recently become the subject of important LTP studies (Thomas 
and Huganir, 2004). Even though it seems to be meaningful for long-lasting form of 
LTP (Rosenblum et al., 2002), Sweatt proposed a model in which ERK plays a role 
during both early and late phases of LTP. According to this model, ERK seems to 
modulate E-LTP by regulating voltage-gated potassium channels, and triggers L-LTP 
by regulating CREB phosphorylation and subsequent gene expression (Sweatt, 2001). 
In addition to post-translational modification of existing proteins it is also evident 
that protein synthesis is equally necessary for LTP. Recent works demonstrated that 
this new protein synthesis does not dependent on gene transcription. So, protein 
translation must be performed from pre-existing mRNAs present in the dendrites of 
most neurons (Sutton and Schuman, 2005). 
 11 
Finally, in 1994 Nguyen et al. demonstrated that the LTP3 or L-LTP depended 
on new gene transcription and that it was necessary to have a critical time window for 
this event. They used rat hippocampal slices stimulated with three stimulation trains 
to induce a long-lasting LTP. To assay the involvement of transcription in L-LTP, 
they applied for two hours - immediately after LTP induction - two inhibitors of 
transcription, actinomycin D (Act D) and 5,6-dichloro-1--D-ribofuranosyl 
benzimidazole (DRB) which have distinct mechanisms of action. So, they found that 
these treatments blocked the induction of L-LTP. Moreover, if the application of the 
inhibitors was delayed 2 hours after the stimulus, there was no blockade of L-LTP 
induction, indicating a critical period for gene transcription (Nguyen et al., 1994).  
Thus, there are three main mechanisms underlying different forms of LTP: i) 
post-translational modification (LTP1), ii) dendritic protein synthesis (LTP2) and iii) 
new gene transcription (LTP3).  
 
2.2.2 Chemically-Induced Long-Term Potentiation 
 
The induction of LTP, as described above, is usually performed by stimulating 
with brief high-frequency trains a group of axons that converge towards a target 
neuron. In this way the stimulation is highly localized and only a small number of 
synapses are potentiated. Moreover, the stimulated synapses are randomly distributed 
along the dendritic tree and cannot be easily identified. Therefore, in order to study 
the electrical and transcriptional modification at the network level, it would be 
necessary to have a model in which the majority of the synapses undergo to plasticity 
changes. For this reason, there has been considerable interest in inducing LTP 
following different protocols. In particular, chemical protocols for inducing LTP 
(cLTP) also exist and have become popular (Ben Ari and Gho, 1988; Ben Ari and 
Represa, 1990; Fleck et al., 1992; Kang and Schuman, 1995; Abegg et al., 2004; 
Otmakhov et al., 2004). 
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Inducing LTP by chemical rather than electrical protocol is advantageous for 
several reasons. First, a chemical stimulation that activates directly a biochemical 
process inducing potentiation can indicate a specific involvement of that process in 
LTP. Second, cLTP ensures potentiation of a large fraction of synapses in the cells 
cultured. Several protocols are reported to induce synaptic potentiation by bath-
application of different chemicals, such as brain-derived neurotrophic factor (BDNF) 
(Kang and Schuman, 1995), forskolin (Otmakhov et al., 2004), potassium (K+) (Fleck 
et al., 1992) and bicuculline (BIC) (Debanne et al., 2006). 
The neurotrophins are a group of signalling molecules and are important for the 
regulation of neuronal survival and differentiation. Moreover, they participate in 
synaptic plasticity (for review, see Reichardt, 2006). These characteristics indicate 
that they could be involved in regulate synaptic strength in the adult brain. Kang and 
Schuman applied BDNF and neurotrophic factor 3 (NT-3) extracellularly for 30 min 
in hippocampal slices from young adult rats and they observed a rapid enhancement 
of the excitatory synaptic transmission which persisted for two hours. The rapid onset 
and the long-lasting duration of the neurotrophin-induced potentiation were similar to 
those observed during LTP induced by high-frequency stimulation. Hence, the 
authors tested the ability of each form of potentiation to occlude subsequent 
induction of the other form, in order to understand whether the neurotrophin-induced 
potentiation shared common cellular mechanisms with synaptically induced LTP. 
They found that both protocols did not occlude the induction of potentiation induced 
by the other form. Thus, these data suggested that these two forms of synaptic 
enhancement may involve at least partially independent cellular mechanisms (Kang 
and Schuman, 1995). 
A frequently used method for inducing cLTP utilizes a bath application of 
agents that raise cAMP levels (Frey et al., 1993; Bolshakov et al., 1997; Patterson et 
al., 2001; Otmakhov et al., 2004). For example, a combination of forskolin, an 
adenylyl cyclase activator, and rolipram, a phosphodiesterase inhibitor, in the 
presence of low magnesium (Mg2+), is able to induced cLTP in hippocampal slices 
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from adult rats, where this cLTP is NMDA receptor-dependent (Otmakhov et al., 
2004).  
The models of cLTP described above are very useful because not only do they 
allow the potentiation of the large majority of the synapses in the cells cultured but 
they also provide important insights into the molecular mechanisms underlying LTP.  
Also bursting activity (epileptiform activity) has been shown to induce long-
lasting potentiation of excitatory synapses in the hippocampus (Ben Ari and Gho, 
1988; Fleck et al., 1992; Morgan and Teyler, 2001; Abegg et al., 2004; Debanne et 
al., 2006). The bursting activity can be chemically induced by elevating K+ to 
increase excitation or by applying -aminobutyric acid (GABA)A-receptor 
antagonists, like bicuculline, to decrease inhibition. For example, the experiments of 
Morgan and Teyler were performed on hippocampal slices from adult rats treated for 
10 min with an elevated K+ concentration. They confirmed that after washout of 
elevated K+ the evoked response increased, resulting in LTP and they also 
demonstrated that this form of LTP consisted of two components mediated by both 
NMDA receptor and L-type VGCCs as well as for classical LTP (Morgan and 
Teyler, 2001). 
 
2.2.3 GABAA Receptors Inhibition: A Model of Synaptic Plasticity 
 
A prolonged period (3 min to 15 h) of bursting activity is able to induced 
potentiation at the excitatory synapses in hippocampal slices (Abegg et al., 2004; 
Debanne et al., 2006). The bursting activity can be initiated decreasing the inhibition 
by application of a GABAA receptors antagonist such as bicuculline or gabazine 
(GBZ). When organotypic hippocampal slices were treated with bicuculline, 
synchronous bursts of network activity were induced (Abegg et al., 2004). In the 
experiments of Abegg et al. (2004), simultaneous recordings of field potential in the 
CA3 region (presynaptic activity) and the membrane potential of a CA1 pyramidal 
cell (postsynaptic activity) revealed that during bursting pre- and postsynaptic cells 
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are activated concomitantly. They observed that an overnight of incubation with 
bicuculline led to an NMDA receptor-dependent activation of silent synapses and a 
potentiation of functional synapses. In addition, they checked the possibility to 
induce LTP with a conventional stimulation protocol in slices treated with 
bicuculline. Their results showed that synapses that were strengthened by 
bicuculline-treatment cannot be further potentiated. On the other hand, the induction 
of long-term depression (LTD) was enhanced. Furthermore, Debanne et al. (2006) 
reported that even a brief (<3 min) exposure of rat hippocampal slices to bicuculline, 
can induce reversible, long-lasting potentiation of glutamatergic transmission at 
CA3-CA1 and at CA3-CA3 pyramidal cell synapses. They demonstrated that this 
potentiation, as classical LTP, depended on NMDA receptor activation. In fact, 
application of bicuculline in the presence of the NMDA receptor antagonist d-2-
amino-5-phosphonopentanoic acid (D-AP5) blocked the synaptic potentiation 
(Debanne et al., 2006). 
Moreover, bursting-induced potentiation shares several characteristics with 
conventional LTP. First, Hebbian conditions for LTP induction are established during 
bursting, i.e. pre- and postsynaptic cells are activated simultaneously. Second, burst-
induced potentiation of synaptic transmission is blocked in a reversible manner by 
NMDA-receptor antagonist, like conventional LTP. Third, bursting-induced 
potentiation occludes induction of LTP with standard pairing protocol and like LTP it 
could be reversed by low-frequency stimulation. Therefore, it is conceivable that 
bursting-induced synaptic potentiation and LTP share a common expression 
mechanism. Moreover, this system is able to potentiate a large fraction, virtually all, 
of the synapses in the cells cultured. This allows the investigation of the response at 
the network level.  
Furthermore, Arnold et al. (2005) developed a cell culture system to study 
neuronal plasticity. They described a model to induce synaptic plasticity in 
dissociated hippocampal cultures applying bicuculline for 15 min. They observed 
that, like in hippocampal slices, bicuculline induced an increase in synaptic efficacy 
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and a change in network activity from uncoordinated firing (lacking any recognizable 
pattern) to a highly organized, periodic and synchronized firing. These changes in the 
network activity persisted for several days after bicuculline washout. This form of 
plasticity depended on NDMA receptors and for the long-lasting expression required 
new gene transcription (Arnold et al., 2005). Thus, this could be a useful model to 
study the changes and the mechanisms underlying synaptic plasticity.  
Starting from these considerations we decided to study at larger scale changes 
that occur in network activity and in gene expression profiling after induction of this 
form of synaptic plasticity. In our model we used dissociated hippocampal cultures 
grown on the multielectrode arrays (MEAs) and treated for 30 min with gabazine as 
GABAA receptor inhibitor, to induce synchronous bursts. Although bicuculline is 
generally used in a variety of experimental models, we preferred to use gabazine 
because it is well known that bicuculline also blocks the afterhyperpolarizing current 
(IAHP) (Debarbieux et al., 1998). 
Dissociated hippocampal neurons are a useful model to study network 
properties. Although cultured neuronal networks developed in vitro lack the 
functional cytoarchitecture from the region where the cells were dissociated and can 
be considered as random networks, they retain many features and characteristics of 
physiological networks (Potter, 2001; Marom and Eytan, 2005). In fact, the primary 
neuronal cultures from hippocampus have been extensively used as a model of 
synaptogenesis, in which the electrical activity is dependent on the connectivity of 
the neurons, rather than the properties of individual cells (Siebler et al., 1993). In 
addition, results obtained from work in our lab using in vitro random networks of rat 
hippocampal neurons, demonstrated that these networks could perform some basic 
image processing operations (Ruaro et al., 2005). All together, these results (Ruaro et 
al., 2005; Marom and Eytan, 2005) indicate that random networks are capable of 
some form of learning and can be used to investigate their mechanisms of induction 
and maintenance.  
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In order to investigate the network functions, it is essential to measure 
simultaneously the activity of a large number of neurons. In the last two decades, 
great efforts were made to develop planar multielectrode arrays (MEAs). MEAs are 
petri dishes with embedded electrodes that allow simultaneous recording from, and 
stimulation of, a large number of neurons for a long period of time, ranging from 
hours up to a month, thanks to their non-invasive extracellular electrodes (Pine, 1980; 
Nisch et al., 1994; Potter, 2001). 
 
2.3 CALCIUM: A MOLECULE FOR SIGNALLING 
 
The acquisition and consolidation of new information is achieved through 
activity-dependent, and sustained, modification of synaptic strength. Activity at 
synapses must therefore be communicated to the nucleus and newly synthesized 
proteins must play a role in modification of synaptic strength. In their pioneering 
paper on excitation-transcription coupling, Morgan and Curran put forward a 
hypothesis on how Ca2+ entry through L-type VGCCs might activate espression of c-
fos, an immediate early gene (IEG) (Morgan and Curran, 1986). They suggested that 
a calmodulin (CaM)-sensitive kinase would phosphorylate a transcription factor that 
activates gene expression.  
Calcium binding to proteins triggers changes in shape and charge, two features 
that govern protein function. The abilities of Ca2+ to alter local electrostatic fields and 
protein conformation are the two universal tools of signal transduction. A very steep 
gradient of Ca2+, over four orders of magnitude, exists across the plasma membrane 
of all eukaryotic cells. Cytosolic free Ca2+ is maintained roughly at 100 nM while 
extracellularly the Ca2+ concentration is over 1 mM. This gradient is maintained 
thanks to the action of plasma membrane Ca2+-ATPases (PMCA) and Na+/ Ca2+ 
exchangers (NCX). In addition, to exert control over cytoplasmic Ca2+ concentration, 
cells chelate and compartmentalize it in the endoplasmic reticulum. Hundreds of 
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cellular proteins act by binding Ca2+, in some cases simply to buffer or lower Ca2+ 
levels, and in others to trigger cellular processes.  
Calcium is an ubiquitous intracellular messenger, controlling a diverse range of 
cellular processes, such as gene transcription, muscle contraction, cell proliferation 
and cell survival or apoptosis. It shows the versatility of a simple ion in playing a 
pivotal role in cell biology results from its spatial and temporal properties (Berridge 
et al., 2000). The spatial properties refer to the subcellular location of the Ca2+ influx 
(microdomain) (Rizzuto and Pozzan, 2006); the temporal properties are defined by 
the amplitude, kinetics or frequency of the Ca2+ signal (Gu and Spitzer, 1995).  
The term Ca2+ microdomain is generally used, referring to all the increases in 
cellular Ca2+ that do not involve the generality of the cell cytoplasm, but remain 
localized in a part of the cell (Rizzuto and Pozzan, 2006). The definition of Ca2+ 
microdomain appeared in the 1970s and 1980s to explain results otherwise 
uninterpretable, but still without a solid experimental support. In fact some 
observations, such as the high Ca2+ buffering capacity of the cytoplasm, the very low 
Ca2+ diffusion rate, 10–50 m2/s (Allbritton et al., 1992), the existence of highly 
organized subcellular structures and the clustering of Ca2+ channels (both of the 
plasma membrane and of organelles) in discrete membrane domains, were ideal to 
describe transient (or even prolonged) local elevations of Ca2+. Only in the late 1980s 
when fluorescent Ca2+ indicators became widely available, localized Ca2+ signals 
within the cytoplasm of living cells were finally measured. One of the first direct 
measurements of a localized Ca2+ increase was reported in 1988: a subplasma 
membrane Ca2+ increase (in the cell body and growth cones) activated in sympathetic 
neurons by membrane potential depolarization or Ca2+ mobilization from intracellular 
stores (Lipscombe et al., 1988a; Lipscombe et al., 1988b). Then, the existence, 
amplitude, and functional role of Ca2+ microdomains became the subject of intense 
investigation over the last decades concerning their role in neurotransmitter release 
(Neher, 1998) and gene expression induction (Dolmetsch et al., 2001; Hardingham et 
al., 2001; Mellstrom and Naranjo, 2001). 
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Fig. 2: Neuronal Ca2+ domains are responsible for carrying out a large number of highly localized neuronal functions. 
(1) In the case of spiny dendrites, those spines that are stimulated by a synaptic input (yellow arrows) create a microdomain of 
Ca2+ responsible for the input-specific synaptic plasticity that underlies learning and memory. The microdomain is created by 
either entry channels, internal release channels or a combination of the two. (2) Similar Ca2+ microdomains are found in aspiny 
dendrites where they are formed by the brief opening of AMPA receptors (AMPARs). (3) The opening of L-type Ca2+ channels 
on the soma create microdomains responsible for activating both the cyclic AMP and MAP kinase signalling pathways to create 
signals that travel into the nucleus to activate gene transcription. (4) In the case of hippocampal mossy fibres, there are a large 
number of boutons where transmitter release is triggered by the spontaneous release of Ca2+ by RYR2 on the endoplasmic 
reticulum (ER). (5) At synaptic endings, release of transmitter can be triggered by either the entry of external Ca2+ or the release 
of internal Ca2+. The classical mechanism depends on the opening of P/Q channels associated with the exocytotic apparatus on 
synaptic vesicles to create a local microdomain responsible for triggering exocytosis. A specialized mechanism based on 
syntillas produced by RYR1s that are activated by L-type channels in the plasma membrane as described in hypothalamic 
neurons. (From Berridge MJ 2006). 
 
 
Calcium microdomains can initially arise as a consequence of Ca2+ influx 
through plasma membrane voltage- and neurotransmitter-activated Ca2+ channels or 
through store-operated Ca2+ channels; activation of Ca2+ release channels present in 
intracellular stores can also generate Ca2+ microdomains (for review, see Berridge, 
2006) (Fig.2). The different outcomes will be the consequences of the action of a 
wide range of Ca2+ sensor proteins, located close to the route of Ca2+ entry, which in 
turn transduce the Ca2+ signals into specific changes in cellular function (Dolmetsch 
et al., 2001; Hardingham et al., 2001; Calin-Jageman and Lee, 2008).  
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Then, Ca2+ influx is essential for synapse-to-nucleus signalling enabling 
information contained in fast electrical activity at the synapse to be transduced into 
long-lasting changes (West et al., 2001). Among the Ca2+-regulated processes critical 
for long-term structural and functional modification of neurons, are changes of gene 
expression (Morgan and Curran, 1986; Ginty et al., 1992). Therefore, a major aim in 
the field has been to identify the mechanisms by which Ca2+ entry - through specific 
ion channels -regulates gene expression in order to produce a specific response for 
long-term synaptic modification.  
 
In the following sections of this introduction I will discuss the possible routes 
of Ca2+ entry and their role in gene expression changes, including the signalling 
pathways involved in the transduction of the electrical signal in a transcriptional 
response. 
 
2.4 ROUTES OF CALCIUM ENTRY 
 
Research from many laboratories has shown that Ca2+ influx through ion 
channels can regulate gene expression by multiple and diverse mechanisms. There 
are four primary routes of calcium entry into the cytoplasm of the postsynaptic 
neuron: extracellular calcium can enter 1) through the ligand-gated ion channels of 
the NMDA and 2) a-amino-3-hydroxy-5-methyl-4-isoxazolepropionate- type 
(AMPA) (Jonas and Burnashev, 1995) glutamate receptors, 3) through VGCCs, or 4) 
calcium can be released from intracellular stores (Berridge, 1998). The different 
molecular nature of these channels, their subcellular distribution and their regulation 
are the key components of the generation of subplasma membrane Ca2+ signalling to 
the nucleus. 
The state of the art tells us that there are two main routes of Ca2+ entry involved 
in inducing gene transcription: the NMDA receptors and the VGCCs. 
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NMDA receptor gating is dependent on the binding of glutamate as the agonist, 
glycine as a co-agonist, and depolarization to a membrane potential of-50 mV or 
more to release the Mg2+ that blocks the channel. NMDA receptor channels have a 
high permeability to Ca2+ compared to other glutamate receptors and their 
activation/deactivation kinetics are slow. In the central nervous system (CNS), 
NMDA receptors are predominantly localized to the postsynaptic region of the 
dendrites (Benke et al., 1993). It is well established that the Ca2+ influx through 
NMDA receptors plays a critical role in the neuronal survival and refinement of 
neuronal connections during brain development, as well as in the synaptic plasticity 
underlying learning and memory (Bliss and Collingridge, 1993; Hardingham and 
Bading, 2002).  
Voltage-gated Ca2+ channels mediate Ca2+ entry into cells in response to 
membrane depolarization. Electrophysiological studies revealed different Ca2+ 
currents: the L-type currents are distinguished by high voltage threshold of 
activation, slow inactivation, and large single-channel conductance, which make 
them ideal for passing the large amount of Ca2+ necessary to increase the Ca2+ 
concentration within the cytoplasm and the nucleus. The N-, P/Q- and R-type 
currents are distinguished by their intermediate threshold of activation and an 
inactivation faster than L-type currents. Finally, the T-type currents are characterized 
by fast activation and inactivation and the lowest threshold of activation (for review 
on VGCCs, see Catterall, 2000). All major types of VGCCs are present in dendritic 
arborization of CA1 hippocampal pyramidal neurons (Bloodgood and Sabatini, 
2007). Immunohistochemical studies of the distribution of different isoforms of alpha 
subunits (i.e. the pore forming subunit) constituting VGCCs in rat hippocampal 
neurons have shown that T and R-types are mainly expressed in the dendrites while 
L, N and P/Q -types are primarily expressed in the soma or proximal dendrites 
(Westenbroek et al., 1990; Westenbroek et al., 1992; McKay et al., 2006; Vinet and 
Sik, 2006).  
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Activation of NMDA receptors induces the transcription of many immediate-
early genes in cultured hippocampal neurons (Cole et al., 1989; Bading et al., 1995). 
Among the VGCCs, Ca2+ influx through the L-type has been extensively studied as 
mediator of changes in gene expression. In fact, activation of L-type VGCCs has 
been coupled to gene expression in the cell line pheochromocytoma 12 (PC12), in 
primary neuron cultures from the cortex, hippocampus, striatum, and cerebellum, as 
well as neurons within hippocampal and cortical slides (Greenberg et al., 1986; 
Murphy et al., 1991; Lerea et al., 1992; Bading et al., 1993; Impey et al., 1996; Tao et 
al., 1998). Besides the involvement of L-type VGCCs in gene transcription, also P/Q-
type VGCCs are shown to be involved in the induction of syntaxin-1A (Sutton et al., 
1999). By contrast, little is known about the regulation of gene expression by Ca2+ 
channels such as the inositol-1,4,5 trisphosphate receptors (IP3-R) and the ryanodine 
receptors (RyR) that release Ca2+ from intracellular stores. 
An important feature of the Ca2+ signalling is the specificity. Since neurons are 
constantly exposed to a variety of extracellular stimuli that can affect cell vitality, 
morphology and synaptic connectivity, the response to such stimuli has to be 
specific. So neurons activate specific genes, which in turn produce proteins that alter 
the structure and function of the cell. 
Over the past decade, studies of Ca2+-dependent gene expression in a number of 
cell types have demonstrated that Ca2+ influx may produce specific responses in the 
nucleus. For example in B-lymphocytes the amplitude of the Ca2+ rise controls 
specific patterns of gene expression (Dolmetsch et al., 1997), whereas different 
frequencies of Ca2+ oscillations in T-lymphocytes were demonstrated to induce the 
expression of different genes (Dolmetsch et al., 1998). The frequency of spontaneous 
Ca2+ transients was also shown to be essential for the expression of certain genes in 
embryonic spinal neurons (Watt et al., 2000). Experiments using neurons of the CNS 
have revealed that the temporal profile of increases in Ca2+ may induce specific 
nuclear responses. As well as Ca2+ temporal profile, also the spatial profile is critical 
for the production of a specific response. Various studies have demonstrated that 
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Ca2+ influx through different types of Ca2+ channel activates different biochemical 
processes that trigger distinct patterns of gene expression (Bading et al., 1993; Gallin 
and Greenberg, 1995; Finkbeiner and Greenberg, 1998; Dolmetsch et al., 2001). 
Bading et al. (1993) demonstrated in primary hippocampal cultures that NMDA 
receptors and L-type VGCCs transmit signals to the nucleus and regulate gene 
transcription through two distinct Ca2+ signalling pathways. In fact, they observed 
that the relative induction of c-fos gene by selective stimulation of NMDA receptors 
and L-type VGCCs, was dependent on different enhancer elements within the 
promoter of the gene. The c-fos promoter contains two well-characterized enhancer 
elements, the serum-response element (SRE) and the cyclic adenosine 
monophosphate response element (CRE). In their experiments, hippocampal neurons 
were transfected with plasmids that contained mutations in each of these enhancer 
elements and consequently stimulated while blocking selectively one of the two 
channels. In this way the authors showed that L-type VGCCs can activate c-fos 
through either SRE or CRE whereas NMDA receptors only activate c-fos through 
SRE. Moreover, also the transcription of Bdnf gene is preferentially driven by Ca2+ 
influx through L-type VGCCs, whereas it is weakly induced by NMDA receptors 
activation (Ghosh et al., 1994). Specific Ca2+ channel-dependent gene expression was 
also demonstrated by Sutton et al. (1999), who found that transfection of HEK293 
cells with P/Q-type VGCCs but not with L-, N- and T-type induced transcription of 
syntaxin-1A. Furthermore, Dolmetsch et al. (2001) using primary cortical neurons 
demonstrated that, even though after stimulation with high K+, the global increase in 
Ca2+ concentration was the same in the presence of L-type VGCC blockers as in the 
presence of N- and P/Q-type VGCC blockers, L-type VGCC blockers completely 
blocked CREB-dependent reporter gene expression whereas N- and P/Q-type VGCC 
blockers did not. 
 
All these observations support the idea that Ca2+ influx through different types 
of Ca2+ channels can direct the transcription of different genes, and control different 
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programs of gene transcription. More than ten years ago, the Bading group, after the 
observations raised about the distinct regulation of gene expression by NMDA 
receptors and L-type VGCCs, discussed some hypothesis about how Ca2+ influx 
through different channels could be specific for different transcriptional responses. 
They hypothesized that it may depend on the availability of a particular mechanism 
for signal processing at the site of Ca2+ entry; or it may depend on the different 
concentration thresholds of Ca2+ that differ locally within the neuron (Bading et al., 
1993). Dolmetsch et al. (2001) demonstrated that the specificity of Ca2+ influx 
through L-type VGCCs to activate CREB was due to the ability of the channel to 
bind Ca2+-calmodulin (CaM) through an isoleucine-glutamine (“IQ”) motif in its 
carboxyl terminus. Ca2+-CaM binding to the L-type VGCCs was necessary for the 
activation of the MAPK pathway, which conveyed local Ca2+ signals from the mouth 
of the channel to the nucleus. 
 
2.5 SIGNALLING FROM SYNAPSE TO THE NUCLEUS 
 
Various studies focused on the pathway triggered by an intracellular Ca2+ rise 
downstream of synaptic activity, and now it has been confirmed that the signal from 
cytoplasm to the nucleus can be conveyed in several ways. Calcium can interact 
directly with a transcription factor in the nucleus modifying its DNA-binding 
properties (i.e. DREAM); or Ca2+ can interact with a protein in the cytoplasm, such 
as calmodulin, to activate signalling pathways involving kinases or phosphatases that 
finally modify and activate transcription factors. All these pathways result in the 
activation of well defined gene expression programs allowing the neurons to modify 
themselves in response to a specific stimulus. 
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2.5.1 Nuclear Factor of Activated T Cells (NFAT) 
 
Calcium regulation of NFAT is the classical example of signalling through 
translocation of the transcription factor itself to the nucleus upon changes in its 
phosphorylation state. Although the NFAT family of transcription factors were 
characterized in immune tissues, they also play an important role in neuronal 
plasticity as well as vascular development and muscular hypertrophy (Crabtree and 
Olson, 2002). 
In particular, NFATc4 is expressed within hippocampal neurons, and undergoes 
activation upon Ca2+ influx through L-type VGCCs (Graef et al., 1999). In resting 
cells, NFATc4 is phosphorylated and resides in the cytoplasm. After L-type VGCCs 
opening, the cytoplasmic Ca2+ rise activated the Ca2+/CaM-dependent phosphatase 
calcineurin that dephosphorylates NFATc4. This modification causes the unmasking 
of multiple nuclear localization signals on NFATc4 and the active transportation of 
the transcription factor into the nucleus. 
 
2.5.2 Downstream regulatory element antagonist modulator (DREAM) 
 
An opposite mechanism of Ca2+ regulation of gene expression is represented by 
the transduction of free Ca2+ that can arise in the nucleus after neuronal excitation. 
The transcription factor DREAM is a Ca2+ binding protein that contains three active 
Ca2+ binding motifs (EF hands) (Carrion et al., 1999). DREAM is abundant in the 
nucleus where it is bound to a downstream regulatory element (DRE) and acts as a 
gene repressor. This process is controlled by Ca2+ concentration, in fact, when 
nuclear Ca2+ is low (0.5 M) DREAM binds to DRE, whereas dissociates upon 
elevation of Ca2+ (10 M) causing activation of downstream genes (Osawa et al., 
2001). For example, de-repression of DRE causes activation of transcription of 
prodynorphin and attenuation of pain signalling in vivo (Cheng et al., 2002). 
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2.5.3 Calcium Regulated Protein Kinases: CaMKs and ERK 
 
Activation of NFAT and DREAM describe the extremes in the Ca2+ signalling 
from the plasma membrane to the nucleus, but the predominant mechanism by which 
Ca2+ signals are further processed within cytoplasm and the nucleus, ultimately 
leading to activation of the transcriptional-regulating machinery, involves protein 
kinase cascades. Two main signalling pathways regulated by Ca2+ are the CaMKs 
pathway and the ERK pathway (Fig. 3). 
 
 
Fig. 3: Calcium-activated signaling pathways that regulate gene transcription. In neurons, neurotransmitter reception 
and membrane depolarization lead to the opening of ligand- and voltage-gated calcium channels. Subsequent calcium influx 
across the plasma membrane drives the activation of a number of signaling molecules, including the calcium-sensitive adenylate 
cyclase, calciumycalmodulin-activated kinases, and Ras. Each of these molecules activates a cascade of signaling proteins that 
amplifies the calcium signal and carries it to the nucleus. Dashed lines represent the components of each pathway that are 
proposed to translocate into the nucleus. Nuclear kinases including protein kinase A, CaMK-IV, and members of the Rsk family 
phosphorylate CREB at Ser-133, rendering it competent to mediate transcription of genes such as BDNF. (from Shaywitz and 
Greenberg 1999).  
 
 
Calmodulin (CaM) is a small (148 amino acids) acidic protein capable of 
binding four Ca2+ ions. The Ca2+/CaM complex interacts and activates a variety of 
cellular effectors which include protein kinases and phosphatases (Means et al., 
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1991). Deisseroth et al. (1998) showed that synaptic stimulation induced the 
translocation of calmodulin from dendrites to the nucleus of hippocampal neurons. In 
addition, the amount of calmodulin in the nucleus correlated with the extent of CREB 
phosphorylation, suggesting that a calmodulin-kinase regulated CREB (Deisseroth et 
al., 1998). Most of the studies have correlated CREB activation with the activity of 
the CaMKIV, which is localized in the nucleus (Matthews et al., 1994; Bito et al., 
1996; Chawla et al., 1998). Furthermore, Dolmetsch et al. (2001) demostrated that 
stimulation of L-type VGCCs mediated CREB phosphorylation and, that this was 
realized through a direct interaction between the L-type channel and CaM with the 
subsequent activation of MAPK pathways. Hence, another molecule which may 
serve as a signal between Ca2+ channels and the nucleus is ERK1/2. Their activity is 
controlled by the MAPK signalling pathway; after activation ERKs translocate from 
the cytoplasm to the nucleus where they phosphorylate and activate transcription 
factors, such as CREB (Curtis and Finkbeiner, 1999). In the work of Wu et al. 
(2001), the authors demonstrated that stimulation of hippocampal neurons with high 
K+ resulted in both activation of rapid CaMK and slow MAPK signalling pathways 
responsible for CREB phosphorylation (Wu et al., 2001).  
 
In summary, the transfer of information from the membrane surface of a neuron 
to the nucleus can be achieved in two different ways: either Ca2+ can directly interact 
with a transcription factor in the nucleus (i.e. DREAM) modifying its activity, or 
Ca2+ can bind to Ca2+-binding proteins that activate in the cytoplasm signalling 
pathways conveying to the activation of diverse transcription factor. 
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2.6 ACTIVITY-REGULATED GENES 
 
Studies of quiescent fibroblast stimulated by growth factors to make it re-enter 
the cell cycle suggested the first observation that extracellular stimuli can trigger 
rapid changes in gene transcription. The addition of platelet-derived growth factor 
(PDGF) or other growth factors to quiescent 3T3 fibroblasts led to the rapid induction 
of the c-fos proto-oncogene (Greenberg and Ziff, 1984). 
Then, the importance of stimulus-induced transcriptional response in neuronal 
cells was first suggested by the observation that c-fos transcription could be induced 
by a number of different stimuli. For example, in PC12 cell line increase in the 
concentration of extracellular K+ that leads to membrane depolarization it triggered c-
fos transcription (Greenberg et al., 1986). The up-regulation of c-fos was observed 
also in neurons from different regions of the brain after seizure induction (Morgan et 
al., 1987) or after tetanic stimulation in hippocampal slices (Abraham et al., 1993). 
One of the steps in gene expression response of the neurons to extracellular 
stimuli is the induction of the immediate early gene (IEG). The IEGs are defined as 
those genes whose expression increases rapidly and transiently in a protein synthesis-
independent manner in response to extracellular stimuli. IEGs encode a wide range of 
proteins including activity-induced transcription factors, and effector IEGs such as 
structural proteins, signal transduction proteins, growth factors and enzymes. Since 
the discovery of c-fos induction, other studies have then focused on the activity-
induced transcription factors such as c-jun, Egr1 and Egr2 (Cole et al., 1989; 
Abraham et al., 1993; Inokuchi et al., 1996). Among the effector IEGs, Arc, 
Homer1a and Bdnf can be identified. 
The IEGs transcription factors are believed to drive the expression of delayed 
induced genes (Clayton, 2000), since a separated group of extracellular stimuli-
responsive genes is induced with slower kinetics, often showing a peak of 
transcriptional activity several hours after stimulation. Delayed induced genes may 
play a role in neurotransmission, cellular maintenance and plasticity. Therefore, this 
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further suggested that the IE class of genes constituted an early genomic response 
required to trigger the mechanisms underlying persistent cell modification. 
 
2.6.1 Early growth response: Egr family of Transcription Factors 
 
The Egr family is composed of four members: Egr1 (also known as Zif268 or 
Krox-24), Egr2 (also known as Krox 20), Egr3 (also known as PILOT) and Egr4 
(also known as NGFl-C). Like c-fos, the members of the Egr family of transcription 
factors are readily inducible in the mammalian brain by a wide array of stimuli. They 
were first discovered more than a decade ago and identified as immediate early genes 
according to their response to growth factors (Milbrandt, 1987; Lemaire et al., 1988). 
A defining feature of the Egr family is the highly conserved DNA-binding domain 
composed of three zinc-finger motifs that allow the proteins to regulate the 
transcription of other genes (Christy and Nathans, 1989; Cao et al., 1990). Together, 
these fingers recognize a nine-base-pair segment of DNA, with each finger spanning 
three nucleotides. The high homology in the 3 zinc finger sequence in all members of 
the Egr family, suggests that the proteins may well bind to the same sites of at least a 
subset of the same target genes, even though little is known about those genes.  
In general, there is a considerable basal expression of all the Egr, which may 
reflect ongoing physiological processes in the brain. All Egr members are expressed 
at their highest levels in CA1–CA3 in the hippocampus, with negligible levels of 
Egr1 and Egr2 in the dentate gyrus (Mack et al., 1990; Herdegen et al., 1993; 
Yamagata et al., 1994). The constitutive levels of Egr2 are higher in layers II and III 
of the cortex and negligible in layers IV and VI, whereas Egr3 and Egr4 are highly 
expressed in layers II and IV, and Egr3 was shown to co-localize with Egr1 
(Yamagata et al., 1994). 
In neurons, Egr genes are robustly and transiently expressed by elevated 
cytosolic calcium produced by synaptic activity (Ghosh et al., 1994). Much 
information has been obtained about Erg1 both in terms of its induction in response 
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to extracellular stimuli and in the molecular process governing its regulation and 
function. Numerous studies have shown that Egr1 was regulated by seizure activity, 
electroconvulsive shock, kindling and pathological stimuli, or by brain injury. Many 
studies both in vivo and in vitro have shown that regulated expression of Egr1 mRNA 
was initiated via the activation of different receptors which include at least, all 
subtypes of glutamatergic receptors (for review, see Hughes and Dragunow, 1995).  
In addition, high-frequency stimulation leading to LTP in the ipsilateral 
hippocampal dentate gyrus in vivo markedly increased Egr1 mRNA in the same area; 
both LTP and Egr1 induction were susceptible to be blocked by NMDA receptor 
antagonists (Cole et al., 1989). Also Egr2 was induced after a high-frequency 
stimulation paradigm that produced a longer-lasting synaptic enhancement (Williams 
et al., 1995). Egr2 protein may be involved in the stabilization of LTP, as the 
induction of Egr2 protein has been correlated with the persistence of LTP (Williams 
et al., 1995). Seen the presumed role of Egr1 and Egr2 in stabilization of LTP, they 
could be good candidates in inducing gene transcription of effector genes that would 
be involved directly in the long-term synaptic modification. 
 
2.6.2 Activity regulated cytoskeletal-associated protein: Arc 
 
Arc (also termed Arg3.1) is an IEG that has been cloned from brain on the basis 
of its rapid induction after seizure stimulation (Lyford et al., 1995; Link et al., 1995). 
Arc received particular attention because of its activation by physiological stimuli 
including hippocampal LTP induction and absence seizures (Lyford et al., 1995; Link 
et al., 1995), and because of its tight experience-dependent regulation in 
behaviourally defined neural networks (Guzowski et al., 1999). 
Arc is unique among the known IEGs since its mRNA is rapidly distributed into 
dendrides after induction, where it is targeted towards recently activated synapses 
and then locally translated into protein (Steward et al., 1998; Steward and Worley, 
2001a; Steward and Worley, 2001b). Given its dynamic regulation by neural activity 
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in vivo and localization to activate regions or the dendritic arbour, Arc is an excellent 
candidate as critical agent in synaptic plasticity. 
Using Arc antisense oligodeoxynucleotide to reduce Arc expression, Guzowski 
et al. (2000) demonstrated that, although the early phase of LTP was not affected by 
the treatment with Arc antisense, the late phase decayed rapidly, supporting a critical 
role of Arc expression in synaptic plasticity.  
Although Arc is likely to play a fundamental role in many natural functions of 
neurons in the brain, its function is still unknown; several studies demonstrated that 
Arc protein interacted with cytoskeleton (Lyford et al., 1995) binding with 
microtubule associated protein 2 (MAP2) (Fujimoto et al., 2004). Such interactions 
could be important in dendritic remodelling associated with long-lasting alterations 
of synaptic efficacy. Another in vitro study suggested that Arc interacted with 
CaMKII, and that this interaction promoted neurite outgrowth in neuroblastoma cells 
(Donai et al., 2003). 
 
2.6.3 Brain-derived neurotrophic factor: Bdnf 
 
The activity-regulated gene Bdnf encodes a neurotrophin that is secreted at 
synapses in an activity-dependent manner and can bind to tyrosine kinase receptor B 
(TrkB) and p75 neurotrophin receptors located in both pre- and postsynaptic 
membranes. BDNF is predominantly present in the central nervous system, and its 
mRNA expression is up-regulated by neuronal activity that is accompanied by Ca2+ 
influx into the postsynaptic spines of neurons (Ernfors et al., 1990; Ghosh et al., 
1994). 
The genomic structure of Bdnf is rather complex. To date, as many as nine 
distinct promoters in the mouse and rat gene have been reported (Aid et al., 2007). 
Transcripts initiated at each of these promoters splice from their first exon to a 
common downstream exon, which contains the entire open reading frame encoding 
the BDNF protein. The complexity of the Bdnf gene is larger; in fact, there are two 
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distinct polyadenylation sites in the 3’ untranslated region (UTR) of the common 
Bdnf exon. The biological importance of this diversity remains a mystery, it has been 
hypothesized that such complicated organization confers additional regulation to 
BDNF production beyond its transcriptional regulation. For instance, the distinct 
Bdnf mRNA could be localized in different subcellular compartments or translate into 
proteins under different cellular conditions or regulate by microRNA. Such complex 
regulation suggests that diversity of Bdnf gene expression is required for the fine-
tuning of BDNF functions, since BDNF can control a large number of distinct 
processes in the nervous system, like dendritic outgrowth, synapse maturation, 
neuronal survival, differentiation and synaptic plasticity (Thoenen, 1995). 
 
2.6.4 Homer1a 
 
Beside activity-regulated genes, either the ones whose product is a secreted 
protein or those involved in transcription or remodelling of dendrites, neuronal 
activity regulates also the expression of genes whose products regulate intracellular 
signalling pathways in the postsynaptic compartment.  
Homer1a is an activity-regulated gene produced by the Homer1 gene locus. 
Beside the transcription of the Homer1 gene, Ca2+ influx causes a switch in Homer1 
pre-mRNA processing. This switch promotes the use of a premature polyadenylation 
site in the fifth intron of the Homer1 gene, which results in the activity-dependent 
production of Homer1a, a truncated mRNA encoding only the N-terminus of Homer1 
(Bottai et al., 2002). So, Homer1a is expressed at a low level in the resting state and 
is induced by neuronal activities such as LTP, seizure (Kato et al., 1997), and 
stimulations like inflammatory pain (Tappe et al., 2006), depolarization (Sato et al., 
2001) and dopamine (Yamada et al., 2007).  
Overexpression of exogenous Homer1a has proved to inhibit spine 
morphogenesis and reduce the densities of postsynaptic proteins in spines (Sala et al., 
2003). Thus, Homer1a is expected to play an important role in the mechanism of 
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activity-dependent synaptic reorganization. It is generally believed that the primary 
cause for the morphological changes at postsynaptic sites is the polymerization–
depolymerization reactions of actin filaments. Using a short hairpin that specifically 
blocked the expression of endogenous Homer1a, Inoue et al. (2007) demonstrated 
that Homer1a was required for the clustering and de-clustering (polymerization–
depolymerization) reactions of actin. Hence, Homer1a may play a fundamental role 
for the long-term change of synaptic structures at synaptic sites (Inoue et al., 2007). 
 
All these activity-dependent genes are clear examples of a fine and complex 
transcriptional regulation. In fact, Arc is rapidly transported to active synapses and 
only when it gets there it is transcribed into proteins. In the same way, Bdnf mRNA is 
actively transported into dendrites where it can be translate into proteins. Moreover, 
the genomic organization of the Bdnf gene is complicated and it could possibly 
transcribe twenty-two different Bdnf transcripts. Also the function of Homer1 is 
modulated by the activity-dependent transcription of a splicing variant of the 
constitutively form of Homer1.  
All together, these observations can suggest the complexity and significance of 
the activity-regulated gene expression program that neurons activate in response to 
extracellular stimuli, to modify their functional properties. 
 
2.7 ACTIVITY-REGULATED GENE EXPRESSION PROFILE 
 
Detailed studies investigating the function of a single gene have yielded 
insights into how this activity-induction of gene expression is fundamental and how 
these genes act to control neuronal modification. However, the concept that synaptic 
modification, like LTP, could be a function of a single gene is not fully correct, since 
it rather seem that an orchestrated expression of multiple activity-dependent genes is 
crucial to integrate several extracellular stimuli and encode new information.  
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Although, after discovery of c-fos induction many additional activity-regulated 
genes have been discovered (Saffen et al., 1988; Bartel et al., 1989; Nedivi et al., 
1993), a comprehensive picture of the gene expression response to external stimuli 
was not possible until recently, because of technical limitations. The use of cDNA 
and high-density oligonucleotide microarrays has then allowed high-throughput 
analysis of gene expression patterns.  
The sequence of a genome can be viewed as a gene database for a given 
organism. Knowing the sequence of its genes, however, is only the first step to 
understand the function of the genome. The intricate circuitry that governs growth, 
development, homeostasis, behaviour and the onset of diseases is largely governed by 
the RNAs and proteins encoded by the genes and the complex and dynamic 
interactions of the genes with each others and with the environment. This is why the 
need for a practical, high-capacity gene expression assay encouraged the creation of 
microarray platforms.  
Microarray analysis is based on standard molecular biology, with the principal 
advantage being higher throughput and greater precision than traditional filter and 
blotting techniques. In general, microarrays use high-density microscopic array 
elements, planar glass substrates, low reaction volumes, high-binding specificity, 
high-speed instrumentation for manufacture and detection, and sophisticated software 
for data analysis and modelling. Then, gene expression arrays can determine the 
simultaneous profiling of thousands of transcripts. 
At the moment, different studies have been using this technique to identify the 
gene regulated in response to membrane depolarization, NMDA application, LTP 
induction and seizure induction (Altar et al., 2004; Hong et al., 2004; Li et al., 2004; 
Park et al., 2006).  
These experiments confirm the presence of several hundreds of neuronal 
activity-regulated genes. Among these genes, some are transcription factors and 
many are effector genes that encode for proteins with important functions in 
dendrites and synapses.  
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The first work in which a combination of MEA and microarray was used to 
monitor the electrical activity and the gene expression profile respectively was 
performed by Valor et al. (2007). The authors were interested in examining synapse 
formation and the activity-dependent gene regulation of this process in mouse 
hippocampal neuronal cultures. They followed the temporal profile of synapse 
formation, of the network activity and of the transcriptome over a period of twenty 
days in vitro. Although the regulated genes found in this screening could be classified 
in a variety of functional categories, the authors divided them into three subsets with 
functional and structural relevance to synapses: genes related to the core postsynaptic 
components; genes linked to synaptic plasticity; genes codified neurotransmitter 
receptor subunits. They observed then that two distinct sequentially active gene 
expression programs underlied the genomic response of synapse formation. The 
concomitant analysis of the network activity and gene expression profile allowed the 
authors to demonstrate that the first and fastest program did not depend on the 
network activity and drove the transcriptional synthesis of the synapse genes, 
whereas the second was slower and activity-dependent. So their results supported the 
conclusion that network activity was not a major force in the synaptogenesis 
program, but played a role in the subsequent activity-dependent gene regulation. This 
conclusion was very attractive, because activity-dependent gene expression was 
believed to be contributing to synaptogenesis, although blockage of neuronal activity 
or synaptic transmission did not prevent synaptogenesis in cultured primary neurons 
(Rao and Craig, 1997; Varoqueaux et al., 2002). An important consideration about 
this work is that the combination of MEA and microarray provides the ideal 
condition to correlate in time the gene expression response to the network 
modifications. 
In the context of activity-dependent modification in response to an external 
stimulus, Hong et al. (2004) provided a molecular dissection of the activity-
dependent long-lasting neuronal responses induced by NMDA receptors activation. 
They used a very sensitive method of differential gene expression analysis (DAzLE) 
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coupled with custom microarray analysis, to identify late-response plasticity-induced 
genes. In their protocol, the activation of NMDA receptors was done by brief (5 min) 
stimulation of primary cortical neurons with NMDA, and DAzLE screening was used 
to identify NMDA-induced genes 6 hours after stimulation. Subsequent DNA 
microarray hybridization was used to measure the temporal changes in mRNA levels 
at five different times ranging from 1 hour to 27 hours after the stimulation. A 
possible limitation of this work is that with the microarray they analysed only the up-
regulated genes, because the initial screening was focused on identifying NMDA-
induced genes. Beyond that, they found that the late response of NMDA receptor 
activation led to changes in many functional groups of genes; many of these were 
dynamically regulated in the late response of NMDA application. In fact, they 
observed five different groups of genes based on their temporal expression profile, 
which probably linked the NMDA receptor activation to long-term changes in 
neuronal function. 
Another example of investigation of the transcriptome and its associated 
molecular programs that support synaptic plasticity changes was performed by Park 
et al. (2006). In this work the authors presented the data of a time course DNA 
microarray analysis of the genomic expression after LTP-inducing tetanic stimulation 
in the mouse dentate gyrus. A potential problem with this protocol is that LTP 
induction may not occur in all neurons in the dentate gyrus and slicing process can 
induce activity-regulated genes, therefore the changes in the gene expression would 
be partially masked by these factors. They also identified a large number of activity-
regulated genes that covered a wide range of cellular processes, responding to LTP 
induction. In addition, these activity-regulated genes were characterized by a 
dynamic temporal regulation and were clustered on chromosomes. Then, the authors 
hypothesized that this gene expression response provided molecular support to 
propose critical cellular changes associated with LTP. Moreover, there was the fact 
that the chromosomal clustering of these activity-regulated genes might have been 
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facilitating the transcriptional coordination of the functionally related genes during 
LTP. 
These last works demonstrated that an external stimulus evokes complex 
transcriptional cascades that may ultimately lead to changes of cellular and synaptic 
functions. In fact, genome-wide analyses have revealed that several hundred activity 
regulated genes can be detected in neurons. Beside those genes that codify for 
transcription factors, there are genes involved in the regulation of cell surface and 
adhesion, extracellular matrix, cytoskeleton, cytokine and growth factor signalling. 
Furthermore, the temporal expression of these genes suggests that they are 
dynamically regulated in time. These observations suggest that multiple molecular 
processes are involved in the modification of the synaptic properties of the cell. 
Therefore, the complete definition of the activity-regulated gene expression program 
is incomplete; nevertheless this should now be possible thanks to the most recent 
advances in genomic technology. 
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Abstract  
Background: Periods of intense electrical activity can initiate neuronal plasticity 
leading to long lasting changes of network properties. By combining a previous 
reported model of chemically-induced plasticity using multielectrode extracellular 
recordings and DNA microarrays, we have investigated the time course of neuronal 
plasticity triggered by a transient exposure to the GABAA receptor antagonist 
gabazine (GabT) in rat hippocampal cultures.  
Results: GabT induced a synchronous bursting pattern of activity. The analysis of 
electrical activity identified three main phases during neuronal plasticity following 
GabT: (i) immediately after termination of GabT, an early synchronization (E-Sync) 
of the spontaneous electrical activity appears that progressively decay after 3-6 h. E-
Sync is abolished by inhibitors of the MAPK/ERK pathways, but not by inhibitors of 
gene transcription; (ii) the evoked response was maximally potentiated 3-6 hours 
after GabT (M-LTP); and (iii) at  24 h after GabT, the spontaneous electrical activity 
became more synchronous (L-Sync). The genomic analysis identified three Clusters 
of genes: The mRNA of genes in Clusters 1 and 2 is maximally up-regulated 
respectively after 1.5 and 3 h after GabT and return close to their original level after 
about 6 h. Many genes of Cluster 1 and 2 are down-regulated 24 h after GabT. Genes 
in Cluster 3 are up-regulated after 24 h after GabT.  
Conclusion: At least five sequential events seem to be initiated by GabT: (i) within 
5-10 minutes the MAPK/ERK pathways are activated and likely underlie E-Sync via 
phosphorylation of several target proteins; (ii) an early rise of transcription factors 
(Cluster 1), primarily composed by members of the EGR, and Nr4a families, 
maximally up-regulated 1.5 h after GabT; (iii) a successive up-regulation of some 
hundred genes many of which known to be involved in LTP (Cluster 2) about 3 h 
after GabT likely underlying M-LTP; (iv) a late down-regulation of several genes 
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coding for K+ channels and the HCN1 channels can participate to L-Sync; (v) a late 
up-regulation occurring 24 h after GabT of several genes (Cluster 3) involved in 
cellular homeostasis. These results allow relating different phases of neuronal 
plasticity to specific molecular events.
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Background  
When the electrical activity of neuronal networks is elevated, even transiently, 
several properties of synapses and neurons are modified, resulting in neuronal 
plasticity. Neuronal plasticity provides the basis for memory and learning [1,2]. This 
activity-dependent neuronal plasticity can be induced either electrically with 
intracellular and/or extracellular electrodes [3] or via pharmacological manipulations 
such as for example elevation of extracellular K+ [4], elevation of the intracellular 
concentration of second messenger such as cAMP using forskolin [5] or addition of 
convulsant drugs such as bicuculline [6] or kaininc acid [7]. Neuronal plasticity is 
mediated by several signaling pathways leading to the modulation of synaptic 
strength, density of ionic channels and morphological changes of neuronal 
arborization [8]. This is further complicated by the fact that intrinsic neural properties 
can alter network dynamics and vice versa. All of these modifications, occurring at 
different time scales, have important consequences for the activity of neuronal 
networks in normal and pathological conditions. On a time scale of a few minutes, 
neuronal plasticity is mediated by local protein trafficking, leading to the insertion or 
removal of proteins into and from the membrane [9,10], whereas modifications 
beyond 2-3 h require changes of gene expression [11,12]. These changes occur at 
different time scales: the mRNA of immediate early genes (c-fos, jun), increases 
within 15 minutes following glutamate application [13,14] but other genes are up-
regulated or down-regulated at longer periods of times. Following intense electrical 
activity, transcription factors of the “ Early Growth Response (EGR) “ family such as 
the Egr1 mRNA and protein increase within 1-2 h, but changes of Egr3 are seen only 
after 2-4 h [15]. Moreover, activity at the network level can trigger alterations in gene 
expression that can affect the firing properties of individual neurons. Thus, in order to 
unravel the complex events underlying neuronal plasticity at the network level, it is 
necessary to relate modifications of network electrical properties to concomitant 
protein and gene expression profile [16,17]. 
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The aim and focus of the investigation described in the present manuscript is to 
identify different phases of neuronal plasticity and to understand their molecular 
basis. We combined a detailed analysis of electrical properties of neuronal networks 
occurring during neuronal plasticity with a transcriptional analysis of the underlying 
changes of gene expression.  We  used a multielectrode array (MEA) to monitor the 
electrical activity from a population of neurons, as MEAs allow stable and long 
lasting recordings (from hours to entire days). We used dissociated neuronal cultures 
grown over MEA for 3-5 weeks, because in this preparation it is possible to record 
extracellular voltage signals which can be reliably ascribed to single spikes of 
identified neurons. When hippocampal slices or organotypic cultures are grown on 
MEAs, local field potentials (LFPs) are usually observed and a detailed investigation 
of neuronal plasticity of a neuronal population at a single spike level is difficult. We 
analysed neuronal plasticity initiated by a transient treatment (30 minutes) with 
gabazine, a well known blocker of inhibitory GABAA receptor, which from now on 
will be referred to as GabT. Since GabT evokes intense periods of neuronal firing 
reminiscent of epileptic seizures, the induced neuronal plasticity is related to the 
neuronal plasticity caused by convulsing agents in models of chemically induced 
epilepsy [6,18,19] GABAA receptor antagonists have been widely used to increase 
neuronal activity in several in vitro hippocampal preparations [6,14] and to study 
seizure-induced plasticity [18,20]. When neuronal plasticity was induced by standard 
electrical protocols changes of gene expression measured in the neuronal culture 
were smaller (in preparation), therefore we used GabT to stimulate neuronal 
plasticity. 
Our investigation of  neuronal plasticity following GabT identifies three main phases: 
an early synchronization (E-Sync) of the spontaneous electrical activity immediately 
after termination of GabT; a potentiation of the evoked electrical activity (M-LTP) 
occurring at medium times, i.e. 3-6 hours, after GabT and a late synchronization of 
the spontaneous electrical activity (L-Sync) 6 to 24 h after GabT. The genomic 
analysis identified three Clusters of genes: The mRNA of genes in Clusters 1 and 2 is 
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maximally up-regulated after 1.5 and 3 h after GabT respectively. Many genes of 
Cluster 1 and 2 are down-regulated 24 h after GabT. Genes in Cluster 3 are up-
regulated after 24 h from GabT. These results allow relating different phases of 
neuronal plasticity to specific molecular events. 
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Methods 
 
Neuronal culture preparation 
Hippocampal neurons dissociated from Wistar rats (P0-P2) were plated on 
polyorhitine/matrigel pre-coated MEA at a concentration of 8 x 105 cells/cm2 and 
maintained in a neuron medium as previously described [19]. After 48 h, 5 M 
cytosine--D-arabinofuranoside (Ara-C) was added to the culture medium in order to 
block glial cell proliferation.  Neuronal cultures were kept in an incubator providing a 
controlled level of CO2 (5%), temperature (37oC) and moisture (95%).  
 
Electrical recordings and electrode stimulation 
Multi electrode array (MEA) recordings were carried out with a MEA60 system 
(Multi Channel Systems, Reutlingen, Germany). Stimulations and recordings were 
carried out after 21-35 days in vitro. Synchronous network bursting was induced by 
30 min. treatment with GABAA receptor antagonists, such as bicuculline methiodide 
(50 M) or gabazine (20 M). GABAA antagonists were washed out by changing the 
medium three times. As bicuculline is known to block also SK K+ channels [18], 
experimental results obtained primarily following gabazine treatment (GabT) are 
described. In some experiments, blockers of the MAPK/ERK pathway such as 
PD98059 (50 M) and U0126 (20 M) or blocker of transcription (Actinomycin D, 8 
M) were used. These drugs were pre-incubated before application of GABAA 
antagonists to insure that the MAPK/ERK pathway or transcription was completely 
blocked. PD98059 and U0126 were pre-incubated for 45 min. and Actinomycin D for 
20 min. All of these drugs were washed out together with GABAA antagonists. In 
other experiments, diverse K+ channel blockers were added to the culture medium in 
order to mimic a down-regulation of genes coding for K+ channels following GabT: 
4-aminopyridine (4-AP, 100M) and tetra-etylammonium chloride (TEA, 10mM) 
which are non-specific K+ channel blockers; apamin (100nM), a specific blocker of 
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SK K+ channels; and Heteropodatoxin 2 (HpTx2, 10M) or arachidonic acid (AA, 
40M) which are specific blockers of the Kv4.2 channel type [38]. Similarly, the 
inhibitor of HCN1 channel ZD7288 (100M) was used to mimic a down-regulation 
of the HCN1 gene following GabT. AA was dissolved in Tocrisolve® and cultures 
were first treated with Tocrisolve® as negative control. Bicuculline methiodide, TEA 
and HpTx2 were obtained from Sigma-Aldrich (St. Louis, MO, USA); gabazine, 
PD98059, U0126, Actinomycin D, 4-AP and arachidonic acid were obtained from 
Tocris Cookson Ltd (Bristol, UK). In order to avoid saturation, the lowest voltage 
pulse evoking an electrical response was used and its amplitude varied between 200 
and 450 mV depending on the culture. For a given culture, the same amplitude was 
used before, during and after GabT. The pattern of stimulation consisted of a train of 
40 bipolar pulses separated by an inter-pulse interval of 4s and applied to a bar of six 
neighbouring electrodes.  
 
Data analysis 
Acquired data were analyzed using MATLAB (The Mathworks, Inc.) as previously 
described [19,21].  The network firing rate is defined as the sum of all electrodes 
firing rates (i.e. the number of all spikes recorded in the network in each bin). The 
average network correlation or network synchronicity, was computed by averaging 
the cross-correlation of individual pairs over all the possible pairs of electrodes as 
previously described [20]. The total number of spikes as a function of the distance d 
was fitted by the exponential function /dAe from which was obtained (inset Fig. 
3G).  
 
RNA extraction 
The total RNA was extracted using TRIzol reagent (Sigma) according to the 
manufacturer’s instructions followed by a DNase I (Invitrogen, Carlsbad, CA, USA) 
treatment to remove any genomic DNA contamination. The total RNA was further 
purified using RNeasy Mini Kit Column (Qiagen, Milan, Italy) and subsequently 
 47 
quantified by ND-1000 Nanodrop spectrophotometer (Agilent Technologies, Milan, 
Italy).  
 
DNA microarray analysis 
Neuronal cultures grown on MEA were treated for 30 minutes with 50 M gabazine. 
Gabazine was removed and RNAs were extracted from cultures 1.5, 3, 6 and 24 h 
from start of GabT or from untreated cultures. Ten minutes of electrical recording 
was collected at each time point before harvesting RNAs. At each time point at least 
3 biological replicates were collected and Standard Affymetrix protocols were 
applied for amplification and hybridization. Gene profiling was carried out with the 
Affymetrix RAT230_2 platform containing 31099 probes, corresponding to 14181 
probes with a gene symbol. Low level analysis was performed using an RMA 
(Robust Multi-array Average) algorithm [22] directly on the scanned images. 
Because of high dimensionality, we removed probe sets labeled as ambiguous and 
those without any gene symbol. The variance 2 of mean value of expression changes 
(in log2 units) relative to untreated controls was computed considering collectively 
samples collected at 1.5,3, 6 and 24 h after GabT. Genes with a variance 2 lower 
than 0.6 were filtered out. The profiles of the three Clusters evident in Fig.4B were 
fitted by the curve: 
 
where xi is the log ratio treatment/control of the i-th gene, t is time in hour and A and 
 are appropriate parameters which were obtained using a nonlinear curve-fitting 
procedure. Each cluster was then enriched by considering genes with a time course 
highly correlated to one of the three profiles.  
 
Quantitative RT-PCR 
RNA (250ng) was reverse transcribed using SuperScript II reverse transcriptase and 
random hexamer (Invitrogen, Milan, Italy). Real-time PCR was performed using iQ 
SYBR Green supermix (Biorad, Milan, Italy) and the iQ5 LightCycler. Gene specific 
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primers were designed using Beacon Designer (Premier Biosoft, Palo Alto, CA, 
USA). The thermal cycling conditions comprised 3 min at 95°C, and 40 cycles of 10 
seconds for denaturation at 95°C and 45 sec for annealing and extension at 58°C. The 
expression level of the target mRNA was normalized to the relative ratio of the 
expression of Gapdh mRNA. The forward primer for Gapdh was 5'-
CAAGTTCAACGGCACAGTCAAGG-3', reverse primer was 5'-
ACATACTCAGCACCAGCATCACC-3'. Fold changes calculations were made 
between treated and untreated samples at each time point using the 2-CT method. 
The forward primer for Egr1 was 5'-AAGGGGAGCCGAGCGAAC-3', reverse 
primer was 5'-GAAGAGGTTGGAGGGTTGGTC-3'; forward primer for Egr2 was 
5'-CTGCCTGACAGCCTCTACCC-3', reverse primer was 5'-
ATGCCATCTCCAGCCACTCC-3'; forward primer for Egr3 was 5'-
ACTCGGTAGCCCATTACACTCAG-3', reverse primer was 5'-
GTAGGTCACGGTCTTGTTGCC-3'; forward primer for Nr4a1 was 5'-
GGTAGTGTGCGAGAAGGATTGC-3', reverse primer was 5'-
GGCTGGTTGCTGGTGTTCC-3'; forward primer for Arc was 5'-
AGACTTCGGCTCCATGACTCAG-3', reverse primer was 5'-
GGGACGGTGCTGGTGCTG-3'; forward primer for Homer1a was 5'-
GTGTCCACAGAAGCCAGAGAGGG-3', reverse primer was 5'-
CTTGTAGAGGACCCAGCTTCAGT-3'; forward primer for Bdnf was 5'-
CGATTAGGTGGCTTCATAGGAGAC-3', reverse primer was 5'-
GAAACAGAACGAACAGAAACAGAGG-3'. 
 
Terminal deoxynucleotidyl transferase (TdT)-mediated fluorescein-dUTP nick-end 
labeling (TUNEL) analysis and immunofluorescence 
Hippocampal cultures were fixed with 4% paraformaldehyde in PBS 24 or 48 h after 
gabazine treatment. TUNEL histochemistry (Roche, Germany) was performed 
according to manufacturer's instructions. Cultures were then labelled with anti-
tubulin III (TUJ1, Covance, Denver, PA, USA, 1:500) followed by Alexa 594 goat 
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anti-mouse (Invitrogen, Milan, Italy) and nuclei stained with DAPI (Sigma, Saint 
Louis, MO, USA) for 10 min, coverslipped with Vectashield mounting medium 
(Vector, Burlingame, CA, USA). 
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Results 
Cultures of dissociated neonatal rat hippocampal neurons grown over MEAs form 
functional networks of interacting neurons [21]. We increased synaptic efficacy by 
exposing hippocampal cultures for 30 min to the GABAA receptor antagonist 
gabazine (gabazine treatment, GabT). After GabT, gabazine was washed out and the 
time course of electrical activity and gene expression was followed. Ten minutes of 
spontaneous activity was recorded at each time point before harvesting RNAs (see 
Methods). In another series of experiments, we characterized changes of the evoked 
activity induced by GabT. 
 
Gabazine treatment induces an early (E-Sync) and a late synchronization (L-Sync) 
Spikes were clearly detected from voltage recordings obtained from MEA 
extracellular electrodes and their frequency was monitored during development of 
neuronal plasticity (first three rows of Fig. 1A-C). In control conditions, neuronal 
firing was usually incoherent, but occasional synchronous bursts were observed (see 
raster plot in Fig. 1B). The global electrical activity was analyzed by computing the 
network firing rate, i.e. the total number of spikes recorded from all MEA electrodes 
in a 250 ms bin width (Fig. 1C, see Methods).  
 
(Fig.1 near here) 
 
During GabT the electrical activity became highly synchronous, and the network 
firing rate exhibited large peaks separated by silent periods (compare raster plots in 
Fig. 1B). Five minutes after GabT (third column of Fig. 1A-C) the spontaneous 
activity was more synchronous than in control conditions and very few spikes among 
burst were detected. These changes were observed for several hours after drug 
removal (fourth and fifth column of Fig. 1A-C), as previously reported [6]. Changes 
of the spontaneous activity were quantified by computing three quantities: (i) the 
network firing rate, computed with a bin width of 250 ms and averaged over 10 
 51 
minutes; (ii) the average network cross-correlation or network synchronicity see 
Methods and (iii) the occurrence of silent electrical periods determined as the 
fraction of 100 ms periods with less than a total of 10 spikes. The network firing rate 
more than doubled during GabT and after its termination remained higher reaching a 
maximum value at 3-6 h and then slowly returning to control values (Fig. 1D, n=6). 
During GabT, the network synchronicity increased more than 50% (59.5 ± 13.4 % of 
control value; Fig. 1E). When gabazine was removed, it slightly decreased and was 
still 28 ± 24 % higher than what originally observed 3 h after GabT. At later times, 
however, the network synchronicity increased again and 24 h after GabT it was 51 ± 
45 % higher. During GabT, the occurrence of silent periods drastically increased to 
244 ± 63 % and remained higher than control value at all time following GabT, being 
still 65 ± 36 % larger than control values 24 h after GabT (Fig. 1F, n=6). 
Thus, after GabT, spontaneous activity between individual bursts quickly recovered 
affects drastically the fraction of silent periods, and has a weak influence on the 
network firing rate and network synchronicity. 
These results indicate that the network firing rate and network synchronicity had a 
different time course: the network firing rate reached a maximum value at about 6 h, 
whereas the network synchronicity showed a biphasic behavior with a minimum 
value at 5,5 h. This biphasic behavior is consistent with the existence of two 
components: one component acting at early times (E-Sync) and a later component 
clearly visible from 6 to 24 h after GabT (L-Synch). This is reminiscent to what is 
observed for LTP, where an early component (E-LTP) independent of transcription 
precedes a later component (L-LTP), associated to new transcription and translation 
[22-25]. 
 
E-Sync and L-Sync depend on different signalling pathways  
On the one hand, E-LTP depends on the MAPK/ERK pathway and is abolished by 
selective blocker of this pathway [26, 27]. Moreover, in hippocampal neurons, 
treatment with bicuculline activates ERK in post-synaptic dendrites within 2 minutes, 
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which then translocates to the nucleus within 15-30 minutes [28]. On the other hand, 
L-LTP is selectively blocked by general blocker of transcription [24]. In order to test 
whether similar mechanisms were could account for the different phases of network 
synchronization, we then investigated the effect of blockers of the MAPK/ERK 
pathway, such as PD98059 [26] and U0126 [29], as well as blocker of transcription, 
such as Actinomycin D [24], on the GabT-induced synchronization. In particular, we 
looked at the effects of these drugs on the network firing rate, the network 
synchronicity and the occurrence of silent periods. 
The gabazine-induced synchronous bursting was unaffected by treatment with 
PD98059 (50 M) or U0126 (20 M). However, the maintenance of recurrent 
synchronous bursting after gabazine washout required MAPK/ERK pathway: the 
network firing rate did not change and remained similar or lower to what observed in 
untreated cultures (red trace in Fig. 2A, left panel) and the network synchronicity 
remained lower than the control value (Fig. 2B, left panel). Similarly, the occurrence 
of silent periods decreased under control value (Fig .2C, left panel): silent periods 
dropped to 26 ± 19 % 1 h after GabT before returning to the control value after 24 h 
(Fig. 2C, left panel). On the other hand, when neuronal cultures (n=3) were treated 
with 8 M Actinomycin D, the network firing rate remained under the control value 
at all times after GabT (Fig. 2A, right panel). In contrast, the network 
synchronicitymore than doubled during GabT (223 ± 32%) and remained relatively 
high up to 3 h after GabT (20 ± 9 % larger than the control value), subsequently 
returning to the control value (Fig. 2B, right panel). During GabT and in the presence 
of Actinomycin D, the occurrence of silent periods increased by 237 ± 55 % and 1 
and 3 h after GabT it was 79 ± 28 % and 46 ± 32 % larger than in control value, 
respectively (Fig. 2C, right panel).  
 
(Fig.2 near here) 
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These results show that in the presence of blockers of the MAPK/ERK pathway, 
changes of the network firing rate, the network synchronicity and the occurrence of 
silent periods induced by GabT were abolished. In contrast, when Actinomycin D 
was added, GabT still evoked a significant increase ofthe network synchronicity and 
of the occurrence of silent periods lasting for 1-3 h. However, changes of the network 
firing rate,the network synchronicity and of the occurrence of silent periods observed 
24 h after GabT were abolished. Therefore, E-Sync seems to be mediated by the 
activity of the MAPK/ERK complex, possibly through the phosphorylation of some 
target proteins [26,28,30], while L-Sync appears to be mediated by changes of gene 
expression, as it is eliminated by drugs blocking the transcription. 
 
The evoked response is maximally potentiated 3 hours after GabT  
MEA’s extracellular electrodes can be used for recording and stimulation. In another 
series of experiments, we quantified changes of the evoked activity in the cultured 
hippocampal networks in response to a simple pattern of stimulation (see Methods). 
40 brief (200 s) bipolar pulses were applied to a row of electrodes (black bar in the 
grid of Fig. 3A) and the propagation of evoked spikes throughout the network was 
recorded. In order to avoid saturation, the lowest voltage pulse evoking at least one 
spike was used, before, during and after GabT (Fig. 3). Its amplitude varied between 
200 to 450 mV depending of the culture (see Methods). After GabT, the number of 
evoked spikes increased in almost all trials (Fig. 3B) and at all time points (Fig. 3C). 
 
(Fig.3 near here) 
 
Changes of the evoked response were quantified by computing the total number of 
evoked spikes in a time window of 100 ms from the stimulus onset, i.e. the network 
firing rate of the evoked response. The network firing rate of the evoked response 
significantly increased between 1 and 6 h after GabT (Fig. 3D): the evoked response 
was maximally potentiated 3 h after GabT and started to decline after 6 h, returning 
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almost to control level 24 h after GabT. Neuronal plasticity induced by GabT caused 
evoked spikes to travel through the network in a faster and more reliable way. In 
some experiments, we could identify a spike produced by the same neuron, and we 
measured how its latency and jitter changed during neuronal plasticity (Fig. 3E,F). 
The latency in control conditions from the stimulus was between 6 and 9 ms and was 
reduced by 2-3 ms after GabT. The standard deviation of the latency (jitter) similarly 
decreased (blue and red symbols in Fig. 3F). A clear reduction of latency and jitter of 
evoked spikes were observed in at least 31 identified single neurons (n=5 cultures). 
We also analyzed how spikes propagated in the network by measuring the space 
constant  of the evoked activity (see Methods and inset of Fig. 3G). Collected data 
from 4 cultures showed that increased by about 25 % within 1 h after GabT and 
remained larger than the control values up to 24 h (Fig. 3G). These results show that 
GabT – also in the absence of a concomitant strong or tetanic electrical stimulation – 
potentiated the electrical response propagating in the culture, inducing in this way a 
form of LTP. 
 
Changes of gene expression 
In order to understand the molecular changes underlying the modification of the 
electrical activity induced by GabT, we investigated changes of gene expression with 
DNA microarrays and real-time PCR. Gene expression was analysed 1.5, 3, 6 and 24 
h after the onset of GabT and the variance of changes relative to the control observed 
at all these times was computed (see Methods). After GabT, the mean value of 
expression changes (in log2 units) relative to untreated controls did not change for the 
great majority of genes (see Fig. 4A). 
 
(Fig.4 near here) 
 
As the standard deviation  of changes of housekeeping genes was about 0.25, we 
filtered out genes with a variance 2 lower than 0.6, obtaining 132 genes significantly 
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modulated (Fig. 4B). Visual inspection of expression changes of these genes (Fig. 
4B) indicated three distinct temporal profiles: genes maximally up-regulated 1.5, 3 
and 24 h after GabT were grouped in Cluster 1, 2 and 3, respectively. The precise 
time course of these three profiles was identified (black traces in Fig. 4B-E; see 
Methods) and the population of the three Clusters was enriched by reanalyzing the 
data with a lower variance (see Methods) looking for genes whose changes were 
highly correlated with one of the three profiles. By using this procedure, 25, 318 and 
93 genes were present in Clusters 1, 2 and 3, respectively (see Fig. 4C-E). The 
complete list of identified genes can be found in Supplementary Table 1. Changes of 
gene expression occurring 1.5 and 3 h after GabT were checked by real-time PCR for 
some selected genes, namely Egr1, Egr2, Egr3, Nr4a1, Bdnf, Homer1a and Arc (Fig. 
4F). Genes in Cluster 1 (see Table 1) had a 2-fold up-regulation 1.5 h after gabazine 
application, returning to the control level or slightly below between 3 and 6 (Fig. 4C). 
Gene Ontology (GO) analysis indicated that 44% (11/25) of these genes were 
regulators of transcription, such as members of the Egr [31] and Nr4a families [32]. 
The identification of genes in Cluster 1 as transcription factors was statistically more 
significant compared to a similar identification for the other clusters (p value<0.01 
Fisher’s exact test; see Methods). Five of these transcription factors (Egr1-3, Nr4a1 
and Junb) have been shown to play a major role also in LTP. Cluster 1 contained 
additional genes such as Arc, Homer1, Ptgs2 and Dusp5 known to be effector genes 
in LTP (see Table 2 and references therein). 
Several genes in Cluster 2 were maximally up-regulated 3 h after gabazine removal 
(Fig. 4D) i.e. at the same time of maximal potentiation of the evoked response (Fig. 
3D). GO analysis indicated that 28 % of these genes are involved in neuronal 
electrical transmission and could be grouped in three classes: genes involved in “ion 
transport” (such as Kcnd2, Cacna2d3, and Gria1), in “signal transduction” (such as 
Cck and Homer1), and in “transmission of nerve impulse” (such as Rab3a Snsap25, 
Syn1 and 2). Of the 435 genes identified, 361 are annotated. To better investigate the 
functionalities of these genes, we performed an extensive PubMed search to extract 
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functional information for all these genes. 43 genes belonging to Cluster 1 and 2 are 
known to be involved in LTP (see Table 2) strongly suggesting that the up-regulation 
of genes in Cluster 2 mediated the electrophysiological changes described in Figure 
3. The list of LTP genes in Table 2 contains many transcription factors and genes 
encoding for ion channels. Besides these, most of the remaining genes could be 
categorized as structural, pre- and post-synaptic based on their biological function. 
We therefore decided to classify all the other 318 genes in these three groups based 
on the PubMed search. The results of this search are listed in Table 3. 39 genes have 
been classified as structural genes for their structural role in cellular function and 
their up-regulation could underlie structural and morphological changes associated to 
LTP. Analogously the 26 pre-synaptic and the 24 post-synaptic genes found in our 
screening and listed in Table 3 could mediate changes of synaptic properties 
occurring during LTP. 
Several genes in Cluster 3 were down-regulated by GabT 3 h after drug removal (like 
Abcb1a, Ccnd1, Il1rl1, Tcf19), and conversely, they were up-regulated at later times 
(Fig. 4E). 11% of the genes belonging to this cluster were put in the “apoptosis” 
category by GO and included both pro-apoptotic (such as Casp4 and Unc5c) and pro-
survival (such as Tgfb3 and Gadd45a) genes. Structural genes were also found in 
Cluster 3 suggesting their possible involvement in the reinforcement and 
consolidation of LTP. 
 
The effect of ERK inhibitors on the potentiation of the evoked response 
As PD98059 and U0126 blocked changes of the spontaneous activity induced by 
GabT (Fig. 2), we investigated their effect on the potentiation of the evoked response 
(Fig. 3). Application of these inhibitors to neuronal cultures decreased the recorded 
spontaneous activity measured at all extracellular electrode (Fig. 5A). The network 
firing rate used to describe the global spontaneous activity (see Fig. 2) was almost 
halved (Fig. 5B) in all tested cultures (n=4), but periods of larger electrical activity 
could be still observed. In these cultures, inhibitors of the MAPK/ERK were 
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incubated for 45 minutes before GabT and changes of the network firing rate of the 
evoked response were analyzed. In the presence of these inhibitors, GabT still 
potentiated the evoked response, although in a lesser extent (red trace in Fig. 5C), 
with a time course similar to that observed in the absence of these inhibitors (black 
trace in Fig. 5C). 3 h after GabT, the number of evoked spikes reached 198 ± 41 % in 
normal conditions, but increased only by 39 ± 15 % in the presence of PD98059 and 
U0126. Therefore, inhibition of the MAPK/ERK pathway reduced but not abolished 
the potentiation of the evoked response caused by GabT. 
 
(Fig.5 near here) 
 
In order to understand the nature of potentiation of the evoked response observed in 
the presence of inhibitors of the MAPK/ERK pathway, we analyzed with real-time 
PCR selected genes up-regulated by GabT (Fig. 4). As shown in Figure 5D, the up-
regulation induced by GabT of genes of the EGR family, Nr4a1 and Arc was 
significantly reduced and almost blocked by inhibitors of the MAPK/ERK pathway, 
but not the up-regulation of Bdnf and Homer1a.  
 
Several genes coding for K+ channels are down-regulated 24 hours after GabT 
The network firing rate of both the spontaneous (Fig. 1D) and evoked activity (Fig. 
3D) returned almost to the control level 24 h after GabT, but not the network 
synchronicity (Fig. 1E) and the occurrence of silent periods (Fig. 1F) observed during 
the spontaneous activity. L-LTP is mediated by multiple changes occurring in the 
pre- and post-synaptic machinery [33] but also involves changes in the density and/or 
properties of ionic channels present in the dendritic arborization and axon of neurons 
forming the network [34]. These changes could affect the degree of synchronization 
of the spontaneous activity. To test this possibility, we investigated in detail changes 
of genes encoding for subunits and/or ancillary regulatory subunits of Na+, K+, Ca 2+, 
HCN  ionic channels, as well as GABA and glutamate receptors. The majority of 
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these genes were not affected by GabT (Fig. 6A-F), but some of them were 
significantly down-regulated 24 h after GabT (red crosses). Down-regulated genes 
related to K+ channels (Fig. 6B) were Kcnc1, Kcnj6, Kcna4, Kcnn2, Kcnc2, Kcnip3, 
Ki55.1, Kcnab1, Kcnd2 and Kcnip4. Also some genes coding for subunits of Ca2+ 
(Cacng2, Cacng3, Cacnb4 and Cacna2d3; Fig. 6C), Na+ channels (Scn1a and 
Scn2a1; Fig.6A) and for glutamate (Gria1 and Gria2; Fig. 6D) and GABA (Gabrb1, 
Gabra5, Gabra1, Gabbr2 and Gabrg2; Fig. 6E) receptors were down-regulated. The 
gene coding for HCN1 channels was significantly down-regulated, but not those 
coding for HCN2-4 channels, in agreement with the larger expression of HCN1 
channels in rat hippocampus [35]. As the degree of correlated activity of neuronal 
networks can also depend on the amount of electrical coupling among neurons, we 
looked for possible changes of genes expressing connexins, i.e. the ionic channels 
mediating electrical coupling. No significant changes of genes coding for connexins 
were found.  
 
(Fig.6 near here) 
 
None of the Ca2+ and Na+ channels or GABA receptors genes found here has been 
reported to be involved in neuronal plasticity. K+ channels encoded by the Kcna4, 
Kcnn2, Kcnab1, and Kcnd2 genes (see references in Table 2) are known to be 
involved in neuronal plasticity and HCN1 down-regulation has been observed 
following seizure like events [35,36]. These observations suggest that a down-
regulation of HCN1 and K+ channels could contribute to L-Sync. In order to test this 
possibility, we pharmacologically blocked HCN1 and K+ channels. We first analyzed 
the effect of unspecific K+ channels blockers, such as 4-aminopyridine (4-AP) and 
TEA. In the presence of 100 M 4-AP, synchronous bursts appeared (Fig. 6G) and  
increased by 304 ± 156 % (Fig. 6J, t-test, p<0.05, n=4). In the presence of 10 mM 
TEA, the network firing became more synchronous (Fig. 6H) and  almost doubled 
(Fig. 6J; 195 ± 67 % of the control value, n=3). Synchronization induced by TEA 
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treatment was transient and in fact, after 10 minutes or so, the value of  substantially 
decreased (data not shown). We also tested the effect of arachidonic acid, a known 
blocker of the A-current [37] and in the presence of 40 M of this drug the 
spontaneous firing was slightly more synchronous (data not shown). Addition of 100 
M of ZD7288, a known blocker of HCN channels, also induced a large and clear 
synchronization of the electrical spontaneous activity (Fig. 6I,J; 202 ± 59 % of the 
control value, n=3). Taken together, these data indicate that a down-regulation of 
genes coding for HCN and K+ channels could contribute to L-Sync. 
 
Integrity of neuronal cultures after gabazine exposure 
The presence of genes linked to apoptosis in Cluster 3, raises the possibility of 
permanent damage induced in the neuronal culture by GabT. Indeed, bursts of 
electrical activity caused by GabT are expected to release large amounts of glutamate 
in synapses, possibly causing spillover reaching extra-synaptic NMDA receptors, 
known to trigger neuronal death [38]. Thus, we checked the integrity of neuronal 
cultures in several ways. Tunel assays (Fig. 7A,B) did not show a significant increase 
in apoptotic nuclei after GabT. In fact we counted 9.2 ± 3.3 % of apoptotic nuclei 
(positive for tunel: green nuclei in left panel of Fig. 7A) in control conditions, 9.5 ± 
5.0 % and 6.7 ± 2.3 %  24 and  48 h after GabT (Fig. 7B), respectively.  
 
(Fig.7 near here) 
 
GABA in the mature hippocampus hyperpolarizes neurons, but can have a 
depolarizing effect in the immature hippocampus [39] or following insults such as 
trauma, ischemia or seizures [40]. As GabT caused electrical bursts reminiscent of 
epileptic seizures, we verified that GabT did not modify the hyperpolarizing effect of 
the activation of GABA receptors.  Addition of 30 M GABA before GabT blocked 
almost completely the spontaneous activity by silencing the great majority of the 
MEA’s electrodes and switching to a tonic mode of firing (Fig. 7C), consistently with 
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the activation of inhibitory synaptic pathways. When the same amount of GABA was 
added 24 h following GabT, the spontaneous activity was similarly blocked (Fig. 
7D). We also verified that subsequent GabT 24 or 48 h after the first GabT had the 
same effect (Fig. 7E): the network cross-correlation  more than doubled for the three 
consecutive GabTs. These results show that a transient exposure to blockers of 
inhibitory GABAergic synaptic pathways initiate neuronal plasticity without causing 
significant damage to neuronal cultures and changes of the hyperpolarizing effect of 
GABA. 
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Discussion 
The present work identifies several sequential steps underlying neuronal plasticity 
induced by a transient gabazine treatment. Immediately after termination of GabT, 
the spontaneous electrical activity becomes more synchronous (E-Sync) than in 
control conditions. Following GabT, ERK proteins are phosphorylated and activated 
within less than 5 minutes [28]. E-Sync is blocked by inhibitors of the MAPK/ERK 
pathway but is not affected by inhibitors of gene transcription (Fig. 2), suggesting 
that post-translational modifications, like phosphorylation, participate in maintains 
this phase. Late synchronization however is blocked by both inhibitors demonstrating 
a major role of MAPK/ERK signalling pathway in neuronal plasticity and showing 
the requirement of new gene transcription for synchronicity consolidation. Some tens 
of genes (Cluster 1) primarily composed by transcription factors such as members of 
the Egr, and Nr4a families, are maximally up-regulated 1.5 h after GabT. Another 
cluster of genes (Cluster 2) is maximally up-regulated about 3 h after GabT and many 
of these genes are known to be involved in LTP. At the same time or slightly later the 
evoked and spontaneous electrical activity are strongly potentiated (Figure 1 and 3). 
At 24 h after GabT, the spontaneous electrical activity was more synchronous (L-
Sync), in addition a down-regulation of genes coding for several K+ channels 
occurred at the same time point. A third group of genes (Cluster 3) involved in 
cellular homeostasis is up-regulated 24 h after GabT. From these results it is possible 
to relate specific events occurring during neuronal plasticity to changes of expression 
of specific gene clusters.  
 
E-Sync of spontaneous activity 
As shown in Figure 2, E-Sync is not blocked by Actinomycin D but by inhibitors of 
the MAPK/ERK pathways. Therefore E-Sync is likely to be dependent on post-
translational modification controlled by the MAPK/ERK pathway. In this regard, E-
Sync is very similar to a component of LTP, referred as Early LTP, which is not 
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blocked by inhibitors of gene expression [24,25,26]. Local protein synthesis and 
regulation of ionic channels, such as phosphorylation of the Kv4.2 channel by ERK 
[30] PKA or CaMKII are likely mechanisms. 
 
Potentiation of evoked activity 
Potentiation of the spontaneous and evoked electrical activity (Fig. 1 and 3) and up-
regulation of genes in Cluster 2 have a very similar time course suggesting of a 
causal relationship between gene activation and electrical potentiation. Potentiation 
of the evoked activity was reduced, but not eliminated by inhibitors of the MAPK/ 
ERK pathway (Fig. 5). Therefore potentiation of the evoked response is mediated by 
several pathways likely to be working in unison. Many genes belonging to Cluster 1 
and 2 are well known players in LTP (see Table 2) such as Bdnf and its receptor TrkB 
[41] (referred to as Ntrk2 in Table 2), Arc [42], Egr1 [43] and Homer1 [44]. We 
hypothesize that the large majority of genes of Clusters 1 and 2 underlie induction of 
LTP and that their activation orchestrates neuronal plasticity. The latter most likely 
depends on the activation of hundreds - rather than tens or thousands - of genes, in 
agreement with our findings. In fact, of the 361 annotated genes in our clusters from 
the PubMed search, we found that one third is, or could be, involved in changes of 
synaptic strength related to LTP. 43 genes have already been implicated in LTP 
(Table 2), 39 genes have been classified as Structural genes for their structural role in 
cellular function and their up-regulation could underlie structural and morphological 
changes associated to LTP. Analogously the 26 Pre-synaptic and the 24 Post-
synaptic genes found in our screening and listed in Table 3 could mediate changes of 
synaptic properties occurring during LTP. 
 
Structural genes 
Among structural genes in Cluster 1 and 2 there are elements that control properties 
of the cytoskeleton and the dynamics of microtubules and neurofilaments like Arc, 
Homer1, Mapt, or  Stmn3 or the formation of new dendritic arborisation like Dscam 
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or Nxph1. Many genes of the cadherin family (Cdh) controlling cell to cell adhesion 
are also member of these categories. The gene Dscam (Down Syndrome Cell 
Adhesion Molecule) plays a major role in axon guiding and development of neuronal 
circuits [45,46] and is well known to be involved in neuronal plasticity. Nrxn3 
(Neurexin) in conjunction with neuroligin is thought to play a major role in the 
formation of new synapses and in particular in adhesion complex [47] and therefore 
besides being structural they can be also classified as pre-post synaptic. Structural 
Genes were also found in Cluster 3 and they could be involved in the reinforcement 
and consolidation of LTP. 
 
Pre- and post-synaptic genes 
Several pre-synaptic genes such as synapsin I [48], syntaxin1A [49], Snap25 [50] 
code for proteins involved in vesicle release from pre-synaptic terminals, and their 
up-regulation could be associated to an increase of vesicle release during synaptic 
transmission. 
Among the post-synaptic genes there are elements associated to Post Synaptic 
Density complex like Cnksr2 and Opcml; to the regulation and local trafficking of 
post-synaptic glutamate ionic channels like Nsf or Ptpn5 and to the regulation of 
post-synaptic spines like Slc12a5 and therefore could be involved in the 
reinforcement of the synaptic strength. As shown in Figure 6, many genes coding for 
ionic channels and their accessory proteins belong to Cluster 2. Their up-regulation 
closely follows the time course of potentiation of the evoked response, suggesting 
that they also could participate to the regulation and orchestration of LTP.  
For these reasons, we propose that genes found in this screening could represent a 
template – to be verified – for genes involved in neuronal plasticity in several other 
preparations.  
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L-Synch of spontaneous activity 
L-Sync could be in part mediated by a down-regulation of K+ and HCN channels and 
in fact, blockers of K+ channels with a wide spectrum of action, such as TEA and 4-
AP, increase the degree of synchronization of the spontaneous activity (Fig. 6). 
Blockage of HCN1 channels by changing dendritic excitability modulates LTP [51] 
and contributes to neuronal plasticity by prolonging the entry of Ca2+ in distal 
dendrites [52]. Synchronous bursts induced by blockage of K+ channels are more 
frequent and less regular and therefore the down-regulation of K+ channels can be 
one of the several mechanisms underlying neuronal plasticity. In addition, network 
synchronization was not observed or was rather small when specific K+ channels 
blockers (Apamin for Kcnn2, Heteropodatoxin 2 and arachidonic acid for Kcnd2) 
were used (data not shown), indicating that a fine tuning and a precise regulation of 
several ionic channels (Fig. 6) underlie L-Sync.  
 
Genes of Cluster 3 
Genes belonging to Cluster 3 are up-regulated 24 h after GabT and some of them 
(5/93) are also up-regulated in mouse hippocampal cultures 2-4 h after addition of 
glutamate or bicuculline [14]. Several genes from Cluster 3 are associated to 
apoptosis, with pro-apoptotic (such as Casp4 and Unc5c) and pro-survival (such as 
Tgfb3 and Gadd45a) genes. The homeostatic mechanisms present in neuronal 
cultures – both in the cytoplasm and at the network level – minimize the number of 
apoptotic neurons (Fig. 7) and provide a way to safely return to control conditions 24 
h after GabT. 
 
Comparison with previous investigations 
Several previous investigations have identified hundreds of genes up-regulated by 
standard electrical protocols inducing LTP [53] or chemically induced seizures using 
convulsant agents such as bicuculline and glutamate [14]. These investigations were 
conducted in the mouse hippocampus [14,53] and in rat hippocampus and cerebral 
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cortex [54]. Zhang and colleagues increased electrical activity either by stimulating 
synaptic NMDA receptors by using bicuculline or extra-synaptic NMDA receptors 
by adding glutamate to the medium in mouse dissociated hippocampal neurons [14]. 
The present investigation used GabT to elevate the global electrical firing. In all these 
investigations an elevated global firing initiates the transcription of several genes 
associated to metabolic and structural components and synaptic functions. 
A parallel analysis of genes up-regulated in these experiments shows a significant 
number of commonly regulated genes. 13 (out of 25) genes in Cluster1 and also some 
genes in Cluster 2 (like Pnoc, Rgs2 and Ntrk2) of the present investigation are also 
up-regulated in mouse hippocampal cultures following a permanent stimulation of 
synaptic NMDA receptors with bicuculline [14]. Similarly, 16 genes (Bdnf, Ptgs2, 
Homer1, Tac2, Egr1,2,4, Arc, Nrp1, TrkB, Vegf, Vgf, JunB, Nr4a3, cFos, and Syn2) 
regulated by increasing the electrical activity with electroconvulsive seizures in vivo 
were also up-regulated in our system. Moreover, 5 LTP genes (Egr2, Fos, Homer1, 
Nrgn, and Rab3a) found in our investigation and listed in Table 2 were also up-
regulated by a tetanic stimulation of the perforant path, a well known protocol for 
LTP induction in the hippocampus [54]. Therefore, despite experimental differences, 
these investigations identify several genes commonly up-regulated in many forms of 
LTP. 
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Conclusion 
By combining MEA and DNA microarrays, we were able to identify distinct events 
in neuronal plasticity initiated by GabT of hippocampal neuronal cultures: (i) within 
5-10 minutes the MAPK/ERK pathways are activated and likely underlie E-Sync via 
phosphorylation of several target proteins; (ii) a cluster of genes (Cluster 1), 
primarily composed by transcription factors such as members of the EGR and Nr4a 
families, is stimulated reaching its maximal up-regulated 1.5 h after GabT; (iii) some 
hundred genes many of which  known to be involved in LTP (Cluster 2) are 
successively stimulated and reach their maximal expression  about 3 h after GabT. 
These genes could underlie M-LTP observed at similar times after GabT; (iv) several 
genes coding for K+ channels and the HCN1 channels are down-regulated at later 
times from 6-24 hours after GabT. Down-regulation of these genes can be one of the 
several mechanisms responsible for L-Sync; (v) a late up-regulation occurring 24 h 
after GabT of several genes (Cluster 3) involved in cellular homeostasis. These 
results allow relating changes of electrical properties occurring during neuronal 
plasticity to specific underlying molecular events. In the near future we will extend 
our analysis to organotypic hippocampal slices and we will analyze changes of gene 
expression when neuronal plasticity is stimulated with conventional electrical 
protocols for inducing LTP. 
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Figure Legends 
Figure 1. Synchronization of the spontaneous electrical activity induced by GabT. 
The spontaneous electrical activity of hippocampal cultures grown on MEAs for 
three weeks was recorded for 10 min before the addition (control) and during 
treatment with gabazine (50 M for 30min, GabT). A, Representative traces from 
three individual extracellular electrodes showing the presence of synchronized bursts 
of electrical activity during GabT and at different time points following gabazine 
washout. B, Raster plots of the activity of all 60 MEA electrodes. Each horizontal 
line represents the activity of a single electrode. Synchronous bursts are represented 
by black vertical lines. Spikes between synchronous bursts are drastically reduced 
during GabT and after the drug washout. C, Network firing rate (NFR) expressed as 
the total number of spikes recorded from all the MEA electrodes in bins of 250 ms. 
The scale bar on the left is similar for all conditions except during GabT. Data from a 
single experiment shown in (A-C). D, Time course of the average NFR. E, Time 
course of the average network synchronicity. The degree of network synchronization 
was estimated by averaging the network cross-correlation over all electrode pairs 
see Methods. F, Time course of the fraction of silent periods, defined as the fraction 
of frames containing ten or less spikes, showing the reduction of the number of 
individual spikes during and after GabT. Bin size was 250 ms. n = 5 cultures for (D, 
E F). Values were normalized relative to control values. Error bars are mean ± s.e.m. 
 
Figure 2. Effects of MAPK inhibitors and Actinomycin D on early and late 
gabazine-induced synchronization A, Left, Average NFR time course in the presence 
of the MAPK cascade inhibitors PD98059 and U0126 (red trace). Data for PD98059 
(50 M; n = 3) and U0126 (20 M; n = 3) were pooled together as they affected 
similarly network properties. The NFR fluctuates around the baseline after GabT and 
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is not potentiated unlike in control conditions (black trace). U0126 and PD98059 
were preincubated 20 and 45 minutes before GabT, respectively, and washed out 
with gabazine. Right, Actinomycin D decreases slightly the NFR. B, E-Sync and L-
Sync depend on different signaling pathways. Left, network synchronicity is 
abolished in the presence of PD98059 or U0126. Right, in the presence of 
Actinomycin D, L-Sync but not E-sync is blocked, indicating that L-Sync depends on 
gene transcription. C, Time course of the fraction of silent periods containing ten or 
less spikes. Left, blockers of the MAPK pathway reduces the fraction of silent 
periods following GabT, i.e. the number of individual spikes increase in the network. 
Right, in presence of Actinomycin D, the fraction of silent periods is smaller than 
control value after tens of hours. Bin size was 250ms. Values were normalized 
relative to control values.  
 
Figure 3. Potentiation of the evoked response induced by GabT. A, Examples of the 
evoked activity’s time course for a single trial for three representative electrodes 
located at 0.5, 1 and 2 mm distance (see inset) from the stimulating electrode 
respectively (black bar in inset). The number of evoked spikes increases following 
the GabT. Hippocampal cultures were stimulated with the lowest intensity (200-450 
mV) evoking a response. 40 pulses (trials) with an inter-pulse interval 4s were used. 
Inset, graphical representation of the MEA grid. Each square represents an electrode. 
Distance between electrodes is 500 m. Black bar corresponds to the stimulated 
electrodes and grey numbered squares to the electrodes whose activity is shown in 
(A). B, Raster plots of the spikes evoked in one electrode at each time point analyzed. 
Each horizontal line represents the response to one trial recorded up to 250 ms after 
the stimulus onset. C, Time course of the NFR. The total number of evoked spikes 
was counted in 10 ms bins, following electrical stimulation. The increase of evoked 
spike is especially pronounced in the first 100 ms following stimulation. Data from a 
single experiment shown in (A-C). D, Average time course of the NFR (n=5 
 69 
cultures). The NFR was normalized relative to control values. Bin size was 250 ms. 
E, Ten overlapping spike traces in control conditions (black traces) and 3h after 
gabazine washout (red traces) of an individual electrode showing the decrease of the 
latency of the first evoked spike. Artifacts have been truncated for clarity. F, Time 
course of the latency (blue traces) and jitter (red traces) of the first spike for three 
neurons showing that the latency and jitter decrease after GabT. Each symbol 
corresponds to a different neuron. G, Time course of the activity propagation 
constant (see Methods showing the increase of the activity spread following 
GabT. Inset, the number of spikes in a 100 ms time window was counted and 
averaged, for electrodes located at 0.5, 1 and 2 mm from the stimulated bar of 
electrodes, and fitted with an exponential function /dAe (grey line). Colours as in 
(E).  
 
Figure 4. Gene expression profile revealed by DNA microarrays. A, Time course of 
all the probe sets unequivocally hybridized. B, Time course the 132 probe sets in A 
whose variance is bigger than 0.6 over the entire time course. C-E, Time course of 
three gene clusters identified in (B). The clusters were identified using the K-means 
method between the specific time profiles (blue traces in B) and the entire probe set 
shown in (A). F, Changes of gene expression occurring 1.5 h and 3 h after GabT  
measured  by Real-Time PCR for  Egr1, Nr4a1, Arc, Homer1a and Bdnf. See also 
Table 1 for a list of genes up-regulated 1.5h after gabazine washout in cluster 1 and 
Table 2 for a list of genes known to be involved in neuronal plasticity and belonging 
to Cluster 1 and 2. 
 
Figure 5. Effect of inhibitors of the MAPK pathway. A, Representative traces from 
two individual extracellular electrodes in control conditions (left) and in presence of 
50 M PD98059 (right). B, Corresponding network firing rate computed with a bin 
width of 25 ms, in normal conditions (left) and in presence of 50 M PD98059 
(right) showing a depression of the spontaneous electrical activity by PD98059. 
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Dotted line indicates zero spike. C, The evoked activity is still potentiated when the 
MAPK pathway was blocked before GabT (see Results). Dashed line corresponds to 
potentiation of the evoked activity without blocking the MAPK pathway before 
GabT. Data for PD98059 (50 M; n = 3) and U0126 (20 M; n = 3) were pooled 
together as they affected similarly network properties. D, Changes of gene expression 
occurring 1.5 h after GabT  measured  by Real-Time PCR for Egr1, Egr2, Egr3, 
Nr4a1, Bdnf, Homer1a and Arc in presence of gabazine and PD98059 (gray bars) 
relative to normalized expression in presence of gabazine alone (black bar).   
 
Figure 6. Ionic channels expression and K+ channel blockers induced-
synchronization. A-F, Time course of the ionic channels and receptors channels 
expression induced by GabT. Red bars correspond to the mean. Horizontal blue bars 
correspond to the first and third quartile. Red crosses represent deviation from the 
mean. G-I, Effects of K+ channels blockers on the network synchronization. Three 
representative electrodes showing the synchronous bursting induced by 100 M 4-
aminopyridine (4-AP, G), 10 mM tetra-etylammonium (TEA, H) and 100 M 
ZD7288 (I), respectively. Bottom panels show the average network firing rate 
computed with a bin width of 100ms. Dashed lines correspond to zero spike. Note the 
absence of individual spikes in the intra-burst intervals in (H). J, Summary of the 
effect of diverse K+ and HCN channel blockers on the average network correlation 
coefficient see Methods.  
 
Figure 7. Gabazine treatment does not interfere with the cell culture integrity. A, 
Staining of hippocampal cells in control conditions with different markers. Nuclei 
positive to TUNEL assay (green, left panel). Neurons expressing type III tubulin 
recognized by TUJ1 antibody (red, middle panel); total nuclei stained with DAPI 
(blue, right panel). Scale bar 20 m. B, Merge pictures of the three markers shown in 
(A), in control conditions (left), 24 h (middle) and 48 h (right) after gabazine 
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treatment demonstrating the absence of apoptosis by this treatment. Scale bar as in 
(A). C, Modification of the network activity by GABA. Top panels, The NFR and 
bursting activity in control conditions (left) are drastically reduced in the presence of 
30 M GABA (right). Bottom panels, raster plots. D, Similar to C but 24h after 
gabazine washout. The same reduction of bursting activity by GABA is observed for 
cultures treated with gabazine. Eime course of the network 
synchronicityfollowing repeated GabT. GBZ 1, 2 and 3 correspond to the first, 
second and third GabT, respectively.  
 
Table 1: List of genes present in Cluster 1, i.e. maximally up-regulated at 1.5h after 
gabazine wash-out. 
 
Table 2: List of genes present in Cluster 1 and 2 known to be involved in LTP. 
 
Table 3: List of genes involved in structural, pre- and post-synaptic processes. 
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TABLE 1 Genes belonging to Cluster 1 and up-regulated at 90 minutes after gabazine wash-out 
 
 
Gene Symbol   Gene Name            TF*   LTP   Reference 
Arc Activity regulated cytoskeletal-associated protein  + Rodriguez JJ et al. (2005) Eur. J. Neurosci. 
21:2384 
Arf4l_pred. ADP-ribosylation factor-like 4D    
Dusp5 Dual specificity phosphatase 5  + Hevroni D et al. (1998) J. Mol. Neurosci.10:75 
Egr1 Early growth response 1 + + M. W. Jones et al.(2001) Nat. Neurosci. 4: 289 
Egr2 Early growth response 2 + + Williams J et al. (1995) Mol. Brain Res. 28: 87 
Egr3 Early growth response 3 + + Li L et al. (2007) Mol. Cell. Neurosci. 35:76 
Egr4 Early growth response 4 +   
Gem_pred. GTP binding protein (expressed in skeletal muscle)    
Homer1 Homer homolog 1 (Drosophila)  + Kato A et al. (2003) Mol. Brain Res. 118: 33 
Jmjd3_pred. Jumonji domain containing 3    
Junb Jun-B oncogene + + Abraham WC et al. (1991) Mol Neurobiol. 5:297 
Klf2_predicted Kruppel-like factor 2 +   
Klf7_predicted Kruppel-like factor 7 +   
LOC684871     
LOC686523     
Mmp12 Matrix metallopeptidase 12    
Nfil3 Nuclear factor, interleukin 3 regulated +   
Nr4a1 Nuclear receptor subfamily 4, group A, member1 + + Dragunow M. et al. (1996) Mol. Brain 
Res.36:349 
Nr4a2 Nuclear receptor subfamily 4, group A, member2 +   
Nr4a3 Nuclear receptor subfamily 4, group A, membe 3 +   
Ptgs2 Prostaglandin-endoperoxide synthase 2  + Slanina KA et al. (2005) Neuropharmacol. 
49:660 
RGD1306880_pred.     
Rgs4 Regulator of G-protein signaling 4    
Serpinb2 Serpin peptidase inhibitor, clade B member2    
Tfpi2 Tissue factor pathway inhibitor 2    
 
* TF Transcription factor 
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TABLE 2 Genes involved in LTP  in cluster 1 and 2        
 
          Gene   Gene Name          Cluster         Reference 
         Symbol                                                                   1        2    
S Arc Activity regulated cytoskeletal-associated protein  +  Rodriguez JJ et al. 2005 Eur. J. Neurosci. 21:2384 
p Bdnf  Brain derived neurotrophic factor  + Ying S-W et al. (2002) J. Neurosci. 22:1532 
P Camk2a Calcium/calmodulin-dependent protein kinase II,    + Wang H et al. (2004) Nat. Neurosci. 7:635 
- Cck Cholecystokinin  + Balschun D et al (1994) Neuropeptides 26:421 
p Cplx2 Complexin 2  + Gibson HE (2005) Eur J Neurosci.22:1701 
- Dusp5  Dual specificity phosphatase 5 +  Hevroni D et al. (1998) J. Mol. Neurosci.10:75 
T Egr1  Early growth response 1  +  M. W. Jones et al.(2001) Nat. Neurosci. 4: 289 
T Egr2  Early growth response 2  +  Williams J et al. (1995) Mol. Brain Res. 28: 87 
T Egr3  Early growth response 3 +  Li L et al (2007) Mol. Cell. Neurosci. 35:76 
T Fos  FBJ murine osteosarcoma viral oncogene homolog   + Dragunow M et al. (1989) Neurosci Lett. 101:274 
C Gria1 Glutamate receptor, ionotropic, AMPA1 (alpha 1)  + Mead  AN et al (2003a) J. Neurosci.  23:1041 
C Gria2 Glutamate receptor, ionotropic, AMPA1 (alpha 2)  + Mead & Stephens (2003b) J Neurosci. 23:9500 
- Grp Gastrin releasing peptide  + Shumyatsky GP et al. (2002) Cell 111: 905 
S Homer1  Homer homolog 1 (Drosophila) + + Kato A et al. (2003) Mol. Brain Res. 118: 33 
T Junb  Jun-B oncogene  +  Abraham WC et al (1991) Mol Neurobiol. 5:297 
C Kcna4 Potassium voltage-gated channel, shaker-related, 4  + Meiri N et al (1998)Proc Natl Acad Sci U S A. 95:15037 
C Kcnab1 Potassium voltage-gated channel shaker-related,  1  + Murphy GG et al (2004) Curr Biol 14:1907 
C Kcnd2 Potassium voltage-gated channel, Shal-related, 2  + Chen X et al (2006) J Neurosci 26:12143 
C Kcnn2 Potassium calcium-activated channel subfamily N, 2  + Kramar EA et al. (2004) J. Neurosci. 24:5151 
p L1cam L1 cell adhesion molecule  + Itoh K et al(2005) Mol CellNeurosci. 29:245 
p Nptx1 Neuronal pentraxin 1  + Ring et al. (2006) J. Neurobiol. 66:361 
T Nr4a1  Nuclear receptor subfamily 4, group A, member 1  +  Dragunow M. et al. (1996) Mol. Brain Res.36:349 
P Nrgn Neurogranin  + Kuo-Ping Huang et al. (2004) J. Neurosci. 24:10660  
- Nsg1 Neuron specific gene family member 1  + Ernfors et al.(2003)TRENDS in Neuroscience 26: 171 
P Ntrk2 Neurotrophic tyrosine kinase, receptor, type 2 (TrkB)  + Gooney M. et al (2001) J. Neurochem. 77: 1198 
P Ntrk3 Neurotrophic tyrosine kinase, receptor, type 3 (TrkC)  + Bramham CR (1996) J. Comp. Neurol. 368:371 
- Pnoc Prepronociceptin  + Ring et al. (2006) J. Neurobiol. 66:361 
- Prkar1b Proteinkinase,cAMPdependent regulatory, type1, beta  + Hensch TK et al (1998) J.Neurosci. 18:2108 
- Prkcc Protein kinase C, gamma  + Gärtner A (2006) J. Neurosci. 26:3496 
P Ptgs2 Prostaglandin-endoperoxide synthase 2 (Cox2) +  Slanina KA et al., (2005) Neuropharmacol. 49:660 
p Rab3a RAB3A, member RAS oncogene family   + Castillo PE et al. (1997) Nature 388: 590 
- Reln Reelin  + Weeber et al. (2002) J.Biol. Chem. 277:39944 
p Rgs2 Regulator of G-protein signaling 2  + Ingi T et al (1998) J. Neurosci. 19:7179 
- Rnf39 Ring finger protein 39  + Matsuo R et al. (2001) BBRC 288: 479 
- Ryr2 Ryanodine receptor 2  + Welsby P. et al. (2006) Eur. J. Neurosci. 24: 3109  
P Shank1 SH3 and multiple ankyrin repeat domain 1  + Hung AY et al (2008) J.Neurosci. 28:1697 
p Snap25 Synaptosomal-associated protein 25  + Roberts LA et al (1998) Neuroreport 9:33 
p Stx1a Syntaxin 1A (brain)   + Fujiwara et al. (2006) J. Neurosci. 26:5767 
p Stx1b2 Syntaxin 1B2  + Helme-Guizon et al. (1998) Eur. J. Neurosci. 10:2231 
p Syn1 Synapsin I  + Sato K et al. 2000 Brain Res. 872:219  
p Syn2 Synapsin II  + Spillane et al. (1995) Neuropharmacol 34:1573 
p Syp Synaptophysin  + Janz R. et al.(1999) Neuron 24: 687 
- Vsnl1 Visinin-like 1  + Brackmann M.et al. (2004) BBRC 322: 1073 
 
         * S= Structural p=presynaptic P=postsynaptic T= transcription factor C= channel 
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TABLE 3 List of genes involved in structural, pre- and post-synaptic processes 
Gene Name Gene Symbol Cluster 
Presynaptic   
ATPase, Ca++ transporting, plasma membrane 2 Atp2b2 2 
ATPase, H+ transporting, V1 subunit G isoform 2 Atp6v1g2 2 
Complexin 1 Cplx1 2 
Dynamin 1 Dnm1 2 
EF hand calcium binding protein 2 Efcbp2 o NECAB2 2 
Kinesin family member 1A Kif1a 2 
Protein kinase C and casein kinase substrate in neurons 1 Pacsin1 o syndapin I 2 
Protein tyrosine phosphatase, receptor type, f polypeptide, interacting protein (liprin), α3 Ppfia3 2 
Regulator of G-protein signaling 4 Rgs4 2 
Regulator of G-protein signaling 7 Rgs7 2 
Solute carrier family 17 (Na-dependent inorganic phosphate cotransporter), member 6 Slc17a6 2 
Solute carrier family 17 (Na-dependent inorganic phosphate cotransporter), member 7 Slc17a7 2 
Solute carrier family 32 (GABA vesicular transporter), member 1 Slc32a1 2 
Solute carrier family 6 (neurotransmitter transporter, GABA), member 1 Slc6a1 o GAT1 2 
Somatostatin Sst 2 
Spectrin beta 3 Spnb3 2 
Synaptic vesicle glycoprotein 2a Sv2a 2 
Synaptogyrin 3 (predicted) Syngr3_predicted 2 
Synaptoporin Synpr 2 
Synaptotagmin I Syt1 2 
Synaptotagmin XIII Syt13 2 
Synaptotagmin-like 2 (predicted) Sytl2_predicted 3 
Synuclein, alpha Snca 2 
Synuclein, beta Sncb 2 
Vesicle-associated membrane protein 1 Vamp1 2 
Vesicular membrane protein p24 (predicted) Vmp_predicted 2 
Postsynaptic   
Calcium binding protein 1 Cabp1 2 
Calcium/calmodulin-dependent protein kinase II, alpha Camk2a 2 
Connector enhancer of kinase suppressor of Ras 2 Cnksr2 2 
Dendrin Ddn 2 
Dipeptidylpeptidase 10 Dpp10 2 
Discs, large homolog 2 (Drosophila) Dlgh2 2 
Dopamine receptor D1 interacting protein Drd1ip 2 
G protein-coupled receptor 85 Gpr85 2 
Glycine receptor, alpha 2 subunit Glra2 2 
Guanine nucleotide binding protein, gamma 2 Gng2 2 
Inositol 1,4,5-trisphosphate 3-kinase A Itpka 2 
Junctophilin 3 (predicted) Jph3_predicted 2 
Kinesin family member C2 KIFC2 2 
Leucine rich repeat and fibronectin type III domain containing 5 (predicted) Lrfn5_predicted 2 
Lin-7 homolog b (C. elegans) Lin7b o MALS 2 
N-ethylmaleimide sensitive fusion protein Nsf 2 
Opioid binding protein/cell adhesion molecule-like Opcml o OBCAM 2 
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Protein kinase C, epsilon Prkce 2 
Protein tyrosine phosphatase, non-receptor type 5 Ptpn5 o STEP  2 
Protein tyrosine phosphatase, receptor type, R Ptprr 2 
Rap guanine nucleotide exchange factor (GEF) 4 Rapgef4 2 
Solute carrier family 12, (potassium-chloride transporter) member 5 Slc12a5 o KCC2 2 
Somatostatin receptor 1 Sstr1 2 
Somatostatin receptor 2 Sstr2 2 
Structural    
Cadherin 10 Cdh10 2 
Cadherin 11 Cdh11 2 
Calcium/calmodulin-dependent protein kinase II, beta Camk2b 2 
Doublecortin Dcx 2 
Down syndrome cell adhesion molecule Dscam 2 
Fibulin 2 Fbln2 3 
Integrin alpha 1 Itga1 3 
Lysyl oxidase Lox 3 
Microtubule-associated protein tau Mapt 2 
Neurexin 3 Nrxn3 2 
Neurexophilin 1 Nxph1 2 
Neurofilament, heavy polypeptide Nefh 2 
Neurofilament, light polypeptide Nefl 2 
Neurotrimin Hnt 2 
Nexilin Nexn 3 
Nidogen 2 Nid2 3 
Plakophilin 2 Pkp2 3 
Plasticity related gene 1 Prg1 2 
Pregnancy upregulated non-ubiquitously expressed CaM kinase Pnck 2 
Procollagen, type I, alpha 2 Col1a2 3 
Procollagen, type IV, alpha 1 Col4a1 3 
Procollagen, type V, alpha 2 Col5a2 3 
Procollagen, type XI, alpha 1 Col11a1 3 
Protocadherin 17 (predicted) Pcdh17_predicted 2 
Protocadherin 20 (predicted) Pcdh20_predicted 2 
Protocadherin 8 Pcdh8 2 
Rho guanine nucleotide exchange factor 7 Arhgef7 2 
Seizure related 6 homolog (mouse) Sez6 2 
SLIT and NTRK-like family, member 1 (predicted) Slitrk1_predicted 2 
Stathmin-like 3 Stmn3 o SCLIP 2 
Stathmin-like 4 Stmn4 o RB3 2 
T-cell lymphoma invasion and metastasis 1 Tiam1 2 
Thrombospondin 1 Thbs1 3 
Tissue inhibitor of metalloproteinase 3 Timp3 3 
Transgelin Tagln 3 
Tubulin, beta 3 Tubb3 2 
Tubulin, beta 4 Tubb4 2 
Unc-5 homolog C (C. elegans) Unc5c 3 
Vasoactive intestinal polypeptide Vip 2 
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Supplementary Table S1 
 
List of all genes present in clusters 1, 2 and 3 
 
CLUSTER 1       
Affymetrix ID GenBank 
ID 
Gene Name Gene Symbol 
1387068_at NM_019361 Activity regulated cytoskeletal-associated protein Arc 
1380383_at AI030650 ADP-ribosylation factor 4-like (predicted) Arf4l_predicted 
1368124_at NM_133578 Dual specificity phosphatase 5 Dusp5 
1368321_at NM_012551 Early growth response 1 Egr1 
1387306_a_at NM_053633 Early growth response 2 Egr2 
1392791_at AA964492 Early growth response 3 Egr3 
1387442_at NM_019137 Early growth response 4 Egr4 
1382351_at AI069972 GTP binding protein (gene overexpressed in skeletal muscle) (predicted) Gem_predicted 
1370997_at AF030088 Homer homolog 1 (Drosophila) Homer1 
1390000_at BE118720 Jumonji domain containing 3 (predicted) Jmjd3_predicted 
1387788_at NM_021836 Jun-B oncogene Junb 
1376569_at BM385790 Kruppel-like factor 2 (lung) (predicted) Klf2_predicted 
1380363_at BF420490 Kruppel-like factor 7 (ubiquitous) (predicted) Klf7_predicted 
1373403_at AI230625 Similar to Protein C8orf4 (Thyroid cancer protein 1) (TC-1) LOC684871 
1397460_at BE119491 Similar to G protein-coupled receptor 158 isoform a LOC686523 
1368530_at NM_053963 Matrix metallopeptidase 12 Mmp12 
1368488_at NM_053727 Nuclear factor, interleukin 3 regulated Nfil3 
1386935_at NM_024388 Nuclear receptor subfamily 4, group A, member 1 Nr4a1 
1369007_at L08595 Nuclear receptor subfamily 4, group A, member 2 Nr4a2 
1369067_at NM_031628 Nuclear receptor subfamily 4, group A, member 3 Nr4a3 
1368527_at U03389 Prostaglandin-endoperoxide synthase 2 Ptgs2 
1397241_at BE101570 Similar to hypothetical protein MGC47816 (predicted) RGD1306880_predicted 
1368506_at U27767 Regulator of G-protein signaling 4 Rgs4 
1368487_at NM_021696 Serine (or cysteine) proteinase inhibitor, clade B, member 2 Serpinb2 
1377340_at AI179507 Tissue factor pathway inhibitor 2 Tfpi2 
     
CLUSTER 2       
Affymetrix ID GenBank 
ID 
Gene Name Gene Symbol 
1384869_at AW531594 Abhydrolase domain containing 7 (predicted) Abhd7_predicted 
1370206_at BM386997 Amiloride-sensitive cation channel 4, pituitary Accn4 
1382608_at BI281712 Actin-like 6B (predicted) Actl6b_predicted 
1370638_at AF069525 Ankyrin 3, epithelial Ank3 
1385910_at AW533307 Rho guanine nucleotide exchange factor 7 Arhgef7 
1376198_at BI303342 Adipocyte-specific adhesion molecule Asam 
1393141_at BF285419 Aspartate-beta-hydroxylase (predicted) Asph_predicted 
1383340_at BG671011 Ataxia, cerebellar, Cayman type (caytaxin) (predicted) Atcay_predicted 
1368701_at NM_012506 ATPase, Na+/K+ transporting, alpha 3 polypeptide Atp1a3 
1368698_at J03754 ATPase, Ca++ transporting, plasma membrane 2 Atp2b2 
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1388037_at J05087 ATPase, Ca++ transporting, plasma membrane 3 Atp2b3 
1377722_at BE100072 ATPase, H+ transporting, V1 subunit G isoform 2 Atp6v1g2 
1369755_at AF106624 Beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S) B3gat2 
1383010_at AW531880 B-cell CLL/lymphoma 11A (zinc finger protein) Bcl11a 
1391948_at BM390227 B-cell leukemia/lymphoma 11B (predicted) Bcl11b_predicted 
1368677_at NM_012513 Brain derived neurotrophic factor Bdnf 
1388802_at AI579422 Brain expressed X-linked 1 Bex1 
1381995_at AW530502 Bruno-like 4, RNA binding protein (Drosophila) (predicted) Brunol4_predicted 
1376707_at AW918311 C1q and tumor necrosis factor related protein 4 (predicted) C1qtnf4_predicted 
1386922_at AI408948 Carbonic anhydrase 2 Ca2 
1369886_a_at AJ315761 Calcium binding protein 1 Cabp1 
1390358_at BF405996 Calcium channel, voltage-dependent, alpha 2/delta 3 subunit Cacna2d3 
1382898_at BG376849 Calcium channel, voltage-dependent, beta 4 subunit Cacnb4 
1368759_at NM_053351 Calcium channel, voltage-dependent, gamma subunit 2 Cacng2 
1370757_at AF361340 Calcium channel, voltage-dependent, gamma subunit 3 Cacng3 
1387133_at NM_053988 Calbindin 2 Calb2 
1391229_at BG381458 Calcium/calmodulin-dependent protein kinase I gamma Camk1g 
1388187_at BM384558 Calcium/calmodulin-dependent protein kinase II, alpha Camk2a 
1398251_a_at NM_021739 Calcium/calmodulin-dependent protein kinase II, beta Camk2b 
1368845_at NM_024000 CaM kinase-like vesicle-associated Camkv 
1370438_at AF037071 C-terminal PDZ domain ligand of neuronal nitric oxide synthase Capon 
1385519_at BE105678 CBFA2T1 identified gene homolog (human) (predicted) Cbfa2t1_predicted 
1387032_at NM_012829 Cholecystokinin Cck 
1369670_at NM_031518 Cd200 antigen Cd200 
1391127_at BF400818 Cell division cycle 42 homolog (S. cerevisiae) Cdc42 
1380317_at BF402765 Cadherin 10 Cdh10 
1391146_at BE111632 Cadherin 11 Cdh11 
1369425_at NM_138889 Cadherin 13 Cdh13 
1368887_at NM_019161 Cadherin 22 Cdh22 
1387194_at U51013 Centaurin, alpha 1 Centa1 
1397549_at AW526039 Centaurin, gamma 1 Centg1 
1373256_at BM391119 Chromodomain helicase DNA binding protein 3 Chd3 
1387235_at NM_021655 Chromogranin A Chga 
1368034_at NM_012526 Chromogranin B Chgb 
1368287_at NM_032083 Chimerin (chimaerin) 1 Chn1 
1387462_at NM_012527 Cholinergic receptor, muscarinic 3 Chrm3 
1395429_at BF281401 Cholinergic receptor, nicotinic, alpha polypeptide 7 Chrna7 
1394334_at BF545197 Carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8 (predicted) Chst8_predicted 
1390566_a_at BI301453 Creatine kinase, mitochondrial 1, ubiquitous Ckmt1 
1372492_at AI412937 Claudin 10 (predicted) Cldn10_predicted 
1369731_at AF102854 Connector enhancer of kinase suppressor of Ras 2 Cnksr2 
1369964_at NM_130411 Coronin, actin binding protein 1A Coro1a 
1368648_at NM_053472 Cytochrome c oxidase subunit IV isoform 2 Cox4i2 
1398357_at BI281575 Complexin 1 Cplx1 
1368584_a_at NM_053878 Complexin 2 Cplx2 
1384780_at BF402747 Copine IV (predicted) Cpne4_predicted 
1368381_at NM_134401 Cartilage acidic protein 1 Crtac1 
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1368059_at NM_053955 Crystallin, mu Crym 
1368200_at NM_134455 Chemokine (C-X3-C motif) ligand 1 Cx3cl1 
1369408_at NM_080482 Deleted in bladder cancer chromosome region candidate 1 (human) Dbccr1 
1374966_at BE109057 Doublecortin Dcx 
1388177_at X96589 Dendrin Ddn 
1387265_at NM_013126 Diacylglycerol kinase, gamma Dgkg 
1375433_at AI412473 Dispatched homolog 2 (Drosophila) (predicted) Disp2_predicted 
1375139_at BF406295 Discs, large homolog 2 (Drosophila) Dlgh2 
1392064_at BF400590 Distal-less homeobox 1 Dlx1 
1377125_at AW523481 DnaJ (Hsp40) homolog, subfamily C, member 6 (predicted) Dnajc6_predicted 
1368292_at NM_080689 Dynamin 1 Dnm1 
1393299_at BF567794 Dipeptidylpeptidase 10 Dpp10 
1376345_at BG381734 Dopamine receptor D1 interacting protein Drd1ip 
1368699_at NM_133587 Down syndrome cell adhesion molecule Dscam 
1391246_at BF390318 Dystrobrevin alpha (predicted) Dtna_predicted 
1387025_at NM_019234 Dynein cytoplasmic 1 intermediate chain 1 Dync1i1 
1367799_at NM_012660 Eukaryotic translation elongation factor 1 alpha 2 Eef1a2 
1368443_at NM_133415 EF hand calcium binding protein 2 Efcbp2 
1383078_at BG381007 Ephrin B3 (predicted) Efnb3_predicted 
1383736_at AI145457 ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B) Elavl2 
1368114_at NM_053428 Fibroblast growth factor 13 Fgf13 
1375043_at BF415939 FBJ murine osteosarcoma viral oncogene homolog Fos 
1387383_at NM_031802 Gamma-aminobutyric acid (GABA) B receptor 2 Gabbr2 
1380828_at AI145413 Gamma-aminobutyric acid A receptor, alpha 1 Gabra1 
1371057_at AW520967 Gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 Gabra5 
1369904_at NM_012956 Gamma-aminobutyric acid (GABA-A) receptor, subunit beta 1 Gabrb1 
1391653_at BE120391 Gamma-aminobutyric acid A receptor, gamma 2 Gabrg2 
1396238_at AI763990 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-
acetylgalactosaminyltransferase 14 
Galnt14 
1387696_a_at X61159 Glycine receptor, alpha 2 subunit Glra2 
1367633_at BI296610 Glutamate-ammonia ligase (glutamine synthase) Glul 
1387906_a_at AF107845 GNAS complex locus Gnas 
1386660_at BF565021 Guanine nucleotide binding protein, gamma 2 Gng2 
1368272_at D00252 Glutamate oxaloacetate transaminase 1 Got1 
1368786_a_at NM_030831 G-protein coupled receptor 12 Gpcr12 
1384004_at AI030360 G protein-coupled receptor 158 (predicted) Gpr158_predicted 
1382319_at BM389005 G protein-coupled receptor 68 (predicted) Gpr68_predicted 
1368299_at NM_080411 G protein-coupled receptor 83 Gpr83 
1387666_at AF203907 G protein-coupled receptor 85 Gpr85 
1375050_at BI294558 G protein-regulated inducer of neurite outgrowth 1 (predicted) Gprin1_predicted 
1371013_at BG376217 Glutamate receptor, ionotropic, AMPA1 (alpha 1) Gria1 
1394578_at BI299761 Glutamate receptor, ionotropic, AMPA2 Gria2 
1368572_a_at NM_017010 Glutamate receptor, ionotropic, N-methyl D-aspartate 1 Grin1 
1368306_at U08259 Glutamate receptor, ionotropic, NMDA2C Grin2c 
1387286_at NM_017011 Glutamate receptor, metabotropic 1 Grm1 
1388189_at AW522430 Glutamate receptor, metabotropic 3 Grm3 
1368611_at NM_133570 Gastrin releasing peptide Grp 
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1369097_s_at NM_012769 Guanylate cyclase 1, soluble, beta 3 Gucy1b3 
1379920_at BG671844 Hyperpolarization-activated cyclic nucleotide-gated potassium channel 1 Hcn1 
1374105_at H31665 Hypoxia induced gene 1 Hig1 
1368255_at NM_017354 Neurotrimin Hnt 
1370454_at AB003726 Homer homolog 1 (Drosophila) Homer1 
1375765_at BI296503 Hippocalcin-like 4 Hpcal4 
1386953_at NM_017080 Hydroxysteroid 11-beta dehydrogenase 1 Hsd11b1 
1373480_at BG670210 Heat shock 70kDa protein 12A (predicted) Hspa12a_predicted 
1387226_at NM_019128 Internexin, alpha Inexa 
1391036_at BG376106 IQ motif and Sec7 domain 3 Iqsec3 
1387291_at NM_017351 Inter-alpha trypsin inhibitor, heavy chain 3 Itih3 
1368462_at NM_031045 Inositol 1,4,5-trisphosphate 3-kinase A Itpka 
1385562_at AI059487 Jjunctophilin 3 (predicted) Jph3_predicted 
1369043_at NM_012971 Potassium voltage-gated channel, shaker-related subfamily, member 4 Kcna4 
1378738_at BE097574 Potassium voltage-gated channel, shaker-related subfamily, beta member 1 Kcnab1 
1368524_at NM_012856 Potassium voltage gated channel, Shaw-related subfamily, member 1 Kcnc1 
1370439_a_at M34052 Potassium voltage gated channel, Shaw-related subfamily, member 2 Kcnc2 
1379863_at AW528891 Potassium voltage gated channel, Shal-related family, member 2 Kcnd2 
1373987_at AI410448 Kv channel-interacting protein 2 Kcnip2 
1383220_at BE114231 Kv channel interacting protein 4 Kcnip4 
1373991_at AI411366 Potassium inwardly-rectifying channel, subfamily J, member 16 Kcnj16 
1369035_a_at AB073753 Potassium inwardly-rectifying channel, subfamily J, member 6 Kcnj6 
1370111_at NM_019314 Potassium intermediate/small conductance calcium-activated channel, 
subfamily N, member 2 
Kcnn2 
1392785_at AA800908 Potassium channel tetramerisation domain containing 12 (predicted) Kctd12_predicted 
1397505_at BE115743 Kinesin family member 1A Kif1a 
1380172_at BE104278 Kinesin family member 5C (predicted) Kif5c_predicted 
1378197_at AW433953 Kinesin family member C2 KIFC2 
1369213_at NM_017345 L1 cell adhesion molecule L1cam 
1386023_at AI229354 Leucine-rich repeat LGI family, member 1 Lgi1 
1370078_at NM_021758 Lin-7 homolog b (C. elegans) Lin7b 
1382207_at BE097085 Similar to Cerebellin-2 precursor (Cerebellin-like protein) LOC288979 
1383571_at BF411217 Hypothetical protein LOC303515 LOC303515 
1377615_at AI112395 Similar to hypothetical protein LOC304280 
1391513_at BE110237 Similar to hypothetical protein FLJ20331 LOC310946 
1383422_at AW252401 Hypothetical LOC362564 LOC362564 
1380866_at AA817746 Similar to adenylate kinase 5 isoform 1 LOC365985 
1378904_at AW529244 Similar to solute carrier family 7, member 14 LOC499587 
1385950_at AI454926 Hypothetical protein LOC500102 LOC500102 
1391030_at AW524694 Similar to calmodulin-binding transcription activator 1 LOC500591 
1398659_at AW528611 Similar to crossveinless 2 CG15671-PA LOC501231 
1378857_at AI716196 Similar to transcription elongation factor A (SII)-like 5 LOC678833 
1381132_at AI501937 Similar to TAFA2 protein LOC680647 
1373648_at AI102627 Similar to Protein C6orf142 homolog LOC681849 
1376736_at BG375419 Hypothetical protein LOC683263 LOC683263 
1396388_at AW522161 Similar to Potassium channel tetramerisation domain-containing protein 4 LOC684884 
1396381_at BE097451 Hypothetical protein LOC684957 LOC684957 
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1378064_at AI144892 Hypothetical protein LOC689106 LOC689106 
1386119_at BE110033 Hypothetical protein LOC689147 LOC689147 
1398405_at BI289917 Similar to septin 6 LOC691335 
1384942_at AA818417 Leucine rich repeat and fibronectin type III domain containing 5 (predicted) Lrfn5_predicted 
1368964_at NM_030856 Leucine rich repeat protein 3, neuronal Lrrn3 
1387947_at U56241 V-maf musculoaponeurotic fibrosarcoma oncogene family, protein B (avian) Mafb 
1368137_at NM_017212 Microtubule-associated protein tau Mapt 
1387834_at NM_021859 Megakaryocyte-associated tyrosine kinase Matk 
1389605_at AI101952 Multiple coiled-coil GABABR1-binding protein MGC125215 
1376106_at AI010157 Similar to hypothetical protein MGC33926 MGC94782 
1370831_at AY081195 Monoglyceride lipase Mgll 
1388300_at AA892234 Microsomal glutathione S-transferase 3 (predicted) Mgst3_predicted 
1378430_at AI555053 Monooxygenase, DBH-like 1 Moxd1 
1370535_at U48809 Myelin transcription factor 1-like Myt1l 
1372953_at AI101330 Neurocalcin delta Ncald 
1367956_at NM_053543 Neurochondrin Ncdn 
1370815_at AF031879 Neurofilament, heavy polypeptide Nefh 
1370058_at NM_031783 Neurofilament, light polypeptide Nefl 
1370016_at NM_031070 Nel-like 2 homolog (chicken) Nell2 
1370977_at X66022 Neuronal d4 domain family member Neud4 
1387288_at NM_019218 Neurogenic differentiation 1 Neurod1 
1369999_a_at NM_053601 Neuronatin Nnat 
1370517_at U18772 Neuronal pentraxin 1 Nptx1 
1376362_at BG380575 Neuronal pentraxin receptor Nptxr 
1370211_at BE106940 Neurogranin Nrgn 
1370570_at AF016296 Neuropilin 1 Nrp1 
1368261_at NM_053817 Neurexin 3 Nrxn3 
1369689_at AF142097 N-ethylmaleimide sensitive fusion protein Nsf 
1387817_at NM_024128 Neuron specific gene family member 1 Nsg1 
1368972_at NM_012731 Neurotrophic tyrosine kinase, receptor, type 2 Ntrk2 
1368939_a_at L14447 Neurotrophic tyrosine kinase, receptor, type 3 Ntrk3 
1368688_at NM_022695 Neurotensin receptor 2 Ntsr2 
1369079_at NM_012994 Neurexophilin 1 Nxph1 
1368993_at NM_020088 Odd Oz/ten-m homolog 2 (Drosophila) Odz2 
1387927_a_at U03415 Olfactomedin 1 Olfm1 
1369417_a_at NM_053848 Opioid binding protein/cell adhesion molecule-like Opcml 
1368958_at NM_017294 Protein kinase C and casein kinase substrate in neurons 1 Pacsin1 
1395792_at AI549034 Poly(rC) binding protein 2 Pcbp2 
1384509_s_at BF558981 Protocadherin 17 (predicted) Pcdh17_predicted 
1391208_at BG379836 Protocadherin 20 (predicted) Pcdh20_predicted 
1368956_at NM_022868 Protocadherin 8 Pcdh8 
1368089_at NM_031079 Phosphodiesterase 2A, cGMP-stimulated Pde2a 
1389597_at BI293445 PiggyBac transposable element derived 5 (predicted) Pgbd5_predicted 
1374862_at AI764464 Phytanoyl-CoA hydroxylase interacting protein Phyhip 
1387281_a_at D86556 Pregnancy upregulated non-ubiquitously expressed CaM kinase Pnck 
1368369_at NM_013007 Prepronociceptin Pnoc 
1370432_at M72711 POU domain, class 3, transcription factor 1 Pou3f1 
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1382821_at AA998957 Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), 
interacting protein (liprin), alpha 3 
Ppfia3 
1379374_at AW526088 Plasticity related gene 1 Prg1 
1372382_at AW527165 Protein kinase, AMP-activated, gamma 2 non-catalytic subunit Prkag2 
1389463_at BG375376 Protein kinase, cAMP dependent regulatory, type I, beta Prkar1b 
1369089_at NM_012628 Protein kinase C, gamma Prkcc 
1374593_at AA799421 Protein kinase C, epsilon Prkce 
1368421_at NM_019253 Protein tyrosine phosphatase, non-receptor type 5 Ptpn5 
1371086_at BE096879 Protein tyrosine phosphatase, receptor type, F Ptprf 
1368358_a_at NM_053594 Protein tyrosine phosphatase, receptor type, R Ptprr 
1368674_at NM_022268 Liver glycogen phosphorylase Pygl 
1369004_at NM_133580 RAB26, member RAS oncogene family Rab26 
1369816_at NM_013018 RAB3A, member RAS oncogene family Rab3a 
1383826_at AA924620 Rab40b, member RAS oncogene family (predicted) Rab40b_predicted 
1388632_at BG665929 RAB6B, member RAS oncogene family (predicted) Rab6b_predicted 
1373631_at BF284067 RAP1, GTPase activating protein 1 Rap1ga1 
1371081_at U78517 Rap guanine nucleotide exchange factor (GEF) 4 Rapgef4 
1373666_at AI102560 Rap guanine nucleotide exchange factor (GEF) 5 Rapgef5 
1370372_at AF134409 RASD family, member 2 Rasd2 
1393081_at AI145237 RasGEF domain family, member 1A (predicted) Rasgef1a_predicted 
1369093_at NM_080394 Reelin Reln 
1370989_at AI639318 Ret proto-oncogene Ret 
1392315_at BE107351 REV1-like (S. cerevisiae) (predicted) Rev1l_predicted 
1384289_at BI281651 Similar to RIKEN cDNA 4631403P03 RGD1305276 
1373414_at BG380515 Similar to Brain specific membrane-anchored protein precursor RGD1305557 
1383706_at BF409331 Similar to RIKEN cDNA 2900011O08 RGD1305733 
1380852_at AI112346 Hypothetical LOC294883 RGD1305844 
1390167_at BI286834 Similar to hypothetical protein FLJ30373 (predicted) RGD1306256_predicted 
1380228_at BG672066 Similar to hypothetical protein MGC47816 (predicted) RGD1306880_predicted 
1385744_at BF389238 Similar to KIAA1679 protein (predicted) RGD1306938_predicted 
1383887_at AA924984 Similar to Protein C20orf103 precursor RGD1306991 
1374176_at AI408727 Similar to DNA segment, Chr 4, Brigham & Womens Genetics 0951 
expressed 
RGD1308059 
1376654_at AW521378 Similar to RIKEN cDNA B130016O10 gene (predicted) RGD1308448_predicted 
1393733_at BF402788 Similar to hypothetical protein FLJ20300 (predicted) RGD1309567_predicted 
1379894_at AI501165 Similar to 3632451O06Rik protein (predicted) RGD1310110_predicted 
1393841_at AA859317 Similar to hypothetical protein FLJ31810 (predicted) RGD1310773_predicted 
1376328_at BI278776 Similar to putative protein (5S487) (predicted) RGD1310819_predicted 
1383794_at AI575277 Similar to RIKEN cDNA A930038C07 (predicted) RGD1311080_predicted 
1390865_at AW524822 Similar to Ca2+-dependent activator for secretion protein 2 (predicted) RGD1559440_predicted 
1383800_at AW523537 Similar to expressed sequence AW121567 (predicted) RGD1559498_predicted 
1376901_a_at AA964675 Similar to Hypothetical protein 6330514E13 (predicted) RGD1559693_predicted 
1376460_at BI286710 Similar to ataxin 2-binding protein 1 isoform 2 (predicted) RGD1560070_predicted 
1391308_at AI101675 Similar to vacuolar protein sorting 13C protein (predicted) RGD1560364_predicted 
1373985_at BI282311 Similar to KIAA1183 protein (predicted) RGD1560435_predicted 
1393408_at BF567707 Similar to NEX-1 (predicted) RGD1562793_predicted 
1396206_at BG665525 Similar to Docking protein 5 (Downstream of tyrosine kinase 5) (Protein dok-
5) (predicted) 
RGD1562846_predicted 
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1376459_at AW533060 Similar to AP2 associated kinase 1 (predicted) RGD1563580_predicted 
1375305_at BI282028 RGD1563912 (predicted) RGD1563912_predicted 
1389086_at BF408444 Similar to RIKEN cDNA E430021N18 (predicted) RGD1564043_predicted 
1380901_at AW527298 Similar to synaptotagmin XIV-related protein Strep14 (predicted) RGD1564654_predicted 
1379460_at BF387898 Similar to RIKEN cDNA 3110007P09 (predicted) RGD1564957_predicted 
1388705_at BI282694 Similar to selenoprotein SelM (predicted) RGD1565037_predicted 
1374785_at BG380471 Similar to CD69 antigen (p60, early T-cell activation antigen) (predicted) RGD1565373_predicted 
1379564_at AW528486 Similar to cajalin 2 isoform a (predicted) RGD1565556_predicted 
1383704_at BF410844 Similar to actin-related protein 3-beta (predicted) RGD1565759_predicted 
1392003_at AA943753 Similar to KIAA0316 protein (predicted) RGD1566031_predicted 
1381462_at BI294541 Similar to mKIAA1940 protein (predicted) RGD1566130_predicted 
1389937_at BF404834 Similar to Neuropilin- and tolloid-like protein 1 (predicted) RGD1566269_predicted 
1384202_at BI287326 Similar to Tescalcin (predicted) RGD1566317_predicted 
1377008_at BI296868 Similar to GTL2, imprinted maternally expressed untranslated (predicted) RGD1566401_predicted 
1368144_at AF321837 Regulator of G-protein signaling 2 Rgs2 
1368505_at NM_017214 Regulator of G-protein signaling 4 Rgs4 
1368373_at NM_019343 Regulator of G-protein signaling 7 Rgs7 
1395991_at BE107556 RIM binding protein 2 Rimbp2 
1368662_at NM_134374 Ring finger protein 39 Rnf39 
1376110_at AI009623 Ribonuclease P 25 subunit (human) Rpp25 
1372690_at AI137471 Reticulon 4 receptor-like 1 Rtn4rl1 
1382088_at AI548753 Ryanodine receptor 2, cardiac Ryr2 
1369210_at NM_030875 Sodium channel, voltage-gated, type I, alpha Scn1a 
1369662_at NM_012647 Sodium channel, voltage-gated, type 2, alpha 1 polypeptide Scn2a1 
1368256_at NM_053779 Serine (or cysteine) peptidase inhibitor, clade I, member 1 Serpini1 
1391032_at AI112194 Seizure related 6 homolog (mouse) Sez6 
1374825_at BG380338 Seizure related 6 homolog (mouse)-like 2 (predicted) Sez6l2_predicted 
1370419_a_at AF230520 SH3-domain kinase binding protein 1 Sh3kbp1 
1396040_at BE108568 SH3 and multiple ankyrin repeat domains 1 Shank1 
1370069_at NM_134363 Solute carrier family 12, (potassium-chloride transporter) member 5 Slc12a5 
1368564_at NM_053427 Solute carrier family 17 (sodium-dependent inorganic phosphate 
cotransporter), member 6 
Slc17a6 
1368986_at NM_053859 Solute carrier family 17 (sodium-dependent inorganic phosphate 
cotransporter), member 7 
Slc17a7 
1383444_at AA964069 Solute carrier family 24 (sodium/potassium/calcium exchanger), member 2 Slc24a2 
1387380_at NM_031782 Solute carrier family 32 (GABA vesicular transporter), member 1 Slc32a1 
1373326_at AI716512 Solute carrier family 4, sodium bicarbonate transporter-like, member 10 Slc4a10 
1368170_at NM_024371 Solute carrier family 6 (neurotransmitter transporter, GABA), member 1 Slc6a1 
1391019_at BF285698 SLIT and NTRK-like family, member 1 (predicted) Slitrk1_predicted 
1368991_at NM_053605 Sphingomyelin phosphodiesterase 3, neutral Smpd3 
1387073_at NM_030991 Synaptosomal-associated protein 25 Snap25 
1367977_at NM_019169 Synuclein, alpha Snca 
1369924_at NM_080777 Synuclein, beta Sncb 
1389752_at BE109861 Sortilin-related VPS10 domain containing receptor 3 (predicted) Sorcs3_predicted 
1367812_at NM_019167 Spectrin beta 3 Spnb3 
1394252_at BG668764 Sparc/osteonectin, cwcv and kazal-like domains proteoglycan 3 (predicted) Spock3_predicted 
1367762_at NM_012659 Somatostatin Sst 
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1369770_at NM_012719 Somatostatin receptor 1 Sstr1 
1368782_at NM_019348 Somatostatin receptor 2 Sstr2 
1368157_at NM_024346 Stathmin-like 3 Stmn3 
1370315_a_at AF026530 Stathmin-like 4 Stmn4 
1387360_at BI290256 Syntaxin 1A (brain) Stx1a 
1368352_at NM_012700 Syntaxin 1B2 Stx1b2 
1368562_at NM_031641 Sulfotransferase family 4A, member 1 Sult4a1 
1368682_at NM_057210 Synaptic vesicle glycoprotein 2a Sv2a 
1369251_a_at NM_019133 Synapsin I Syn1 
1369482_a_at NM_019159 Synapsin II Syn2 
1390209_at BE097982 Synaptogyrin 3 (predicted) Syngr3_predicted 
1368865_at BG666364 Synaptoporin Synpr 
1368276_at NM_012664 Synaptophysin Syp 
1373896_at AA943569 Synaptotagmin I Syt1 
1374427_at AI144986 Synaptotagmin XIII Syt13 
1369309_a_at BG671061 Tachykinin 1 Tac1 
1387138_at NM_019162 Tachykinin 2 Tac2 
1370150_a_at NM_012703 Thyroid hormone responsive protein Thrsp 
1369651_at NM_012673 Thymus cell antigen 1, theta Thy1 
1374257_at BM389265 T-cell lymphoma invasion and metastasis 1 Tiam1 
1387850_at NM_023020 Ttransmembrane protein with EGF-like and two follistatin-like domains 1 Tmeff1 
1397227_at BE120895 Transmembrane protein 35 Tmem35 
1376721_at BF400666 Triple functional domain (PTPRF interacting) Trio 
1371618_s_at AI229029 Tubulin, beta 3 Tubb3 
1384927_at AI230430 Tubulin, beta 4 Tubb4 
1397612_at BF391002 Ubiquitin protein ligase E3A (predicted) Ube3a_predicted 
1395054_at BF416262 Ubiquitin specific protease 29 (predicted) Usp29_predicted 
1373510_at BF281373 Vesicle-associated membrane protein 1 Vamp1 
1377146_at AI412212 Vasoactive intestinal polypeptide Vip 
1376893_at AI406821 Vesicular membrane protein p24 (predicted) Vmp_predicted 
1368853_at NM_012686 Visinin-like 1 Vsnl1 
    
CLUSTER 3       
Affymetrix ID GenBank 
ID 
Gene Name Gene Symbol 
1384603_at AI602131 ATP-binding cassette, sub-family A (ABC1), member 4 (predicted) Abca4_predicted 
1370464_at AF286167 ATP-binding cassette, sub-family B (MDR/TAP), member 1A Abcb1a 
1394483_at AW535310 A disintegrin-like and metallopeptidase (reprolysin type) with 
thrombospondin type 1 motif, 5 (aggrecanase-2) 
Adamts5 
1367974_at NM_012823 Annexin A3 Anxa3 
1372601_at BM391471 Activating transcription factor 5 Atf5 
1398431_at BI294910 Carbonic anhydrase 8 Car8 
1387818_at NM_053736 Caspase 4, apoptosis-related cysteine peptidase Casp4 
1379935_at BF419899 Chemokine (C-C motif) ligand 7 Ccl7 
1379582_a_at AA998516 Cyclin A2 Ccna2 
1371150_at X75207 Cyclin D1 Ccnd1 
1374139_at BG671589 Cerebellar degeneration-related 2 Cdr2 
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1376193_at AA819658 Kohjirin Chrdl1 
1384068_at BI295150 Cytoskeleton associated protein 2 (predicted) Ckap2_predicted 
1377765_at AA848723 Chloride intracellular channel 4 Clic4 
1384211_at BM388456 Procollagen, type XI, alpha 1 Col11a1 
1387854_at BI282748 Procollagen, type I, alpha 2 Col1a2 
1373245_at BE111752 Procollagen, type IV, alpha 1 Col4a1 
1370895_at AI179399 Procollagen, type V, alpha 2 Col5a2 
1370269_at X00469 Cytochrome P450, family 1, subfamily a, polypeptide 1 Cyp1a1 
1368990_at NM_012940 Cytochrome P450, family 1, subfamily b, polypeptide 1 Cyp1b1 
1369590_a_at NM_024134 DNA-damage inducible transcript 3 Ddit3 
1389533_at AA944398 Fibulin 2 Fbln2 
1374726_at AI411941 Fibronectin type III domain containing 1 Fndc1 
1371331_at BG665037 Follistatin-like 1 Fstl1 
1379440_at AW144239 Follistatin-like 3 Fstl3 
1368947_at NM_024127 Growth arrest and DNA-damage-inducible 45 alpha Gadd45a 
1372273_at AA944212 Glycophorin C (Gerbich blood group) Gypc 
1387273_at NM_013037 Interleukin 1 receptor-like 1 Il1rl1 
1376845_at AA819034 Putative ISG12(b) protein Isg12(b) 
1387144_at NM_030994 Integrin alpha 1 Itga1 
1372870_at BM391302 KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 3 
(predicted) 
Kdelr3_predicted 
1372478_at AI137605 Similar to chemokine-like factor super family 7 LOC501065 
1378094_at BM389654 Similar to pleckstrin homology-like domain, family B, member 2 LOC685611 
1384231_at BE108276 Similar to Shc SH2-domain binding protein 1 LOC687121 
1368171_at NM_017061 Lysyl oxidase Lox 
1372006_at BM391274 Lysyl oxidase-like 2 (predicted) Loxl2_predicted 
1388102_at U66322 Leukotriene B4 12-hydroxydehydrogenase Ltb4dh 
1367912_at NM_021587 Latent transforming growth factor beta binding protein 1 Ltbp1 
1368448_at NM_021586 Latent transforming growth factor beta binding protein 2 Ltbp2 
1390585_at AI169829 Mannan-binding lectin serine peptidase 1 Masp1 
1376055_at AA859768 Minichromosome maintenance deficient 5, cell division cycle 46 (S. 
cerevisiae) (predicted) 
Mcm5_predicted 
1371074_a_at U17565 Minichromosome maintenance deficient 6 (MIS5 homolog, S. pombe) (S. 
cerevisiae) 
Mcm6 
1374775_at AI714002 Antigen identified by monoclonal antibody Ki-67 (predicted) Mki67_predicted 
1370854_at AA799423 Nexilin Nexn 
1372559_at AI103527 Ng23 protein Ng23 
1387454_at NM_022242 Niban protein Niban 
1388618_at BM389302 Nidogen 2 Nid2 
1371052_at AA859752 Noggin Nog 
1388340_at BF281153 NS5A (hepatitis C virus) transactivated protein 9 Ns5atp9 
1368547_at NM_130402 Osteoclast inhibitory lectin Ocil 
1393129_at AI711403 Procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), 
alpha polypeptide III 
P4ha3 
1367949_at NM_017139 Proenkephalin 1 Penk1 
1385182_at BG371843 Plakophilin 1 (predicted) Pkp1_predicted 
1388539_at BE113268 Plakophilin 2 Pkp2 
1384558_at BI276313 Placenta-specific 9 (predicted) Plac9_predicted 
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1393982_at AI070935 Polymerase (DNA directed), epsilon 2 (p59 subunit) (predicted) Pole2_predicted 
1372729_at AI137406 Protein C receptor, endothelial Procr 
1368259_at NM_017043 Prostaglandin-endoperoxide synthase 1 Ptgs1 
1374284_at AI227769 Ras association (RalGDS/AF-6) domain family 4 Rassf4 
1389107_at AI008974 Similar to KIAA1749 protein (predicted) RGD1304623_predicted 
1380243_at BE098614 Similar to CG14803-PA (predicted) RGD1304693_predicted 
1373447_at BF281350 Similar to HN1-like protein RGD1305117 
1393451_at BI295149 Similar to RIKEN cDNA 2610510J17 RGD1310953 
1371970_at AA799328 Similar to expressed sequence AW413625 (predicted) RGD1560913_predicted 
1374805_at AW251849 Similar to hypothetical protein MGC5528 (predicted) RGD1561749_predicted 
1376231_at BF389244 Similar to Hypothetical UPF0080 protein KIAA0186 (predicted) RGD1562246_predicted 
1375857_at AW917760 Similar to Myoferlin (Fer-1 like protein 3) (predicted) RGD1564216_predicted 
1373250_at AI229404 Similar to Anillin (predicted) RGD1566097_predicted 
1377967_at AI112987 Retroviral integration site 2 (predicted) Ris2_predicted 
1389408_at BG379338 Ribonucleotide reductase M2 Rrm2 
1368519_at NM_012620 Serine (or cysteine) peptidase inhibitor, clade E, member 1 Serpine1 
1388569_at AI179984 Serine (or cysteine) peptidase inhibitor, clade F, member 1 Serpinf1 
1387134_at NM_053687 Schlafen 3 Slfn3 
1393041_at AW535052 SMC2 structural maintenance of chromosomes 2-like 1 (yeast) (predicted) Smc2l1_predicted 
1373026_at BI303598 Spindle pole body component 24 homolog (S. cerevisiae) (predicted) Spbc24_predicted 
1390107_at BG670294 Synaptotagmin-like 2 (predicted) Sytl2_predicted 
1367570_at NM_031549 Transgelin Tagln 
1389555_at BM387190 Transcription factor 19 Tcf19 
1367859_at NM_013174 Transforming growth factor, beta 3 Tgfb3 
1375951_at AA818521 Thrombomodulin Thbd 
1374529_at AI406660 Thrombospondin 1 Thbs1 
1372926_at AI009159 Tissue inhibitor of metalloproteinase 3 (Sorsby fundus dystrophy, 
pseudoinflammatory) 
Timp3 
1373401_at AI176034 Tenascin C Tnc 
1379331_at AA965084 Tenascin N (predicted) Tnn_predicted 
1368838_at NM_012678 Tropomyosin 4 Tpm4 
1368912_at M12138 Thyrotropin releasing hormone Trh 
1370694_at AB020967 Tribbles homolog 3 (Drosophila) Trib3 
1372639_at AA800245 Tripartite motif-containing 54 Trim54 
1379448_at BE110883 Ttk protein kinase (predicted) Ttk_predicted 
1384506_at H33706 Unc-5 homolog C (C. elegans) Unc5c 
1368463_at NM_053653 Vascular endothelial growth factor C Vegfc 
1368359_a_at NM_030997 VGF nerve growth factor inducible Vgf 
1369484_at NM_031590 WNT1 inducible signaling pathway protein 2 Wisp2 
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Abstract: 
 
Blockage of GABA-A receptors in hippocampal neuronal cultures by gabazine 
treatment (GabT) triggers synchronous bursts of spikes initiating neuronal plasticity 
partly mediated by changes of gene expression. By using specific blockers, we have 
investigated which sources of Ca2+ entry primarily control changes of gene 
expression. Intracellular Ca2+ transients were monitored with Ca2+ imaging while 
recording electrical activity with patch clamp microelectrodes. Concomitant 
transcription profiles were obtained using Affymetrix oligonucleotide microarray. 
Blockage of NMDA receptors with 2-amino-5-phosphonovaleric acid (APV) did not 
reduce significantly somatic Ca2+ transients, which, on the contrary, were reduced by 
selective blockage of L, N and P/Q types voltage gated calcium channels (VGCCs). 
Therefore, we investigated changes of gene expression in the presence of blockers of 
NMDA receptors and L, N and P/Q VGCCs. Our results show that: i - among genes 
upregulated by GabT, there are genes selectively dependent on NMDA activation, 
genes selectively dependent on L-type VGCCs and genes dependent on the activation 
of both channels; ii - NMDA receptors play a major role in inducing gene 
transcription 1.5 hours after GabT, whereas L-type VGCCs become more important 3 
hours after GabT; iii - blockage of N and P/Q VGCCs has an effect similar but not 
identical to blockage of L-type VGCCs. 
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Introduction 
 
Activity-dependent plasticity is a fundamental property of the nervous system and is 
at the basis of the formation and consolidation of memory and learning (Bliss and 
Collingridge, 1993). Neuronal plasticity has a complex phenomenology resulting 
from multiple biological mechanisms. Local protein trafficking is responsible for 
rapidly decaying forms of plasticity while gene transcription dependent mechanisms 
account for more persistent changes (Goelet et al., 1986; Schuman, 1997; Malenka 
and Nicoll, 1999; Martin et al., 2000; Rao et al., 2006; Raymond, 2007). Neuronal 
plasticity is initiated by events  occurring across the plasma membrane activating 
signal transduction pathways in the cytoplasm and reaching the nucleus, in which 
calcium (Ca2+) ions play a major role (Cavazzini et al., 2005). Ca2+ entry into the 
cytoplasm can initiate gene transcription (Bading et al., 1993) through  the mitogen-
activated protein kinases (MAPKs) cascade and/or the activation of Ca2+/calmodulin-
dependent protein kinases (CaMKs) (Dolmetsch et al., 2001).  
A very useful model of neuronal plasticity is provided by neuronal cultures where it 
is possible to study in details how changes of electrical activity initiate neuronal 
plasticity. It has been shown that periods of intense synchronous electrical activity 
modify both neuronal firing properties and synaptic efficiency (Abegg et al., 2004; 
Arnold et al., 2005; Debanne et al., 2006; Remy and Spruston, 2007). Large bursts of 
spontaneous synchronous spikes can be induced by blockage of GABA-A receptors 
with application of gabazine or bicuculline (Traub et al., 1993; Arnold et al., 2005). 
Ca2+ ions enter into the cytoplasm mainly through opening of ligand- and voltage-
gated Ca2+ channels (VGCCs) and by release from internal stores. All neuronal 
classes of VGCCs have been found and described in hippocampal neurons (Eliot and 
Johnston, 1994; Avery and Johnston, 1996; Vinet and Sik, 2006; Bloodgood and 
Sabatini, 2007).  
The purpose of the present manuscript is to determine which source of Ca2+ entry into 
cytoplasm controls changes of gene expression initiated by gabazine treatment 
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(GabT). We have analyzed the contribution of Ca2+ entry through NMDA receptors 
and different types of VGCCs. Changes of gene expression were determined using 
Affymetrix oligonucleotide microarray in the presence or absence of blockers of 
NMDA receptors and L, N and P/Q -type VGCCs. Our results show that calcium 
transients reaching the soma were amplified and conveyed by the activation of L, N 
and P/Q type Ca2+ channels and that blockage of NMDA receptors did not affect 
significantly Ca2+ transients in the soma during GabT, but profoundly reduced 
changes of gene expression observed 1.5 h after GabT. Changes of gene expression 
measured 3 h after GabT became more sensitive to blockage of L-type and of N and 
P/Q type VGCCs. Therefore changes of gene expression induced by GabT depend - 
in a complex and time related way - on Ca2+ entry through NMDA receptors and 
different types of VGCCs. 
 105
Methods 
 
Neuronal culture preparation 
Hippocampal neurons from Wistar rats (P0-P2) were prepared as previously 
described (Ruaro et al., 2005). Cells were plated on polyorhitine/matrigel pre-coated 
coverslips (Ruaro et al., 2005) at a concentration of 8 x 105 cells/cm2 and maintained 
in Minimal Essential Medium with Earle’s salts (Invitrogen, Carlsbad, CA) 
supplemented with 5% fetal calf serum, 0.5% D-glucose, 14 mM Hepes, 0.1 mg/ml 
apo-transferrin, 30 g/ml insulin, 0.1 g/ml D-biotin, 1 mM Vit. B12, and 2g/ml 
gentamycin. After 48 hours 5 M cytosine--D-arabinofuranoside (Ara-C) was 
added to the culture medium, in order to block glial cell proliferation. Half of the 
medium was changed twice a week. Neuronal cultures were kept in an incubator 
providing a controlled level of CO2 (5%), temperature (37oC) and moisture (95%). In 
order to induce synchronous electrical activity initiating neuronal plasticity, cultures 
were treated for 30 min with 20 M of gabazine (GabT), a specific GABA-A 
receptor antagonist (Uchida et al., 1996). 
 
Electrophysiological recordings 
Dissociated hippocampal neuronal cultures were transferred to a recording chamber, 
perfused in Ringer’s solution (in mM:145 NaCl, 3 KCl, 1.5 CaCl2, 1 MgCl2, 10 
Glucose, 10 Hepes, adjusted to pH 7.4 with NaOH) and visualized with an upright 
microscope (Olympus BX50WI) with differential interference contrast (DIC) optics. 
Patch-clamp recordings were performed with an Axoclamp 2-B amplifier (Axon 
Instruments, Foster City, CA). Experiments were performed at 37° C. Electrodes 
were pulled (Narishige, Japan) and filled with an intracellular solution containing in 
mM: 120 K-gluconate, 10 Na-gluconate, 10 Hepes, 10 Na-phosphocreatine, 4 
MgATP, 4 NaCl, 2 Na2ATP and 0.3 Na3GTP (adjusted to pH 7.4 with KOH): in 
these conditions the electrode resistance was 10-15 MΩ. The data were digitized at 
20 kHz (Digidata 1200, Axon Instruments) and analyzed using pClamp9 software 
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(Axon Instruments). Values of membrane potentials were not corrected for the effects 
of liquid junction potential during seal formation. 
 
Imaging 
Calcium imaging experiments were performed using water immersion optics 
(40x/0.80 NA) a mirror unit (U-MSWB: exciter filter BP 420-480 nm, barrier BA 
>515 nm and dichroic mirror 500 nm) and a halogen lamp (Olympus, Japan) for 
illumination. The fluorescence emitted light was collected with a fast CCD camera 
(Neuro CCD-SM, RedShirtImaging). Images were taken at 40 Hz with a spatial 
resolution of 80x80 pixels. Experiments were analyzed with Neuroplex Software, 
Igor (Wavemetrics, Lake Oswego, OR) and Matlab (Mathworks, Natick, MA). 
Cultures were loaded with cell permeant calcium dye Oregon Green 488 BAPTA1-
AM, (Molecular Probes O-6807). 4mM stock solution of this calcium dye was 
prepared in Pluronic F-127 20% solution in DMSO (Molecular Probes P3000MP). 
Cultures were incubated with a final concentration of 1.5 µM of the calcium dye for 
30 min. After incubation the cultures were washed and then transferred under the 
microscope for imaging.  In order to load single cells for electrophysiology and 
simultaneous calcium imaging 150 µM Oregon Green 488 BAPTA1, cell impermeant 
(Molecular Probes O-6806) was included in the patch pipette solution.  A period of at 
least 20 min after reaching the whole cell configuration was necessary to reach a 
good fluorescent signal from the dendrites. Calcium imaging data are expressed as 
DF/F values. The collected fluorescence F(t) was first dark frame subtracted to 
minimize the noise, then it was averaged over the regions of interest (ROIs). F0, the 
baseline fluorescence, was calculated as the time average of the fluorescence during 
the absence of any signal for each ROI. Finally (DF/F)(t) = (F(t)-F0)/F0 was 
calculated.  
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Pharmacology 
The following chemicals were used: 2-amino-5-phosphonovalerate (APV, Sigma-
Aldrich, St Louis, MO), gabazine (SR95531, Tocris, Bristol, UK), ω-conotoxin 
MVIIC (Tocris), kurtoxin (Sigma-Aldrich), SNX-482 (Sigma-Aldrich), different 
dihydropyridines (nimodipine, nifedipine, nitrendipine, Tocris). After completion of 
the measurements, chemicals were washed out by 3 medium replacements, and the 
original extracellular medium was restored.  
 
RNA extraction andoligonucleotide microarray analysis 
Cultures were incubated with APV or other blockers of VGCCs for 10 minutes 
before gabazine addition. In all these experiments the amplitude of somatic Ca2+ 
transients was monitored by loading cultures with the membrane permeable calcium 
dye Oregon Green 488-BAPTA-1-AM and by measuring the optical signals. After 30 
minutes, gabazine was removed, but not the tested blocker. mRNA was harvested 
from these cultures either 1.5 or 3 hours after GabT. The total RNA was extracted 
using TRIzol reagent (Sigma) according to the manufacturer’s instructions followed 
by a DNase I (Invitrogen) treatment to remove any genomic DNA contamination. 
The total RNA was further purified using RNeasy Mini Kit Column (Qiagen, 
Valencia, CA) and subsequently quantified by ND-1000 Nanodrop 
spectrophotometer (Agilent Technologies, Palo Alto, CA). At each time point, 3 
biological replicates were collected and Standard Affymetrix protocols were applied 
for amplification and hybridization. Gene profiling was carried out with the 
Affymetrix RAT230_2 GeneChip containing 31099 probes, corresponding to 14181 
probes with a gene symbol. Low level analysis was performed using an RMA 
(Robust Multi-array Average) algorithm (Irizarry et al., 2003) directly on the scanned 
images. Because of the high dimensionality we removed those probe sets labeled as 
ambiguous and those without any gene symbol. In each replica (Ri i=1-3) four 
cultures were considered: an untreated culture (Ci), a culture treated with gabazine 
(Gi), a culture treated with gabazine and APV (GAPVi), a culture treated with 
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gabazine and nifedipine (GNifi). Data were analyzed by considering changes of gene 
expression in each replica against its own untreated control, i.e. Gi/Ci , GAPVi/Ci and 
GNifi/Ci.  
 
Quantitative RT-PCR 
RNA (250ng) was reverse-transcribed using SuperScript II reverse transcriptase and 
random hexamer (Invitrogen). qRT-PCR was performed using iQ SYBR Green 
supermix (Bio-Rad, Munich, Germany) and the iQ5 LightCycler (Bio-Rad). Gene 
specific primers were designed using Beacon Designer (Premier Biosoft, Palo Alto, 
CA). The thermal cycling conditions comprised 3 min at 95°C, and 40 cycles of 10 s 
for denaturation at 95°C and 45 s for annealing and extension at 58°C. The 
expression level of the target mRNA was normalized to the relative ratio of the 
expression of Gapdh mRNA. The forwarded primer for Gapdh was -
CAAGTTCAACGGCACAGTCAAGG-3', reverse primer was 5'-
ACATACTCAGCACCAGCATCACC-3'. Fold changes calculations were made 
between treated and untreated samples at each time point using the 2-CT method. 
The forward primer for Egr2 was 5'-CTGCCTGACAGCCTCTACCC-3', the reverse 
primer was 5'-ATGCCATCTCCAGCCACTCC-3'; the forward primer for Nr4a1 was 
5'-GGTAGTGTGCGAGAAGGATTGC-3', the reverse primer was 5'-
GGCTGGTTGCTGGTGTTCC-3'; the forward primer for Arc was  5'-
AGACTTCGGCTCCATGACTCAG-3', the reverse primer was 5'-
GGGACGGTGCTGGTGCTG-3'; the forward primer for Homer1a was 5'-
GTGTCCACAGAAGCCAGAGAGGG-3', the reverse primer was 5'-
CTTGTAGAGGACCCAGCTTCAGT-3'; the forward primer for Bdnf was 5'-
CGATTAGGTGGCTTCATAGGAGAC-3', the reverse primer was 5'-
GAAACAGAACGAACAGAAACAGAGG-3'; the forward primer for Nr4a3 was 5'-
TCGGGATGGTGAAGGAAGTTGTG-3', the reverse primer was 5'-
GTTGTAGTGGGCTCTTTGGTTTGG-3'. 
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Results 
 
After pharmacological blockage of GABA-A receptors, spontaneous bursts of 
synchronous spikes appear in dissociated neuronal cultures from rat hippocampus 
(Arnold et al., 2005; Mazzoni et al., 2007). Even a small number of these bursts can 
initiate neuronal plasticity (Debanne et al., 2006; Remy and Spruston, 2007). 
Gabazine exposure lasting 5-15 minutes (Arnold et al., 2005), triggers significant 
changes of gene expression (Zhang et al., 2007, Broccard, personal comunication). In 
order to link specific sources of calcium influx to changes of gene expression, we 
have tested the effect of VGCC blockers and NMDA receptor antagonists on Ca2+ 
entry during bursts and concomitant changes of gene expression. Changes of 
intracellular Ca2+ were analyzed by imaging neuronal cultures stained with the 
membrane permeable calcium dye Oregon Green 488-BAPTA-1-AM and/or by 
imaging single neurons loaded with the cell impermeable calcium dye Oregon Green 
488-BAPTA-1. The fluorescence F emitted by these dyes is an indicator of the 
intracellular Ca2+ and changes of F (DF) report Ca2+ transients, quantified by the 
relative fluorescence change DF/F. By using membrane permeable dyes, Ca2+ 
transients occurring in the soma of several dozen of neurons were simultaneously 
measured. By imaging single neurons, changes of intracellular Ca2+ could be 
measured both in the soma and in the dendrites and compared with the intracellular 
electrical activity recorded with a patch pipette. Changes of gene expression were 
measured with DNA microarray (Affymetrix RAT230_2 GeneChip) and with qRT-
PCR from the same neuronal cultures where Ca2+ transients were recorded. 
 
Calcium signals from hippocampal neurons 
When neuronal cultures were stained with the membrane permeable Ca2+ dye, the 
soma of several dozens of neurons could be visualized simultaneously (fig.1A). In 
control conditions, spontaneously occurring Ca2+ transients were observed in the 
soma (fig.1B). These Ca2+ transients usually occurred randomly in different neurons, 
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but a partial synchronization was observed in some cultures (15/107). The average 
amplitude DF/F of spontaneous Ca2+ events in control conditions was 0.069 ± 0.035 
(range: 0.006-0.24, number of cells: 100, from 6 representative cultures). Addition of 
20 M gabazine to the extracellular medium caused the appearance of large Ca2+ 
transients occurring synchronously in the stained neurons (fig.1C).  These Ca2+ 
transients had an average amplitude of 0.33 ± 0.15 (range: 0.10-0.68) which lasted 
for some seconds (average half height duration: 3.26 ± 1.48 s, range: 0.85-8.6 s) and 
occurred almost periodically (average frequency: 0.075 ± 0.053 Hz range: 0.02-0.16 
Hz). These Ca2+ transients were associated to burst of spikes caused by a prolonged 
depolarization of the membrane potential, as shown from the simultaneous 
intracellular recordings reported in fig.4-7, and persisted for several hours after 
termination of GabT.  
 
(Fig.1 near here) 
 
In order to dissect the origin of these Ca2+ transients (fig.1C), the action of specific 
blockers of VGCCs and NMDA receptors was tested (fig.1D). Optical signals from 
the soma of several tens of neurons were averaged, so to obtain an estimate of the 
effect of different blockers averaged over several tens of neurons (fig.1D bottom 
traces). 
 
Blockers of L-type VGCCs significantly reduced somatic Ca2+ transients: nifedipine 
(20 µM, fig.1D first column) reduced the amplitude of DF/F by 69 ± 23 % from its 
control value (data from 77 cells, from 5 cultures, fig.2A). Nifedipine increased 
significantly also the burst frequency from 0.05 ± 0.03 Hz to 0.13 ± 0.05 Hz, 
probably by interfering with mechanisms controlling synaptic release (Hirasawa and 
Pittman, 2003; Piriz et al., 2003). Therefore the effect of two other dihydropiridines - 
nitrendipine and nimodipine - known to block L-type VGCCs without interfering 
with synaptic release were tested. Nitrendipine and nimodipine decreased somatic 
 111
Ca2+ transients by 87 ±10 % (data from 45 cells, from three cultures) and 40 ± 9 % 
(data from 38 cells, from three cultures) respectively. Nitrendipine reduced the burst 
frequency from 0.14 to 0.08 Hz, while nimodipine did not modify the burst 
occurrence. The differences in affinity that may exist between the drugs, the 
distribution of the channels (pre- and post-synaptic) and the side effects of some of 
the drugs could be explain the heterogeneity of our results. Blockers of T and R-type 
VGCCs were also tested. 100 M NiCl2 (fig.1D, second column), known to block T-
type and some R-type VGCCs (Tottene et al., 1996; Huguenard, 1996; Pinato and 
Midtgaard, 2003; Metz et al., 2005) reduced by 21 ± 12 % (data from 71 cells taken 
from 6 cultures, fig.2B) the amplitude of Ca2+ transients and increased the burst rate 
from 0.10 ± 0.04 Hz to 0.15 ± 0.02 Hz.  300 nM of kurtoxin, a blocker of  T-type 
VGGC  (Sidach and Mintz, 2002) reduced by 20 ± 9 % the amplitude of Ca2+ 
transients and increased the burst rate from 0.08 to 0.26 Hz (data from 10 cells taken 
from one culture, data not shown). 500 nM SNX-482, a selective antagonist of 
recombinant Cav2.3 (Newcomb et al., 1998), which inhibits some native R-type 
channels (Totenne et al., 2000) reduced by 13 ± 9 % (data from 30 cells taken from 
two cultures) the amplitude of Ca2+ transients (fig.1D, third column) without 
affecting the burst occurrence. The blocker of N and P/Q types Ca2+ channels, -
conotoxinMVIIC (Losonczy and Magee, 2006) reduced the amplitude of calcium 
transients by 44 ± 25 % (data from 43 cells, from 4 cultures, fig.1D fourth column 
and fig.2C) from the control value without affecting the burst frequency.  
 
The effect of blockage of NMDA receptors with APV was rather variable (Fig.2E). 
We analyzed the effect of APV in 18 neuronal cultures by monitoring Ca2+ transients 
with membrane permeable (10 cultures) and impermeable (8 cultures) Ca2+ dye. In 4 
of these cultures, 20 M APV completely blocked both synchronous bursts and Ca2+ 
transients. In 2 of these cultures the number of neurons present in 1 mm2 was counted 
and the average density of neurons was 500-700 cells/mm2, i.e. 2-3 times less than in 
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our usual cultures (1500-2000 cells/mm2, Bonifazi et al., 2005). Results obtained in 
these sparse neuronal cultures were not included in the statistical analysis shown in 
Fig.2. In the 8 cultures treated with the cell permeable Ca2+ dye APV decreased the 
duration of the late phase of synchronous bursts as previously reported by Traub and 
colleagues (1993). APV decreased the half-duration of somatic Ca2+ transients by 46 
± 17% of control (P<0.01, data from 132 cells 8 cultures), but did not significantly 
affect either their amplitude (P>0.4, fig.2D) or the burst frequency (P>0.1). As shown 
by the distribution of fractional blockage in Fig.2D, in many neurons the amplitude 
of the peak of somatic Ca2+ transients was not significantly affected by the presence 
of APV, but the positive and negative tails in the histogram indicate the existence of 
two small populations where the amplitude of Ca2+ transients was either reduced (left 
panel of Fig.2E) or increased (middle and right panels of Fig.2E). Simultaneous 
electrical and optical recordings (see Fig.2E) showed that a reduction of the 
amplitude of peak Ca2+ transients correlated with a reduction in the number of spikes 
occurring during the burst, whereas a rise in the instantaneous firing rate during the 
early phase of the burst caused an increase of peak Ca2+ transients. The variability of 
the effect of APV was caused by the combination of neuronal diversity and 
differences in the degree of connectivity of the cultures under investigation. 
In order to elucidate whether these results could be due to an insufficient blockage of 
NMDA receptors, the effect of increasing APV concentration up to 500 was then 
tested (Hardingham et al., 2001). Ca2+ transients in the soma persisted in the presence 
of 50, 100 and 500 M APV and the concomitant presence of large synchronous 
bursts of electrical activity was verified by simultaneously monitoring 
electrophysiological signals and Ca2+ transients. In the presence of 500 M APV, 
however, Ca2+ transients became less frequent. 
 
(Fig.2 near here) 
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These results were obtained with the calcium dye Oregon Green 488-BAPTA-1 
which has a KD for Ca2+ ions of 170 nM. Given the high affinity of this dye for Ca2+, 
i.e. a low value of KD, in the presence of a massive increase of cytosolic Ca2+ induced 
by gabazine exposure, the dye could become saturated and as a consequence the 
measurements would not reveal a decrease in Ca2+ entry. In order to exclude this 
possibility, the experiments were repeated with the calcium dye Oregon green 488-
BAPTA-2 (OGB-2-AM) which has a higher KD value of 580 nM. Fig. 3 shows the 
effect of nifedipine (fig.3A) and APV (fig.3B) on DF/F obtained with the dye OGB-
2-AM. When cultures were stained with this dye the signal to noise ratio was low and 
in order to detect an appreciable optical signal it was necessary to average the 
fluorescence from many cells. Nifedipine reduced DF/F by 22 ± 8 % (48 cells, 3 
cultures), while APV had no significant effect (P>0.2) (52 cells, 3 cultures). 
 
(Fig.3 near here) 
 
Somatic calcium transients during spikes evoked by current injection 
When the membrane permeable Ca2+ dye is used, the entire neuronal culture is 
stained, and therefore it is possible to measure the simultaneous Ca2+ transients from 
the soma of several neurons. However, but it is not possible to reliably resolve optical 
signals originating from dendrites and to make a precise correlation between 
fluorescence measurements and electrical recordings. Single cell imaging obtained by 
staining single neurons with cell impermeable Ca2+ dye during patch clamp 
recordings allows to compare the time course of Ca2+ transients in different 
compartments of the cells with changes of membrane voltage recorded from the 
soma. In particular, with this technique it is possible to measure the contribution of 
different VGCCs by stimulating the cell to fire a fixed number of spikes with a 
current step - before and after the application of a given pharmacological blocker 
(fig.4) - and by recording simultaneous Ca2+ transients in these two conditions. In 
fact, since VGCCs are known to be implicated in exocytosis (Gasparini et al., 2001; 
 114
Carbone et al., 2006), the decreased somatic Ca2+ transients associated to bursts 
observed in previous experiments (fig. 1D) could be caused also by a reduction of the 
underlying electrical activity following a decrease of synaptic efficacy.   
 
(Fig.4 near here) 
 
As shown in fig.4, nifedipine (A), NiCl2 (B) and -conotoxinMVIIC (C) reduced 
somatic Ca2+ transients by 43± 26 % (3 neurons), 56± 30 % (3 neurons) and 43± 19 
% (2 neurons) respectively. Complete blockage of Ca2+ transients in the soma was 
observed by perfusing the neuronal culture with NiCl2, blocking T and R -type 
VGCCs and CdCl2 blocking L, N and P/Q types VGCCs (fig. 4D). However this 
treatment did not influence the ability of the neurons to fire spikes.  
 
Calcium transients in the soma and dendrites 
Patch clamp voltage recordings during GabT (black trace in figs. 2A and 5A) showed 
that bursts had a complex structure, composed of several spikes with different height 
and duration often superimposed on a plateau potential lasting for some seconds. 
During these bursts, large Ca2+ transients were recorded in the soma (see red traces in 
fig. 5A). Several types of VGCCs as well as other intrinsic conductances are 
activated during these depolarizations, as observed both in hippocampal and cortical 
neurons (Straub et al., 1990; Timofeev et al., 2004; Schiller, 2004). Ca2+ transients in 
dendrites (see green trace in fig.5A) could be as large as those recorded in the soma, 
but usually had a shorter duration, reflecting different mechanisms of intracellular 
Ca2+ control, i.e. extrusion, compartmentalization and buffering in the periphery with 
respect to the somatic compartment (Markram et al., 1995). In several neurons, 
optical signals had a larger amplitude in dendrites (green trace in fig. 5A) where the 
peak was reached in about 100 ms whereas somatic Ca2+ peak occurred with a delay 
of 200-400 ms (red trace in fig.5A) and could be detected for several seconds when 
Ca2+ transients in the dendrites had already extinguished. Optical signals associated 
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to somatic Ca2+ transients were less noisy because the larger volume underlying each 
pixel contributed to an increased signal to noise ratio. It was often possible to detect 
very clearly step-like fluorescence increase associated to the generation of individual 
spikes (see red trace in fig5A). 
 
(Fig. 5 near here) 
 
When 20 M nifedipine was added to the extracellular medium, bursts lasted for a 
shorter time. A decrease in the peak of Ca2+ was observed in the soma, while in 
dendrites the peak reached almost the same value as in control but the duration of 
Ca2+ transients was shorter both in the dendrites and in the soma (fig.5 A and C). 
Ionic currents implicated in this complex pattern of activity were not investigated in 
details, but our experiments show that the activation of L-type VGCCs plays a major 
role during the long lasting potentials underlying GabT induced bursts. Moreover, as 
shown by the color coded map of Ca2+ transients (fig.5B and D), nifedipine reduced 
more powerfully Ca2+ transients in the soma than in the dendrites, showing that 
activation of L-type VGCCs has a major role in the accumulation of calcium in the 
soma. 
 
(Fig.6 near here) 
 
We then investigated the effect of blockage of N and P/Q types VGCCs on Ca2+ 
transients in different cellular compartments (fig.6). In the presence of 1 M -
conotoxinMVIIC, the amplitude of Ca2+ transients in the dendrites was not 
significantly affected (compare the initial component of green traces in fig.6A and C) 
whereas somatic Ca2+ transients decreased at a much larger extent (compare red 
traces in fig.6A and C). The differential effect of -conotoxinMVIIC on somatic and 
dendritic Ca2+ transients is also evident in the color images of fig.6 B and D. 
Treatment with -conotoxinMVIIC did not alter significantly the long lasting 
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depolarization underlying the bursts, as it was observed in the presence of nifedipine, 
suggesting that N and P/Q -type VGCCs, did not play a major role in sustaining 
bursts (fig.5 A and C). 
 
As shown above (fig.1D), experiments with cell permeable Ca2+ dye, demonstrated 
that NMDA receptors did not contribute significantly to Ca2+ transients in the soma 
during bursts. Since NMDA receptors are normally activated in the dendrites during 
glutamatergic transmission (Kovalchuk et al., 2000), the contribution of calcium 
through NMDA receptors was investigated in distal compartments. Fig.7 illustrates 
an experiment in which NMDA receptors were blocked by the addition of 20 M 
APV to the extracellular medium. Electrophysiological recordings (fig.7 A and C, 
black traces) show that APV reduced the excitatory events present in the late part of 
the bursts, but either the somatic or the dendritic Ca2+ transients did not reduce them. 
 
(Fig.7 near here) 
 
Changes of gene expression induced by gabazine and regulation by Ca2+ entry 
through NMDA receptors and L-type VGCCs  
The analysis presented in the previous sections showed that the contribution to 
somatic Ca2+ transients during gabazine was predominantly due to L, N and P/Q -
type VGCCs, and, to a minor extent, to Ca2+ entry through NMDA receptors. NMDA 
receptors and L-type VGCCs are key elements in activity dependent changes of gene 
expression in neurons (Deisseroth et al., 2003; Xiang et al., 2007). In order to 
elucidate the role of changes of cytosolic Ca2+ in the communication between 
synapse and nucleus in our model (Zhang et al., 2007, Broccard, personal 
comunication), we compared the effect of blockers of NMDA receptors and of L-type 
VGCCs on a transcriptional profile after GabT by microarray analyses. 
In order to check whether the network activity was preserved after the 
pharmacological treatments, in all the microarray experiments the amplitude of 
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somatic Ca2+ transients was monitored by imaging the cultures loaded with the 
membrane permeable calcium dye Oregon Green 488-BAPTA-1-AM (fig.8 A-C). 
Changes of gene expression were assessed at 1.5 and 3 hours after GabT, using 
Affymetrix GeneChip Rat Expression 230 2.0, that allows the simultaneous detection 
of 31099 probes set. Changes of gene expression were analyzed in three replicas. In 
each replica four cultures derived from the same neonatal rats were considered: an 
untreated culture (Ci), a culture treated with gabazine (Gi), a culture treated with 
gabazine and APV (GAPVi) and a culture treated with gabazine and nifedipine 
(GNifi). Changes of gene expression were evaluated comparing each replica against 
its own untreated control. Genes with ratio value greater than 1.5 were considered as 
up-regulated, while genes with ratio value lower than 1.5 were considered as down-
regulated. The number of up-regulated genes 1.5 hours after GabT in the three 
replicas were 1070, 685 and 710 and those down-regulated were 1355, 331 and 360 
respectively. 3 hours after GabT the number of up-regulated genes were 451, 351 and 
571 and those down-regulated were 394, 231 and 154 in the three replicas 
respectively.  
 
(Fig.8 near here) 
 
Genes up and down-regulated in the three replicas were - to some extent - different 
and therefore, for further analysis, only those genes that were up-regulated in at least 
two replicas were considered: on the basis of this criterion, genes up-regulated and 
down-regulated 1.5 hours after GabT were reduced to 83 and 20 respectively and 3 
hours after GabT to 68 and 48 respectively. The expression profile of these genes was 
then analyzed when the stimulation with gabazine was done in the presence of APV 
or nifedipine, to evaluate the contribution of the NMDA receptors and L-type 
VGCCs to their regulation (fig.8 D-G). With this criterion the genes regulated by 
gabazine were classified in four groups. The first group represented the genes up-
regulated (or down-regulated) by GabT in the presence of nifedipine but not in the 
 118
presence of APV. These genes were presumably controlled primarily by activation of 
NMDA receptors (GenesNMDA, indicated in white in the pie charts of fig.8). The 
second group included genes which were up-regulated (or down-regulated) by GabT 
and in the presence of APV but not in the presence of nifedipine, therefore 
presumably controlled by Ca2+ entry through L-type VGCCs (GenesL, indicated in 
black in the pie charts of fig.8 ). The third group of genes was composed of those up-
regulated (or down-regulated) genes either in the presence of blockers of NMDA 
receptors or of L-type VGCCs. This group of genes could be activated by NMDA 
receptors or by L-type VGCCs or by a different pathway (GenesNMDAorL indicated 
in pale grey in the pie charts of fig.8). The fourth and final group of genes was 
composed of those genes up-regulated by gabazine, but neither in the presence of 
APV nor in nifedipine (GenesNMDAandL indicated in dark grey in the pie charts of 
fig.8). The regulation of these genes needs Ca2+ entry through both NMDA receptors 
and L-type VGCCs. 
 
Among the 83 up-regulated genes taken 1.5 hours after GabT, 71 (85%) were 
blocked by APV. Of these genes 45 (54%) were controlled only by NMDA receptor, 
since they remained up-regulated in the presence of nifedipine. At this time point, up-
regulation of genes was poorly dependent on blockage of L-type VGCCs. In fact 28 
(33%) genes were dependent on Ca2+ entry through L-type VGCCs, but only 2 of 
these genes (2.4%) were blocked selectively by nifedipine. A different behavior, 
however, was observed at longer time intervals: 3 hours after GabT 36 over 68 genes 
up-regulated by gabazine (53%), were blocked by APV, and 41 (60.5%) by 
nifedipine. In particular the up-regulation of 22 (32.4%) genes was blocked only by 
APV and 27 (40%) genes only by nifedipine. So 3 hours after GabT the proportion of 
genes blocked specifically by nifedipine increased from 2.4% to 40% and that of 
genes controlled only by NMDA slightly decreased from 54% to 32.4%. At both time 
points there was a considerable proportion of up-regulated genes that were blocked 
both by APV and by nifedipine, 31% and 20.4% at 1.5 and 3 hours after GabT 
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respectively. There were also genes whose up-regulation was affected neither by 
APV nor by nifedipine at 1.5 (12%) and 3 (7.5%) hours after GabT. Therefore, the 
regulation of the majority of the genes induced by GabT was controlled by Ca2+ entry 
through NMDA receptors and L-type VGCCs. Moreover, NMDA receptors 
activation is a key event for the up-regulation of genes induced by gabazine after 1.5 
hours, whereas, 3 hours after GabT also Ca2+ entry through L-type VGCCs becomes 
significant. 
Our results show that NMDA receptors and L-type VGCCs play a less specific role 
for the down-regulation with respect to up-regulation of genes. In fact, after 1.5 and 3 
hours down-regulated GenesNMDA were respectively 20% and 12.5% compared to 
54% and 32.4% of up-regulated GenesNMDA. After 3 hours, down-regulated 
GenesL were 4.2% compared to 40% of up-regulated GenesL.  
 
(Table 1 near here) 
 
As shown in Table 1, at 1.5 hours after, GabT 45/83 genes represented the group 
defined GenesNMDA. Several transcription factors, such as Egr4, Fosl2, Nr4a1, 
Nr4a3, Klf4 and Klf5 belong to this group, as well as the two effector genes Homer1 
and Arc. The group of GenesNMDAandL included 23 genes, among which we found 
synapsin II (Syn2) and the beta 4 subunit of voltage dependent Ca2+ channels 
(Cacnb4), two genes involved in synaptic function. Serpinb2, Errfi1, Bdnf and the 
transcription factors Nr4a2 and Egr2 belonged to the group called GenesNMDAorL. 
Only two genes, with an unknown function, were classified as GenesL.  
 
(Table 2 near here) 
 
Seventeen genes were up-regulated after GabT after 1.5 and 3 hours. Among these 
genes Dusp1, Arc, Arf4l_predicted, Egr4, Homer1 (Ania-3), Nr4a1 and Ptgs2 were 
classified as GenesNMDA at both time points. In contrast, Egr2, Nr4a2 and 
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Homer1a were classified as GenesNMDAandL after 1.5 hours and GenesNMDA 
after 3 hours. These results suggest possible modifications in the signalling pathway 
responsible for the regulation of Egr2, Nr4a2 and Homer1a between 1.5 and 3 hours. 
 
The gene expression analysis shown in fig.8 and reported in Table 1 and 2 was 
obtained from neuronal cultures loaded with the membrane permeable Ca2+ dye, 
which - to some extent - acts also as a Ca2+ buffer. Therefore, we verified whether the 
presence of the dye could affected the results of our experiments on gene expression. 
Fig.9 compares the mRNA level of Nr4a1 measured with qRT-PCR in cultures 
loaded with Ca2+ dye Oregon Green 488-BAPTA-1-AM (black bars) with that in 
unloaded cultures (white bars). The presence of the Ca2+ dye does not alter 
significantly (ANOVA p>0.5) either up-regulation induced by GabT or that observed 
during the simultaneous exposure to APV or nifedipine. The same results were 
obtained with all the other genes tested with qRT-PCR (data not shown). 
 
(Fig.9 near here) 
 
The up-regulation of a group of selected genes 1.5 hours after GabT, and the effect of 
APV and nifedipine on their induction was also verified with qRT-PCR (fig.10 A-B). 
These genes, Arc, Bdnf, Homer1a, Nr4a1, Nr4a3 and Egr2, were selected because of 
their known involvement in synaptic plasticity. From microarray analysis Nr4a1, 
Nr4a3 and Arc resulted to belong to the group GenesNMDA, while Bdnf, Homer1a 
and Egr2 to the group GenesNMDAorL. As shown in fig.10 A, 20 M APV reduced 
the up-regulation of Nr4a1, Nr4a3 (t test p<0.05) and Arc by at least 50% of the 
induction in gabazine alone, in contrast, nifedipine did not alter their regulation. For 
Nr4a1 and Arc, qRT-PCR detected a slight up-regulation in the cultures treated with 
APV in respect to the control that was not observed with microarray. This difference 
can be ascribed to the sensitivities of the two techniques used to assay gene 
expression changes. In fact, it is known that microarray experiments underestimate 
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the fold-changes in gene expression compared to qRT-PCR (Irizarry et al., 2003). 
However, for these genes, qRT-PCR confirmed the same trend obtained in 
microarray experiments. From the results obtained during Affymetrix experiments 
the up-regulation of Bdnf, Egr2 and Homer1a was not affected by either APV or 
nifedipine, and with qRT-PCR we confirm these results. As shown in fig.10 B there 
were not significant differences (t test p>0.05) between the up-regulation after GabT 
with or without the addiction of APV or nifedipine.  
 
(Fig. 10 near here) 
 
Comparison of the effect of blockage of N and P/Q-type VGCCs and L-type VGCCs 
on changes of gene expression induced by Gabazine 
As shown in figs 1 and 2, blockage of L-type VGCCs with nifedipine and of N and 
P/Q type VGCCs channels with -conotoxinMVIIC significantly reduce the 
amplitude of somatic Ca2+ transients. If the intracellular signal relevant for the Ca2+-
dependent gene transcription is the elevation of the concentration of the somatic free 
Ca2+, then blockage of L-type VGCCs and of N and P/Q type VGCCs should have 
similar effects on gene transcription. In contrast, if activation of L-type VGCCs is 
necessary, because of their association with specific signalling pathways (Dolmetsch 
et al., 2001) blockage of N and P/Q type VGCCs will not affect significantly gene 
transcription changes. Therefore, in order to discriminate between these two possible 
mechanisms, we compared the effect of nifedipine and -conotoxinMVIIC on up-
regulation of genes observed 3h after GabT, when Ca2+ entry through L-type VGCCs 
becomes more relevant (see previous section). In order to minimize experimental 
variability, we compared the pattern of gene up-regulation in replicas obtained from 
neuronal cultures derived from hippocampal neurons obtained from the same rats. 
 
(Fig. 11 near here) 
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As shown in fig.11A, 65% of genes whose up-regulation was blocked by nifedipine, 
was also blocked by -conotoxinMVIIC. Similarly, 75% of genes whose up-
regulation was not blocked by nifedipine, was not blocked by -conotoxinMVIIC 
(fig.11B). Therefore blockage of N and P/Q VGCCs and of L-type VGCCs have 
similar – but not identical - effects on gene expression induced by GabT. 
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Discussion 
 
Blockage of GABA-A inhibitory receptors by GabT causes the appearance of 
synchronous bursts of spikes (Arnold et al., 2005) associated to large Ca2+ transients 
both in the soma and in the dendrites (fig.1, 3, 5-7). GabT in hippocampal cultures 
(Zhang et al., 2007) initiates also concomitant changes of gene expression, becoming 
prominent 1-3 hours after GabT. The present manuscript analyzes the origin of the 
large somatic Ca2+ transients and their contribution to changes of gene expression. 
Somatic Ca2+ transients were significantly reduced by blockers of L, N and P/Q -type 
VGCCs. As shown in figs.1-3 and 7, blockage of NMDA receptors did not modify 
significantly somatic Ca2+ transients. Blockage of NMDA receptors, in contrast, 
drastically reduced changes of gene expression initiated by GabT. Blockage of L, N 
and P/Q -type VGCCs significantly decreased Ca2+ transients measured in the soma 
but did not modify in similar way changes of gene expression 1.5 hours after GabT. 
Blockage of these VGCCs, however, had a more pronounced role on gene expression 
3 hours after GabT. 
 
Somatic Ca2+ transients in hippocampal neurons 
Somatic Ca2+ transients associated to spontaneous bursts were reduced with the 
application of specific blockers of different types of VGCCs. Nifedipine, nitrendipine 
and nimodipine reduced the amplitude of somatic Ca2+ transients by 64±31 %, 87 
±10 % and 40 ± 9 %. Nifedipine reduced by 43 ±26 % Ca2+ transients associated to 
spikes elicited by passing a depolarizing step of current in the soma. -
conotoxinMVIIC, a blocker of N and P/Q, reduced somatic Ca2+ transients associated 
to spontaneous bursts by 36±21 % and those associated to directly evoked spikes by 
43±19 %. Blockage of T and R-type VGCCs with NiCl2 reduced somatic Ca2+ 
transients associated to bursts by 27±8 %. Blockage of T-type and R-type VGCCs 
with kurtoxin and SNX-482 respectively reduced somatic Ca2+ transients by 20±9 % 
and 13±9 % respectively. These results demonstrate that all major types of VGCCs 
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are expressed in hippocampal neurons and that changes of somatic Ca2+ are mediated 
primarily by L, N and P/Q types (Christie et al., 1995). 
All major types of VGCCs are present in dendritic arborization of CA1 hippocampal 
pyramidal neurons (Bloodgood and Sabatini, 2007). However, in spines Ca2+ 
transients are primarily controlled by T and R -type VGCCs and, in their parent 
dendrites, by T type VGCCs. Electrophysiological investigations have demonstrated 
the existence of T-type VGCCs in hippocampal rat pyramidal neurons (Eliot and 
Johnston, 1994; Magee and Johnston, 1995; Kavalali et al., 1997) with an increase of 
their density in distal dendrites. Immunohistochemical studies of the distribution of 
different isoforms of alpha subunits constituting VGCCs in rat hippocampal neurons 
have also shown that T and R-types are prominently expressed in the dendrites while 
L, N and P/Q -types are mainly expressed in the soma or proximal dendrites 
(Westenbroek et al., 1990; Westenbroek et al., 1992; Vinet and Sik, 2006; McKay et 
al., 2006). These results suggest that during spontaneous bursts of spikes, Ca2+ 
transients are initiated in spines by the activation of NMDA, and are locally 
amplified by T and R type VGCCs. Ca2+ transients are then conveyed to the soma by 
the activation of other VGCCs such as L, N and P/Q types VGCCs. 
 
Ca2+ dependent changes of gene expression induced by GabT 
Somatic Ca2+ transients were modified by APV in a variable way: in many neuronal 
cultures (figs. 1-3 and 7) and in those used for the genomic assays (fig.8), APV did 
not reduce the amplitude of somatic Ca2+. As shown in fig.8, 9 and 10, APV 
significantly reduced changes of gene expression 1.5 hours after GabT and also at 
some extent 3 hours after GabT (fig.8). Several genes, such as Nr4a3 and Homer1a 
are not up-regulated by GabT in the presence of APV either after 1.5 or 3 hours. 
However, as shown in fig.8, many genes are up-regulated and down-regulated in a 
significant way by GabT also in the presence of APV. Therefore, activation of 
NMDA receptors is not the only pathway by which GabT influences gene expression 
and different sources of increase of intracellular Ca2+ concentration are likely to be 
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contributed. Our results demonstrate that also Ca2+ entry through VGCCs, L, N and 
P/Q types, contributes to GabT-induced gene expression. 
The fraction of GenesNMDA - i.e. genes up-regulated by GabT but not in the 
presence of APV - was 54% (45/83) 1.5 hours after GabT but this proportion 
decreased to 32 % (22/68) 3 hours after GabT (fig.8). Similarly, at early times (1.5 
hours after GabT) the up-regulation of only two genes (2/83) was blocked 
specifically by nifedipine. A different behavior, however, was observed for longer 
time intervals: 3 hours after GabT, 40% (27/68) of up-regulated genes were GenesL. 
These results suggest that at early times NMDA activation is the major route for gene 
up-regulation but at later times gene up-regulation mediated by Ca2+ entry through L-
type VGCCs becomes more significant. As shown in Fig.11, blockage of N and P/Q 
VGCCs has an effect similar to what observed when L-type VGCCs are blocked. 
 
If activation of NMDA receptors and Ca2+ entry through L-type, N and P/Q type 
VGCCs play a major role for gene up-regulation initiated by GabT, a different 
behavior seems to occur for gene down-regulation. As shown in fig.8, both APV and 
nifedipine 3 hours after GabT changed the number of down-regulated genes by less 
than 20%. Therefore, down-regulation seems to be mediated by signaling pathways 
different - to some extent - from those controlling up-regulation.  
 
It has been assumed that the elevation of mRNA caused by blockage of inhibitory 
pathways mediated by GABAergic receptors is primarily mediated by Ca2+ 
dependent signaling pathways (Hardingham et al., 2001; Hardingham and Bading, 
2002). Entry of Ca2+ ions through NMDA receptors and L-type VGCCs is known to 
activate the MAPK/ERK signaling pathways (Murphy and Blenis, 2006) in which 
phosphorylated ERK translocates to the nucleus where it activates transcription. Ca2+ 
ions entering through VGCCs activate different signaling pathways mediated by a 
variety of Ca2+/calmodulin-dependent protein kinases (CaMKs) (Konur and Ghosh, 
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2005) leading to the activation of the nuclear CREB transcription factor (Wu et al., 
2001; Lonze and Ginty, 2002). 
 
Our results show that blockage of NMDA receptors by APV, consistently modifies 
changes of gene up-regulation, without a concomitant drastic reduction of the 
amplitude of somatic Ca2+ transients. On the other hand, blockage of L, N and P/Q –
type VGCCs also modifies changes of gene expression with concomitant reduction of 
somatic Ca2+ influx. In the first case, Ca2+ entering through the NMDA receptors is 
supposed to act as a second messenger in confined regions at the neuronal periphery, 
by activating locally signaling pathways and modifying gene transcription (CaMKII, 
ERK). During neuronal firing, membrane potential repetitively depolarizes, opening 
VGCCs that cause influx of Ca2+ both in the dendrites and in the soma. Ca2+ 
transients in the dendrites and the soma have very specific buffering properties so 
that the kinetics of Ca2+ signaling varies in distinct neuronal compartments. Indeed, 
somatic Ca2+ transients are characterized by a slower decay kinetics that makes them 
integrators of the global neuronal activity. Moreover the slower kinetics of Ca2+ 
transients could be suitable for Ca2+ ions to permeate the nuclear pores (Eder and 
Bading, 2007). Nuclear Ca2+ activates the nuclear CaMKIV with consequent 
induction of CREB dependent transcription, or can directly bind to the transcriptional 
repressor DREAM. 
Given the ubiquitous role of Ca2+ in cell physiology and homeostasis, it is not 
surprising to see complex interactions between the activation of NMDA receptors 
and Ca2+ ions. It is also possible that NMDA activation modifies intracellular Ca2+ 
stores and that the level of nuclear Ca2+ is the result of entry and uptake of this ion 
occurring through a variety of channels and pumps present in the plasma membrane 
and in the intracellular compartments.  
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Figure legends 
 
Fig.1. A: Fluorescence image of a neuronal culture stained with the membrane 
permeable calcium dye Oregon Green 488-BAPTA-1-AM. Four regions of interest 
(ROIs) are marked with colored spots. B: optical signals (DF/F) recorded from the 
soma of four distinct neurons corresponding to the ROIs indicated in A. C: as in B 
but in the presence of 20 M gabazine. D: DF/F from the soma of three different 
neurons in control conditions (black traces) and in the presence of a blocker (red 
traces): 20 M nifedipine (first column), 100 M NiCl2 (second column), 500 nM 
SNX-482 (third column), 1 M of -conotoxinMVIIC (fourth column) and 20 M 
APV (fifth column). The last row in each column reports optical signals obtained by 
averaging DF/F obtained from 15, 10, 30, 22 and 21 soma in control conditions 
(black traces) and in the presence of the blocker (red traces). 
 
Fig.2. A: histogram of the fractional reduction of the peak of DF/F observed during 
GabT induced burst of electrical activity caused by the addition of 20 M nifedipine. 
Collected data from the soma of 77 neurons. 
B: histogram of the fractional reduction of the peak of DF/F observed during GabT 
induced burst of electrical activity caused by the addition of 100 M NiCl2. Collected 
data from the soma of 71 neurons. 
C: histogram of the fractional reduction of the peak of DF/F observed during GabT 
induced burst of electrical activity caused by the addition of 1 M -
conotoxinMVIIC. Collected data from the soma of 43 neurons. 
D: histogram of the fractional reduction of the peak of DF/F observed during GabT 
induced burst of electrical activity caused by the addition of 20 M APV. Collected 
data from the soma of 132 neurons. 
E: Simultaneous somatic calcium imaging (top traces) and electrophysiological 
recordings from different experiments showing the effects of APV on dissociated 
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hippocampal cultures treated with 20 M gabazine. Black traces are recordings in 
control conditions (GabT), red traces, after APV. 
 
Fig.3. A: GabT induced Ca2+transients in control (black trace) and after nifedipine 
(red traces), measured with the calcium dye Oregon green 488-BAPTA-2 (OGB-2-
AM) which has a higher value of KD of 580 nM with respect of 488-BAPTA-1-AM 
(KD of 170 nM). Optical traces were averaged over a large area to increase signal to 
noise ratio. B: as in A but testing the effect of APV. 
 
Fig.4. A: somatic optical signals DF/F during injection of a depolarizing step of 
current evoking 9 spikes (upper trace, electrophysiological recording) in control 
conditions (black traces) and in the presence of 20 M nifedipine (red trace). B: as in 
A but evoking 6 spikes and testing 100 M NiCl2. C: as in A but testing the effect of 
1 M -conotoxinMVIIC. D: as in A but evoking 4 spikes and testing the effect of 
100 M NiCl2 and 100 M Cd2+.  
 
Fig.5. A: voltage recording of the membrane potential of a neuron (black trace) 
during GabT induced bursts. The neuron  was loaded with the membrane 
impermeable calcium dye Oregon Green 488-BAPTA-1-AM included in the patch 
pipette and was imaged in B and D. Red and green traces are optical signals DF/F 
recorded from the soma and the dendrite indicated by arrows of the same color in B.  
B: color coded map of the amplitude of DF/F at the time t1 indicated in A. 
C: as in A, but after the addition of 20 M nifedipine. 
D: as in B, but after the addition of 20 M nifedipine, at the time t2 indicated in C. 
 
Fig.6. A: voltage recording of the membrane potential of a neuron (black trace) 
during GabT induced bursts. The neuron was loaded with the membrane 
impermeable calcium dye Oregon Green 488-BAPTA-1-AM included in the patch 
pipette and was imaged in B and D. Red and green traces are optical signals DF/F 
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recorded from the soma and the dendrite indicated by arrows of the same color in B. 
B: color coded map of DF/F obtained in the presence of 20 M gabazine at the time 
t1 indicated in A. C: as in A but after the addition of 1 M -conotoxinMVIIC. D: as 
in B but after the addition of 1 M -conotoxinMVIIC, at the time t2 indicated in C.  
 
Fig.7. A: voltage recording of the membrane potential of a neuron (black trace) 
during GabT induced burst. The neuron was loaded with the membrane impermeable 
calcium dye Oregon Green 488-BAPTA-1- and was imaged in B and D. Red and 
green traces are optical signals DF/F recorded from the soma and the dendrite 
indicated by the arrows with the same color as in A. 
B: color coded map of the amplitude of DF/F at the time t1 indicated in A. 
C: as in A but after the addition of 20 M APV. 
D: as in B but after the addition of 20 M APV, at the time t2 indicated in C. 
 
Fig.8. A-C: optical signals (DF/F) recorded from the soma of three neurons 
composing the culture used for the genomic analysis shown in the following panels. 
In the presence of 20 M gabazine (A), + 20 M APV (B) and + 20 M nifedipine 
(C). D-G: pie charts illustrating the number of up-regulated (D and E) and down-
regulated (F and G) genes 1.5 and 3 hours after GabT. The pie charts illustrate the 
fraction of genes sensitive or not sensitive to APV and/or nifedipine treatments. The 
color white indicates genes controlled primarily by activation of NMDA receptors 
(GenesNMDA), i.e. their up-regulation (down-regulation) being blocked by APV. 
The color black indicates genes controlled primarily by Ca2+ entry through L-type 
Ca2+ channels (GenesL), i.e. their up-regulation (down-regulation) being blocked by 
nifedipine. Pale grey indicates genes which were up-regulated (down-regulated) 
either in the presence of APV or nifedipine (GenesNMDAorL). Dark grey indicates 
genes whose up-regulation (down-regulation) was blocked either by APV or by 
nifedipine (GenesNMDAandL). The pie charts indicated also the number of genes 
belonging to each group. 
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Fig.9. mRNA expression fold changes measured with qRT-PCR for Nr4a1 in the 
absence (white bars) or presence (black bars) of the membrane permeable calcium 
dye Oregon Green 488-BAPTA-1-AM. Untreated hippocampal dissociated cultures 
(C), cultures treated with 20 M gabazine alone (GBZ), or in the presence of 20 M 
APV (APV+GBZ) or 20 M nifedipine (nifedipine+GBZ). 
 
Fig.10. A-B: effect of APV and nifedipine on gene up-regulated after 1.5 h GabT 
measured with qRT-PCR. Results are expressed in fold change signal between 
untreated hippocampal dissociated cultures(C) and cultures treated with 20 M 
gabazine alone (GBZ) or in the presence of 20 M APV (APV+GBZ) or 20 M 
nifedipine (nifedipine+GBZ). Analyzed genes were Nr4a1, Bdnf (exon 9), Arc, Egr2, 
Nr4a and Homer1a. The analysis was performed using Gapdh as a housekeeping 
gene. Bars represent means ± SEM (n=6-4). 
 
Fig.11. A: Genes up-regulated 3 hours after GabT and blocked by nifedipine; red 
represents the proportion of genes also blocked by -conotoxinMVIIC. B: Genes up-
regulated 3 hours after GabT and not blocked by nifedipine; red representes the 
proportion of genes also not blocked by -conotoxinMVIIC. 
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Table 1. Up-regulated genes 1.5 hours after GabT. Classification in four groups is determined by their sensitivity to 
APV and nifedipine. 
 
Group 1-GenesNMDA 1.5 h after GabT 
Up-regulated genes in GBZ and GBZ+nifedipine but not in GBZ+APV 
Affy ID Gene Symbol Gene Name 
1368144_at    Rgs2  regulator of G-protein signaling 2 
1368146_at    Dusp1  dual specificity phosphatase 1 
1368223_at    Adamts1  a disintegrin-like and metallopeptidse (reprolysin type) with thrombospondin type 1 motif, 1 
1368488_at    Nfil3  nuclear factor, interleukin 3 regulated 
1368527_at    Ptgs2  prostaglandin-endoperoxide synthase 2 
1368662_at    Rnf39  ring finger protein 39 
1369217_at    Nr4a3  nuclear receptor subfamily 4, group A, member 3 
1369268_at    Atf3  activating transcription factor 3 
1370652_at    Ntrk2  neurotrophic tyrosine kinase, receptor, type 2 
1370997_at    Homer1  homer homolog 1 (Drosophila) 
1371019_at    Trib1  tribbles homolog 1 (Drosophila) 
1373035_at     ---  Transcribed locus 
1373759_at     ---  Transcribed locus 
1374446_at    Tiparp_predicted  TCDD-inducible poly(ADP-ribose) polymerase (predicted) 
1376275_at     ---  Transcribed locus 
1378393_at    RGD1306214_predicted  similar to TGF-beta induced apotosis protein 2 (predicted) 
1378489_at    ---  Transcribed locus 
1378925_at    Crem  CAMP responsive element modulator 
1380229_at    ---  Transcribed locus 
1380383_at    Arf4l_predicted  ADP-ribosylation factor 4-like (predicted) 
1381903_at    Fbxo33_predicted  F-box only protein 33 (predicted) 
1383860_at    Fosl2  fos-like antigen 2 
1385691_at    RGD1560454_predicted  similar to RIKEN cDNA 5830435K17 (predicted) 
1386935_at    Nr4a1  nuclear receptor subfamily 4, group A, member 1 
1387068_at    Arc  activity regulated cytoskeletal-associated protein 
1387260_at    Klf4  kruppel-like factor 4 (gut) 
1387337_at    Cort  Cortistatin 
1387442_at    Egr4  early growth response 4 
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1389402_at    ---  Transcribed locus 
1391643_at    ---  --- 
1392152_at    ---  Transcribed locus 
1392791_at    ---  Transcribed locus 
1393119_at    ---  Transcribed locus 
1393550_at    ---  Transcribed locus 
1393782_at    ---  Transcribed locus 
1394012_at    ---  Transcribed locus, moderately similar to XP_001094447.1  zinc finger, SWIM domain 
containing 5 [Macaca mulatta] 
1394039_at  Klf5  kruppel-like factor 5 
1394689_at    ---  Transcribed locus 
1394940_at    RGD1311381_predicted  similar to hypothetical protein FLJ20037 (predicted) 
1396545_at    ---  Transcribed locus 
1396563_at     ---  Transcribed locus 
 
Group 2-GenesL 1.5 h after GabT 
Up-regulated genes in GBZ and GBZ+APV but not in GBZ+nifedipine 
Affy ID Gene Symbol Gene Name 
1373403_at    LOC684871  similar to Protein C8orf4 (Thyroid cancer protein 1) (TC-1) 
1380400_at ---  Transcribed locus 
 
Group 3-GenesNMDAorL 1.5 h after GabT 
Up-regulated genes either in GBZ or  GBZ+APV or GBZ+nifedipine 
Affy ID Gene Symbol Gene Name 
1368487_at    Serpinb2  serine (or cysteine) proteinase inhibitor, clade B, member 2 
1368677_at    Bdnf  brain derived neurotrophic factor 
1369871_at    Areg  Amphiregulin 
1370454_at    Homer1  homer homolog 1 (Drosophila) 
1373093_at    Errfi1  ERBB receptor feedback inhibitor 1 
1387306_a_at    Egr2  early growth response 2 
1387410_at    Nr4a2  nuclear receptor subfamily 4, group A, member 2 
1389211_at    ---  Transcribed locus 
1392108_at    ---  RM2 mRNA, partial sequence 
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Group 4-GenesNMDAandL 1.5 h after GabT 
Up-regulated genes in GBZ but not in GBZ+APV and GBZ+nifedipine 
Affy ID Gene Symbol Gene Name 
1368892_at    ---  adenylate cyclase activating polypeptide 1 (Adcyap1) mRNA, 3' UTR 
1369130_at    Rasgrp1  RAS guanyl releasing protein 1 
1370509_at    Pdp2  pyruvate dehydrogenase phosphatase isoenzyme 2 
1374257_at    Tiam1  T-cell lymphoma invasion and metastasis 1 
1375179_at    ---  --- 
1377663_at    Rnd3  Rho family GTPase 3 
1378654_at    ---  Transcribed locus 
1380063_at    Ch25h  cholesterol 25-hydroxylase 
1380138_at    RGD1564397_predicted  Similar to heparan sulfate 6-O-sulfotransferase 2 isoform S (predicted) 
1382009_at    Chd1_predicted  chromodomain helicase DNA binding protein 1 (predicted) 
1382291_at    ---  Transcribed locus, strongly similar to XP_001081628.1  similar to Transcription factor SOX-
9 [Rattus norvegicus] 
1382850_at    Syn2  synapsin II 
1382898_at    Cacnb4  calcium channel, voltage-dependent, beta 4 subunit 
1385578_at    ---  Transcribed locus 
1385903_at    ---  Transcribed locus, moderately similar to XP_001094447.1  zinc finger, SWIM domain 
containing 5 [Macaca mulatta] 
1386396_at    Dusp8_predicted  dual specificity phosphatase 8 (predicted) 
1388000_at    Slc24a2  solute carrier family 24 (sodium/potassium/calcium exchanger), member 2 
1389864_at    ---  --- 
1390205_at    ---  --- 
1391418_at    ---  --- 
1391771_at    Atp2a2  ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 
1392157_at    Plxna2_predicted  plexin A2 (predicted) 
1393910_at    RGD1309807  similar to Fam13a1 protein 
1397194_at    Txndc13  thioredoxin domain containing 13 
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Table 2. Up-regulated genes 3 hours after GabT. Classification in four groups is determined by their sensitivity to 
APV and nifedipine. 
 
Group 1-GenesNMDA 3 h after GabT 
Up-regulated genes in GBZ and GBZ+nifedipine but not in GBZ+APV 
Affy ID Gene Symbol Gene Name 
1368146_at    Dusp1  dual specificity phosphatase 1 
1368321_at    Egr1  early growth response 1 
1368527_at    Ptgs2  prostaglandin-endoperoxide synthase 2 
1370454_at    Homer1  homer homolog 1 (Drosophila) 
1370997_at    Homer1  homer homolog 1 (Drosophila) 
1372016_at    Gadd45b  growth arrest and DNA-damage-inducible 45 beta 
1373559_at    Nptx2  neuronal pentraxin II 
1373759_at    ---  Transcribed locus 
1373807_at    ---  Transcribed locus 
1375043_at    Fos  FBJ murine osteosarcoma viral oncogene homolog 
1380383_at    Arf4l_predicted  ADP-ribosylation factor 4-like (predicted) 
1380967_at    Nts  Neurotensin 
1386935_at    Nr4a1  nuclear receptor subfamily 4, group A, member 1 
1387068_at    Arc  activity regulated cytoskeletal-associated protein 
1387219_at    Adm  Adrenomedullin 
1387306_a_at    Egr2  early growth response 2 
1387410_at    Nr4a2  nuclear receptor subfamily 4, group A, member 2 
1387442_at    Egr4  early growth response 4 
1387788_at    Junb  jun-B oncogene 
1390626_at    ---  Transcribed locus 
1392108_at    ---  RM2 mRNA, partial sequence 
1396823_at    ---  Transcribed locus 
 
Group 2-GenesL 3 h after GabT 
Up-regulated genes in GBZ and GBZ+APV but not in GBZ+nifedipine 
Affy ID Gene Symbol Gene Name 
1367973_at    Ccl2  chemokine (C-C motif) ligand 2 
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1368073_at    Irf1  interferon regulatory factor 1 
1368308_at    Myc  myelocytomatosis viral oncogene homolog (avian) 
1368489_at    Fosl1  fos-like antigen 1 
1368490_at    Cd14  CD14 antigen 
1370177_at    PVR  poliovirus receptor 
1370371_a_at   Ceacam1 /// Ceacam10  CEA-related cell adhesion molecule 1 /// CEA-related cell adhesion molecule 10 
1373403_at    LOC684871  similar to Protein C8orf4 (Thyroid cancer protein 1) (TC-1) 
1373421_at    Tgif  TG interacting factor 
1373485_at    RGD1561238_predicted  Similar to ring finger protein 122 homolog (predicted) 
1375617_at    ---  Transcribed locus 
1376908_at    Ifit3  interferon-induced protein with tetratricopeptide repeats 3 
1377092_at    ---  Transcribed locus 
1377340_at    Tfpi2  tissue factor pathway inhibitor 2 
1379365_at    Cxcl11  chemokine (C-X-C motif) ligand 11 
1379935_at    Ccl7  chemokine (C-C motif) ligand 7 
1380229_at    ---  Transcribed locus 
1384415_at    ---  Transcribed locus 
1386160_at    Thh_predicted  trichohyalin (predicted) 
1387260_at    Klf4  kruppel-like factor 4 (gut) 
1387316_at    Cxcl1  chemokine (C-X-C motif) ligand 1 
1387870_at    Zfp36  zinc finger protein 36 
1387969_at    Cxcl10  chemokine (C-X-C motif) ligand 10 
1388587_at    Ier3  immediate early response 3 
1389230_at    ---  Transcribed locus 
1397929_at    ---  Transcribed locus 
1398655_at    Myod1  myogenic differentiation 1 
 
Group 3-GenesNMDAorL 3 h after GabT 
Up-regulated genes in GBZ and GBZ+APV and GBZ+nifedipine 
Affy ID Gene Symbol Gene Name 
1368224_at    Serpina3n  serine (or cysteine) peptidase inhibitor, clade A, member 3N 
1369268_at    Atf3  activating transcription factor 3 
1369415_at    Bhlhb2  basic helix-loop-helix domain containing, class B2 
1383242_a_at   ---  Transcribed locus 
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1394948_at    ---  Transcribed locus 
 
Group 4-GenesNMDAandL 3 h after GabT 
Up-regulated genes in GBZ but neither  in GBZ+APV nor GBZ+nifedipine 
Affy ID Gene Symbol Gene Name 
1368124_at    Dusp5  dual specificity phosphatase 5 
1368223_at    Adamts1  a disintegrin-like and metallopeptidse (reprolysin type) with thrombospondin type 1 
motif, 1 
1368290_at    Cyr61  cysteine rich protein 61 
1368650_at    Klf10  kruppel-like factor 10 
1368674_at    Pygl  liver glycogen phosphorylase 
1381565_at    ---  Transcribed locus 
1382138_at    LOC499745 /// LOC688240  similar to Notch-regulated ankyrin repeat protein 
1383519_at    Hk2  hexokinase 2 
1385641_at    ---  Transcribed locus 
1388189_at    Grm3  glutamate receptor, metabotropic 3 
1389402_at    ---  Transcribed locus 
1390391_at    ---  Transcribed locus 
1393728_at    ---  Transcribed locus 
1394423_at    ---  Transcribed locus 
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The aim of my thesis was to study the network properties of dissociated 
cultures from rat hippocampus after blockage of the inhibitory synaptic pathways 
mediated by GABAA receptors. This neuronal system provides a good model of 
activity-induced changes in network properties and it allows the study of network 
functions related to neuronal plasticity. In my work I have also combined the use of 
genome-wide analysis, MEA technology and calcium imaging in order to analyze 
network functions at three main levels: transcriptional profile, network electrical 
activity and calcium dynamics. Therefore this thesis establishes a useful model for 
the study of concomitant changes at different network levels and for the investigation 
of activity-regulated changes in gene expression underlying synaptic plasticity.  
The major results consist of the integration of transcriptome, calcium 
contribution and network electrical activity profiles for a functional genomic 
approach aimed at studying activity-dependent modification of neuronal networks. In 
recent years, genome-wide analyses have been made to detect activity-regulated 
genes in neurons (Altar et al., 2004; Hong et al., 2004; Li et al., 2004; Park et al., 
2006). These studies revealed that several hundreds of genes are regulated in 
response to extracellular stimuli that change the electrical activity of the neurons. But 
the activation of this new transcriptional program seems to be complicated. In fact, 
two features of the activity-regulated transcriptional program have emerged from 
these studies: the new gene transcription can be activated through several 
mechanisms mediated principally by Ca2+, and with different kinetics.  
The first achievement of this research was the characterization of an activity-
regulated gene expression program in response to the transiently blockage of the 
GABAA receptors by pharmacological inhibitors, such as bicuculline or gabazine. In 
hippocampal dissociated neurons, blockage of GABAA receptors triggers large 
synchronous bursts of electrical activity. Interestingly, after GABAA receptor 
blockers washout, the network activity changed into a new state characterized by a 
synchronous bursting pattern of activity. Moreover, disinhibiting the network with 
gabazine was sufficient to induce long-term modification of both the evoked and 
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spontaneous activity for several hours. In fact, after pharmacological manipulation, 
the neuronal network displayed a bursting synchronous activity that persists for 
hours, up to several days. In addition, the evoked activity was potentiated for several 
hours. These features indicated that a form of plasticity was induced during 
pharmacological manipulation. Furthermore, the long-lasting changes in the 
spontaneous network activity were mediated by new gene transcription, since the 
transcription inhibitors were able to block this late component. The microarray 
technology allowed a genome-wide analysis of the gene expression changes that took 
place in the above described conditions. By using this technique I was able to verify 
that hundreds of genes were regulated. The transcriptional program activated was 
very complex. In fact, here it is also shown that, apart from the genes involved in the 
regulation of the gene transcription, a large number of genes encoding for proteins 
that have an important role in pre-synaptic or post-synaptic functions or have a 
structural role in cellular function, were regulated. The results suggest that this 
transcriptional program consists of two parts: the induction of transcription factors 
that coordinate the expression of the effector genes and the induction of genes, with a 
pre- or post-synaptic or structural role, that directly regulates the synaptic properties 
and morphological changes. Therefore, these findings indicate a complex molecular 
cascade participating in the regulation and orchestration of the plasticity changes 
induced.  
The second achievement of this work comprises the temporal dissection of the 
activity-regulated gene expression program. First we analyzed the spontaneous and 
evoked network electrical activity at different times after the pharmacological 
manipulation. Principally, we identified several sequential phases underlying this 
form of neuronal plasticity: an early component of synchronization initiated 
immediately after termination of the stimulation (E-Sync) dependent on the 
MAPK/ERK pathway, and a late component - from 6 to 24 hours - (L-Sync) 
dependent on the new gene transcription. In addition, an intermediate phase (from 1 
hour to 6 hours) was characterized by an increased in the evoked response (M-LTP). 
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Then, it was shown that also the gene expression program was dynamically regulated 
in time. In fact, the gene expression profile revealed three main clusters of genes that 
displayed a similar temporal expression profile. A first component of gene expression 
was primarily composed of transcription factors, and then a second wave of gene 
transcription was temporally associated with the potentiation of the evoked electrical 
response. Moreover, when the spontaneous electrical activity became more 
synchronous, a down-regulation of genes coding for several K+ channels appeared 
evident. The time course profiling of the activity-regulated gene expression would 
provide a mean to uncover the dynamics of molecular processes during the different 
phases emerged from the network activity. Considered all together, these results 
provide the possibility to relate specific events occurring during neuronal plasticity to 
changes of expression of specific gene clusters. Although previous works identified 
several activity-regulated genes in different models of neuronal plasticity, a 
comprehensive description of the molecular events is still incomplete. In this work, 
the concomitant analysis of the network activity and of the gene expression profile 
could provide some definitions describing the cellular and molecular events that 
underlie synaptic activity modification.  
The third achievement of this thesis consists of elucidating the diffent routes by 
which Ca2+ regulates the gene expression program activated after disinhibition. 
During the large bursts of spontaneous synchronous spikes induced by blockage of 
GABAA receptors, also large Ca2+ transients occur synchronously in the network 
neurons. The pharmacological dissection of the cytoplasmic Ca2+ concentration 
increase during these events revealed that the VGCCs, in particular L-, N- and P/Q-
type, predominated over NMDA receptors. Nevertheless, in this work it is also shown 
that Ca2+ entry through NMDA receptors mostly mediated the changes in gene 
expression.  
However, the results obtained proved that NMDA receptors were not the only 
pathway by which gene expression was regulated. In fact, also Ca2+ entry through 
VGCCs, L, N and P/Q-types, had a role in the gene expression induction. Previous 
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works demonstrated that the signalling through NMDA receptors had an important 
role in inducing and maintaining the synchronous bursting pattern of activity (Arnold 
et al., 2005). In agreement with this observation, the conclusion that can be drawn 
here is that Ca2+ entry through NMDA receptors is a key event in mediating gene 
expression, in the used model of neuronal plasticity. Moreover, the communication 
between the synapse and the nucleus was more intricated, and beside NMDA 
receptors also L, N and P/Q-types VGCCs mediated in a composite and time 
dependent way the gene expression program that coordinated each synaptic changes 
occurring in the neurons. Therefore, these results demonstrate that the complexity of 
the gene expression program activated was not only characterized by the intricate 
molecular cascade of genes expression and by their temporal regulation, but also by 
the signalling pathways that mediate their induction.  
 
In summary, these results show that this neuronal system is a good and simple 
model to study the network properties at different levels and in particular to study the 
neuronal plasticity at the network level. In addition, they also show that the activity-
regulated transcriptional program is dynamically modulated by Ca2+ ions. 
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